ENSPHENO:0000001	17-@ALPHA-HYDROXYLASE/1720-LYASE DEFICIENCY COMBINED COMPLETE	[MIM:609300.0001,MIM:609300.0001]	[CYP17A1.0001,CYP17A1.0001]
ENSPHENO:0000002	17-@ALPHA-HYDROXYLASE/1720-LYASE DEFICIENCY COMBINED PARTIAL	[]	[]
ENSPHENO:0000003	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	[MIM:264300,MIM:264300]	[17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY,17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
ENSPHENO:0000004	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	[MIM:300438,MIM:300438]	[17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY,17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY]
ENSPHENO:0000005	2-PRIME5-PRIME-@OLIGOADENYLATE SYNTHETASE 1	[MIM:164350,MIM:164350]	[2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 1,2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 1]
ENSPHENO:0000006	3-@BETA-HYDROXYSTEROID DEHYDROGENASE TYPE II DEFICIENCY OF	[MIM:201810,MIM:201810]	[3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF,3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF]
ENSPHENO:0000007	3-@KETOTHIOLASE DEFICIENCY	[MIM:607809.0001,MIM:607809.0001]	[ACAT1.0001,ACAT1.0001]
ENSPHENO:0000008	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	[MIM:210210,MIM:210210]	[3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY,3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY]
ENSPHENO:0000009	3-@METHYLGLUTACONIC ACIDURIA TYPE III	[MIM:258501,MIM:258501]	[3-@METHYLGLUTACONIC ACIDURIA, TYPE III,3-@METHYLGLUTACONIC ACIDURIA, TYPE III]
ENSPHENO:0000010	46XY GONADAL DYSGENESIS COMPLETE WITHOUT ADRENAL FAILURE	[]	[]
ENSPHENO:0000011	46XY GONADAL DYSGENESIS PARTIAL WITH MINIFASCICULAR NEUROPATHY	[MIM:607080,MIM:607080]	[46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY,46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY]
ENSPHENO:0000012	46XY SEX REVERSAL 3	[]	[]
ENSPHENO:0000013	5-@FLUOROURACIL TOXICITY	[]	[]
ENSPHENO:0000014	A breast cancer sample	[]	[]
ENSPHENO:0000015	A colon cancer sample	[]	[]
ENSPHENO:0000016	A colorectal cancer sample	[]	[]
ENSPHENO:0000017	A familial cancer not matching LFS	[]	[]
ENSPHENO:0000018	A metastatic melanoma sample	[]	[]
ENSPHENO:0000019	AB1-42	[]	[]
ENSPHENO:0000020	ABO GLYCOSYLTRANSFERASE	[MIM:110300,MIM:110300]	[ABO GLYCOSYLTRANSFERASE,ABO GLYCOSYLTRANSFERASE]
ENSPHENO:0000021	ACID ALPHA-GLUCOSIDASE ALLELE 2	[MIM:606800.0001,MIM:606800.0001]	[GAA.0001,GAA.0001]
ENSPHENO:0000022	ACRODERMATITIS ENTEROPATHICA	[DOID:0050605,DOID:0050605,MIM:607059.0001,MIM:607059.0001]	[acrodermatitis enteropathica,acrodermatitis enteropathica,SLC39A4.0001,SLC39A4.0001]
ENSPHENO:0000023	ACTH DEFICIENCY ISOLATED	[MIM:201400,MIM:201400]	[ACTH DEFICIENCY, ISOLATED,ACTH DEFICIENCY, ISOLATED]
ENSPHENO:0000024	ACTININ ALPHA-3 POLYMORPHISM	[MIM:102574.0001,MIM:102574.0001]	[ACTN3.0001,ACTN3.0001]
ENSPHENO:0000025	ADENOMATOUS POLYPOSIS COLI ATTENUATED	[]	[]
ENSPHENO:0000026	ADENOMATOUS POLYPOSIS COLI SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000027	ADIPONECTIN SERUM LEVEL OF QUANTITATIVE TRAIT LOCUS 1	[MIM:612556,MIM:612556]	[ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1,ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1]
ENSPHENO:0000028	ADRENAL HYPOPLASIA CONGENITAL	[HP:0008244,MIM:300200,MIM:300200]	[Congenital adrenal hypoplasia,ADRENAL HYPOPLASIA, CONGENITAL,ADRENAL HYPOPLASIA, CONGENITAL]
ENSPHENO:0000029	ADRENOLEUKODYSTROPHY NEONATAL	[MIM:600414.0001,MIM:600414.0001,MIM:608666.0001]	[PEX5.0001,PEX5.0001,PEX26.0001]
ENSPHENO:0000030	ADULT SYNDROME	[DOID:0050601,DOID:0050601,MIM:103285,MIM:103285]	[ADULT syndrome,ADULT syndrome,ADULT SYNDROME,ADULT SYNDROME]
ENSPHENO:0000031	AGE-RELATED HEARING IMPAIRMENT 1	[MIM:612448,MIM:612448]	[AGE-RELATED HEARING IMPAIRMENT 1,AGE-RELATED HEARING IMPAIRMENT 1]
ENSPHENO:0000032	AGE-RELATED HEARING IMPAIRMENT 2	[MIM:612976,MIM:612976]	[AGE-RELATED HEARING IMPAIRMENT 2,AGE-RELATED HEARING IMPAIRMENT 2]
ENSPHENO:0000033	AICARDI-GOUTIERES SYNDROME 1	[MIM:225750,MIM:225750]	[AICARDI-GOUTIERES SYNDROME 1,AICARDI-GOUTIERES SYNDROME 1]
ENSPHENO:0000034	AICARDI-GOUTIERES SYNDROME 2	[MIM:610181,MIM:610181]	[AICARDI-GOUTIERES SYNDROME 2,AICARDI-GOUTIERES SYNDROME 2]
ENSPHENO:0000035	AICARDI-GOUTIERES SYNDROME 3	[MIM:610329,MIM:610329]	[AICARDI-GOUTIERES SYNDROME 3,AICARDI-GOUTIERES SYNDROME 3]
ENSPHENO:0000036	AICARDI-GOUTIERES SYNDROME 4	[MIM:610333,MIM:610333]	[AICARDI-GOUTIERES SYNDROME 4,AICARDI-GOUTIERES SYNDROME 4]
ENSPHENO:0000037	AICARDI-GOUTIERES SYNDROME 5	[MIM:612952,MIM:612952]	[AICARDI-GOUTIERES SYNDROME 5,AICARDI-GOUTIERES SYNDROME 5]
ENSPHENO:0000038	AIDS	[DOID:635,DOID:635]	[acquired immunodeficiency syndrome,acquired immunodeficiency syndrome]
ENSPHENO:0000039	AIDS progression	[]	[]
ENSPHENO:0000040	ALBINISM OCULOCUTANEOUS TYPE IA	[MIM:203100,MIM:203100]	[ALBINISM, OCULOCUTANEOUS, TYPE IA,ALBINISM, OCULOCUTANEOUS, TYPE IA]
ENSPHENO:0000041	ALBUMIN	[MIM:103600,MIM:103600]	[ALBUMIN,ALBUMIN]
ENSPHENO:0000042	ALBUMIN CASEBROOK	[]	[]
ENSPHENO:0000043	ALBUMIN HIROSHIMA 1	[]	[]
ENSPHENO:0000044	ALBUMIN HONOLULU 1	[]	[]
ENSPHENO:0000045	ALBUMIN HONOLULU 2	[]	[]
ENSPHENO:0000046	ALBUMIN LAMBADI	[]	[]
ENSPHENO:0000047	ALBUMIN LARINO	[]	[]
ENSPHENO:0000048	ALBUMIN NAGASAKI 2	[]	[]
ENSPHENO:0000049	ALBUMIN PARKLANDS	[]	[]
ENSPHENO:0000050	ALCOHOL DEPENDENCE PROTECTION AGAINST	[MIM:103720.0001,MIM:103720.0001,MIM:103730.0001,MIM:103730.0001]	[ADH1B.0001,ADH1B.0001,ADH1C.0001,ADH1C.0001]
ENSPHENO:0000051	ALCOHOLISM SUSCEPTIBILITY TO	[MIM:137140.0001,MIM:137140.0001]	[GABRA2.0001,GABRA2.0001]
ENSPHENO:0000052	ALKALINE PHOSPHATASE PLASMA LEVEL OF QUANTITATIVE TRAIT LOCUS 3	[MIM:612368,MIM:612368]	[ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3,ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3]
ENSPHENO:0000053	ALLAN-HERNDON-DUDLEY SYNDROME	[DOID:0050631,DOID:0050631,MIM:300523,MIM:300523]	[Allan-Herndon-Dudley syndrome,Allan-Herndon-Dudley syndrome,ALLAN-HERNDON-DUDLEY SYNDROME,ALLAN-HERNDON-DUDLEY SYNDROME]
ENSPHENO:0000054	ALLERGIC RHINITIS	[DOID:4481,DOID:4481,HP:0003193,HP:0003193,MIM:607154,MIM:607154,SCTID_61582004,SCTID_61582004]	[allergic rhinitis,allergic rhinitis,Allergic rhinitis,Allergic rhinitis,ALLERGIC RHINITIS,ALLERGIC RHINITIS,Allergic rhinitis,Allergic rhinitis]
ENSPHENO:0000055	ALOPECIA ANDROGENETIC 3	[MIM:612421,MIM:612421]	[ALOPECIA, ANDROGENETIC, 3,ALOPECIA, ANDROGENETIC, 3]
ENSPHENO:0000056	ALPHA-MANNOSIDOSIS TYPE II	[MIM:609458.0001,MIM:609458.0001]	[MAN2B1.0001,MAN2B1.0001]
ENSPHENO:0000057	ALPORT SYNDROME X-LINKED	[MIM:301050,MIM:301050]	[ALPORT SYNDROME, X-LINKED,ALPORT SYNDROME, X-LINKED]
ENSPHENO:0000058	ALZHEIMER DISEASE 11	[MIM:609790,MIM:609790]	[ALZHEIMER DISEASE 11,ALZHEIMER DISEASE 11]
ENSPHENO:0000059	ALZHEIMER DISEASE 2	[MIM:104310,MIM:104310]	[ALZHEIMER DISEASE 2,ALZHEIMER DISEASE 2]
ENSPHENO:0000060	ALZHEIMER DISEASE FAMILIAL 1	[]	[]
ENSPHENO:0000061	ALZHEIMER DISEASE FAMILIAL 3	[MIM:104311.0001,MIM:104311.0001]	[PSEN1.0001,PSEN1.0001]
ENSPHENO:0000062	ALZHEIMER DISEASE FAMILIAL 3 WITH SPASTIC PARAPARESIS AND APRAXIA	[]	[]
ENSPHENO:0000063	AMEGAKARYOCYTIC THROMBOCYTOPENIA CONGENITAL	[MIM:604498,MIM:604498]	[AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL,AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL]
ENSPHENO:0000064	AMELOGENESIS IMPERFECTA X-LINKED 1	[MIM:300391.0001,MIM:300391.0001]	[AMELX.0001,AMELX.0001]
ENSPHENO:0000065	AMYLOID BETA A4 PRECURSOR PROTEIN	[MIM:104760,MIM:104760]	[AMYLOID BETA A4 PRECURSOR PROTEIN,AMYLOID BETA A4 PRECURSOR PROTEIN]
ENSPHENO:0000066	AMYLOIDOSIS CARDIAC AND CUTANEOUS	[]	[]
ENSPHENO:0000067	AMYLOIDOSIS FAMILIAL VISCERAL	[DOID:0050636,DOID:0050636,MIM:105200,MIM:105200]	[familial visceral amyloidosis,familial visceral amyloidosis,AMYLOIDOSIS, FAMILIAL VISCERAL,AMYLOIDOSIS, FAMILIAL VISCERAL]
ENSPHENO:0000068	AMYLOIDOSIS HEREDITARY TRANSTHYRETIN-RELATED	[DOID:0050638,DOID:0050638,MIM:105210,MIM:105210]	[transthyretin amyloidosis,transthyretin amyloidosis,AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED,AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED]
ENSPHENO:0000069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS	[]	[]
ENSPHENO:0000070	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	[]	[]
ENSPHENO:0000071	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS	[]	[]
ENSPHENO:0000072	AMYOTROPHY HEREDITARY NEURALGIC	[MIM:162100,MIM:162100]	[AMYOTROPHY, HEREDITARY NEURALGIC,AMYOTROPHY, HEREDITARY NEURALGIC]
ENSPHENO:0000073	ANALBUMINEMIA	[MP:0000199,MP:0000199]	[abnormal circulating serum albumin level,abnormal circulating serum albumin level]
ENSPHENO:0000074	ANDROGEN INSENSITIVITY PARTIAL	[MIM:312300,MIM:312300]	[ANDROGEN INSENSITIVITY, PARTIAL,ANDROGEN INSENSITIVITY, PARTIAL]
ENSPHENO:0000075	ANEMIA CONGENITAL DYSERYTHROPOIETIC TYPE I	[MIM:224120,MIM:607465.0001,SCTID_59548005]	[ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I,CDAN1.0001,Congenital dyserythropoietic anemia, type I]
ENSPHENO:0000076	ANEMIA DYSERYTHROPOIETIC CONGENITAL TYPE I	[MIM:224120,MIM:224120,SCTID_59548005]	[ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I,ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I,Congenital dyserythropoietic anemia, type I]
ENSPHENO:0000077	ANEURYSM INTRACRANIAL BERRY 1	[MIM:105800,MIM:105800]	[ANEURYSM, INTRACRANIAL BERRY, 1,ANEURYSM, INTRACRANIAL BERRY, 1]
ENSPHENO:0000078	ANEURYSM INTRACRANIAL BERRY 10	[MIM:612587,MIM:612587]	[ANEURYSM, INTRACRANIAL BERRY, 10,ANEURYSM, INTRACRANIAL BERRY, 10]
ENSPHENO:0000079	ANGIOEDEMA INDUCED BY ACE INHIBITORS SUSCEPTIBILITY TO	[MIM:300145.0001,MIM:300145.0001]	[XPNPEP2.0001,XPNPEP2.0001]
ENSPHENO:0000080	ANONYCHIA CONGENITA	[DOID:0050643,DOID:0050643,MIM:206800,MIM:206800]	[anonychia congenita,anonychia congenita,ANONYCHIA CONGENITA,ANONYCHIA CONGENITA]
ENSPHENO:0000081	APLASTIC ANEMIA	[DOID:12449,DOID:12449,HP:0001915,HP:0001915,MIM:609135,MIM:609135,SCTID_306058006,SCTID_306058006]	[aplastic anemia,aplastic anemia,Aplastic anemia,Aplastic anemia,APLASTIC ANEMIA,APLASTIC ANEMIA,Aplastic anemia,Aplastic anemia]
ENSPHENO:0000082	APOLIPOPROTEIN C-II (AUCKLAND)	[]	[]
ENSPHENO:0000083	APPARENT MINERALOCORTICOID EXCESS	[MIM:218030.0001,MIM:218030.0001]	[HSD11B2.0001,HSD11B2.0001]
ENSPHENO:0000084	ARGININOSUCCINIC ACIDURIA	[DOID:14755,DOID:14755,MIM:207900,MIM:207900]	[argininosuccinic aciduria,argininosuccinic aciduria,ARGININOSUCCINIC ACIDURIA,ARGININOSUCCINIC ACIDURIA]
ENSPHENO:0000085	AROMATASE DEFICIENCY	[MIM:613546,MIM:613546]	[AROMATASE DEFICIENCY,AROMATASE DEFICIENCY]
ENSPHENO:0000086	ARTHROGRYPOSIS RENAL DYSFUNCTION AND CHOLESTASIS 1	[MIM:208085,MIM:208085]	[ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1,ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1]
ENSPHENO:0000087	ARTS SYNDROME	[DOID:0050647,DOID:0050647,MIM:301835,MIM:301835]	[Arts syndrome,Arts syndrome,ARTS SYNDROME,ARTS SYNDROME]
ENSPHENO:0000088	ARYLSULFATASE A PSEUDODEFICIENCY	[MIM:607574.0001,MIM:607574.0001]	[ARSA.0001,ARSA.0001]
ENSPHENO:0000089	ARYLSULFATASE A PSEUDODEFICIENCY SEVERE	[]	[]
ENSPHENO:0000090	ASTHMA-RELATED TRAITS SUSCEPTIBILITY TO 6	[MIM:611403,MIM:611403]	[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6,ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6]
ENSPHENO:0000091	ATAXIA-TELANGIECTASIA WITHOUT IMMUNODEFICIENCY	[]	[]
ENSPHENO:0000092	ATOPY SUSCEPTIBILITY TO	[MIM:147781.0001,MIM:147781.0001]	[IL4R.0001,IL4R.0001]
ENSPHENO:0000093	ATRIAL FIBRILLATION FAMILIAL 5	[MIM:611494,MIM:611494]	[ATRIAL FIBRILLATION, FAMILIAL, 5,ATRIAL FIBRILLATION, FAMILIAL, 5]
ENSPHENO:0000094	ATRIAL FIBRILLATION FAMILIAL 7	[MIM:612240,MIM:612240]	[ATRIAL FIBRILLATION, FAMILIAL, 7,ATRIAL FIBRILLATION, FAMILIAL, 7]
ENSPHENO:0000095	ATRIAL FIBRILLATION FAMILIAL 8	[MIM:613055,MIM:613055]	[ATRIAL FIBRILLATION, FAMILIAL, 8,ATRIAL FIBRILLATION, FAMILIAL, 8]
ENSPHENO:0000096	ATRIAL SEPTAL DEFECT 2	[MIM:607941,MIM:607941]	[ATRIAL SEPTAL DEFECT 2,ATRIAL SEPTAL DEFECT 2]
ENSPHENO:0000097	ATYPICAL MYCOBACTERIAL INFECTION DISSEMINATED FAMILIAL	[MIM:107470.0001,MIM:147569.0001,MIM:600555.0001]	[IFNGR1.0001,IFNGR2.0001,STAT1.0001]
ENSPHENO:0000098	ATYPICAL MYCOBACTERIAL INFECTION FAMILIAL DISSEMINATED	[MIM:107470.0001,MIM:107470.0001,MIM:147569.0001,MIM:147569.0001,MIM:600555.0001,MIM:600555.0001]	[IFNGR1.0001,IFNGR1.0001,IFNGR2.0001,IFNGR2.0001,STAT1.0001,STAT1.0001]
ENSPHENO:0000099	AUTISM SUSCEPTIBILITY TO 5	[MIM:606053,MIM:606053]	[AUTISM, SUSCEPTIBILITY TO, 5,AUTISM, SUSCEPTIBILITY TO, 5]
ENSPHENO:0000100	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE IIA	[MIM:603909,MIM:603909]	[AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA,AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA]
ENSPHENO:0000101	AUTOIMMUNE THYROID DISEASE SUSCEPTIBILITY TO 2	[MIM:608174,MIM:608174]	[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2,AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000102	AXENFELD-RIEGER ANOMALY	[]	[]
ENSPHENO:0000103	Achromatopsia type 3	[]	[]
ENSPHENO:0000104	Activated partial thromboplastin time	[]	[]
ENSPHENO:0000105	Acute lymphoblastic leukemia (childhood)	[]	[]
ENSPHENO:0000106	Acyl-CoA dehydrogenase short-chain deficiency	[MIM:201470,MIM:201470]	[ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF,ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF]
ENSPHENO:0000107	Adenylosuccinase deficiency	[MIM:103050,MIM:103050]	[ADENYLOSUCCINASE DEFICIENCY,ADENYLOSUCCINASE DEFICIENCY]
ENSPHENO:0000108	Adiponectin levels	[]	[]
ENSPHENO:0000109	Adiposity	[]	[]
ENSPHENO:0000110	Adrenal hyperplasia type 3	[]	[]
ENSPHENO:0000111	Adult fetal hemoblogbin levels (HbF) by F cell levels	[]	[]
ENSPHENO:0000112	Age-related macular degeneration	[DOID:10871,DOID:10871,SCTID_267718000,SCTID_267718000]	[age related macular degeneration,age related macular degeneration,Age-related macular degeneration,Age-related macular degeneration]
ENSPHENO:0000113	Age-related macular degeneration (wet)	[]	[]
ENSPHENO:0000114	Age-related macular degeneration type 2	[]	[]
ENSPHENO:0000115	Aging (time to death)	[]	[]
ENSPHENO:0000116	Aging (time to event)	[]	[]
ENSPHENO:0000117	Aging traits	[]	[]
ENSPHENO:0000118	Alcohol consumption	[]	[]
ENSPHENO:0000119	Alcohol dependence	[MIM:103780,MIM:103780,SCTID_66590003,SCTID_66590003]	[ALCOHOL DEPENDENCE,ALCOHOL DEPENDENCE,Alcohol dependence,Alcohol dependence]
ENSPHENO:0000120	Alcoholism (alcohol dependence factor score)	[]	[]
ENSPHENO:0000121	Alcoholism (alcohol use disorder factor score)	[]	[]
ENSPHENO:0000122	Alcoholism (heaviness of drinking)	[]	[]
ENSPHENO:0000123	Alexander disease	[DOID:4252,DOID:4252,MIM:203450,MIM:203450,SCTID_81854007,SCTID_81854007]	[Alexander disease,Alexander disease,ALEXANDER DISEASE,ALEXANDER DISEASE,Alexander's disease,Alexander's disease]
ENSPHENO:0000124	Alkaptonuria	[DOID:9270,DOID:9270,MIM:203500,MIM:203500]	[alkaptonuria,alkaptonuria,ALKAPTONURIA,ALKAPTONURIA]
ENSPHENO:0000125	Alopecia universalis congenita	[DOID:0050634,DOID:0050634,MIM:203655,MIM:203655]	[alopecia universalis,alopecia universalis,ALOPECIA UNIVERSALIS CONGENITA,ALOPECIA UNIVERSALIS CONGENITA]
ENSPHENO:0000126	Alternating hemiplegia of childhood	[DOID:0050635,DOID:0050635,MIM:104290,MIM:104290,SCTID_230466004,SCTID_230466004]	[alternating hemiplegia of childhood,alternating hemiplegia of childhood,ALTERNATING HEMIPLEGIA OF CHILDHOOD,ALTERNATING HEMIPLEGIA OF CHILDHOOD,Alternating hemiplegia of childhood,Alternating hemiplegia of childhood]
ENSPHENO:0000127	Alzheimer disease type 3	[]	[]
ENSPHENO:0000128	Alzheimer's disease	[DOID:10652,DOID:10652,HP:0002511,HP:0002511,MIM:104300,MIM:104300,SCTID_26929004,SCTID_26929004]	[Alzheimer's disease,Alzheimer's disease,Alzheimer disease,Alzheimer disease,ALZHEIMER DISEASE,ALZHEIMER DISEASE,Alzheimer's disease,Alzheimer's disease]
ENSPHENO:0000129	Alzheimer's disease (late onset)	[]	[]
ENSPHENO:0000130	Alzheimer's disease biomarkers	[]	[]
ENSPHENO:0000131	Alzheimer's disease-Alzheimer's disease gender differentiated in males	[]	[]
ENSPHENO:0000132	Amyloid A Levels	[]	[]
ENSPHENO:0000133	Amyotrophic Lateral Sclerosis (ALS)	[]	[]
ENSPHENO:0000134	Amyotrophic Lateral Sclerosis (ALS)-Amyotrophic Lateral Sclerosis (ALS) bulbar onset	[]	[]
ENSPHENO:0000135	Amyotrophic lateral sclerosis	[DOID:332,DOID:332,HP:0007354,HP:0007354,SCTID_86044005,SCTID_86044005]	[amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,Amyotrophic lateral sclerosis,Amyotrophic lateral sclerosis,Amyotrophic lateral sclerosis,Amyotrophic lateral sclerosis]
ENSPHENO:0000136	Angiotensin-converting enzyme activity	[]	[]
ENSPHENO:0000137	Anorexia nervosa	[DOID:8689,DOID:8689,SCTID_56882008,SCTID_56882008]	[anorexia nervosa,anorexia nervosa,Anorexia nervosa,Anorexia nervosa]
ENSPHENO:0000138	Aortic root size	[]	[]
ENSPHENO:0000139	Argininemia	[DOID:9278,DOID:9278,MIM:207800,MIM:207800]	[hyperargininemia,hyperargininemia,ARGININEMIA,ARGININEMIA]
ENSPHENO:0000140	Arginosuccinicaciduria	[]	[]
ENSPHENO:0000141	Arthritis (juvenile idiopathic)	[]	[]
ENSPHENO:0000142	Asperger disorder	[DOID:0050432,SCTID_23560001,SCTID_23560001]	[Asperger syndrome,Asperger's disorder,Asperger's disorder]
ENSPHENO:0000143	Asthma	[DOID:2841,DOID:2841,HP:0002099,HP:0002099,SCTID_195967001,SCTID_195967001]	[asthma,asthma,Asthma,Asthma,Asthma,Asthma]
ENSPHENO:0000144	Ataxia with isolated vitamin E deficiency	[]	[]
ENSPHENO:0000145	Atelosteogenesis type 1	[]	[]
ENSPHENO:0000146	Atrial fibrillation	[HP:0005110,HP:0005110,MP:0008543,MP:0008543,MIM:121013.0001,MIM:121013.0001,SCTID_49436004,SCTID_49436004]	[Atrial fibrillation,Atrial fibrillation,atrial fibrillation,atrial fibrillation,GJA5.0001,GJA5.0001,Atrial fibrillation,Atrial fibrillation]
ENSPHENO:0000147	Atrial fibrillation/atrial flutter	[]	[]
ENSPHENO:0000148	Atrial septal defect with atrioventricular conduction defects	[MIM:108900,MIM:108900]	[ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS,ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS]
ENSPHENO:0000149	Atrioventricular conduction	[]	[]
ENSPHENO:0000150	Attention deficit hyperactivity disorder	[DOID:1094,DOID:1094,HP:0007018,HP:0007018,MIM:143465,MIM:143465,SCTID_406506008,SCTID_406506008]	[attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,Attention deficit hyperactivity disorder,Attention deficit hyperactivity disorder,ATTENTION DEFICIT-HYPERACTIVITY DISORDER,ATTENTION DEFICIT-HYPERACTIVITY DISORDER,Attention deficit hyperactivity disorder,Attention deficit hyperactivity disorder]
ENSPHENO:0000151	Attention deficit hyperactivity disorder (time to onset)	[]	[]
ENSPHENO:0000152	Attention deficit hyperactivity disorder and conduct disorder	[]	[]
ENSPHENO:0000153	Attention deficit hyperactivity disorder symptoms (interaction)	[]	[]
ENSPHENO:0000154	Autism	[DOID:12849,DOID:12849,HP:0000717,HP:0000717,MIM:209850,MIM:209850]	[autistic disorder,autistic disorder,Autism,Autism,AUTISM,AUTISM]
ENSPHENO:0000155	BARDET-BIEDL SYNDROME	[DOID:1935,DOID:1935,MIM:209900,MIM:209900,SCTID_5619004,SCTID_5619004]	[Bardet-Biedl syndrome,Bardet-Biedl syndrome,BARDET-BIEDL SYNDROME,BARDET-BIEDL SYNDROME,Bardet-Biedl syndrome,Bardet-Biedl syndrome]
ENSPHENO:0000156	BARDET-BIEDL SYNDROME 1	[MIM:209901.0001,MIM:209901.0001]	[BBS1.0001,BBS1.0001]
ENSPHENO:0000157	BARDET-BIEDL SYNDROME 3	[MIM:608845.0001,MIM:608845.0001]	[ARL6.0001,ARL6.0001]
ENSPHENO:0000158	BARDET-BIEDL SYNDROME 6	[]	[]
ENSPHENO:0000159	BARTTER SYNDROME TYPE 4A	[MIM:602522,MIM:602522]	[BARTTER SYNDROME, TYPE 4A,BARTTER SYNDROME, TYPE 4A]
ENSPHENO:0000160	BASAL CELL CARCINOMA SUSCEPTIBILITY TO 1	[MIM:605462,MIM:605462]	[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1,BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1]
ENSPHENO:0000161	BASAL CELL CARCINOMA SUSCEPTIBILITY TO 2	[MIM:613058,MIM:613058]	[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2,BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000162	BECKWITH-WIEDEMANN SYNDROME	[DOID:5572,DOID:5572,MIM:130650,MIM:130650,SCTID_81780002,SCTID_81780002]	[Beckwith-Wiedemann syndrome,Beckwith-Wiedemann syndrome,BECKWITH-WIEDEMANN SYNDROME,BECKWITH-WIEDEMANN SYNDROME,Beckwith-Wiedemann syndrome,Beckwith-Wiedemann syndrome]
ENSPHENO:0000163	BERNARD-SOULIER SYNDROME TYPE A	[MIM:606672.0001,MIM:606672.0001]	[GP1BA.0001,GP1BA.0001]
ENSPHENO:0000164	BERNARD-SOULIER SYNDROME TYPE A1	[]	[]
ENSPHENO:0000165	BERNARD-SOULIER SYNDROME TYPE C	[MIM:173515.0001,MIM:173515.0001]	[GP9.0001,GP9.0001]
ENSPHENO:0000166	BEST MACULAR DYSTROPHY	[DOID:0050661,DOID:0050661,MIM:607854.0001,MIM:607854.0001]	[vitelliform macular dystrophy,vitelliform macular dystrophy,BEST1.0001,BEST1.0001]
ENSPHENO:0000167	BETA-THALASSEMIA	[DOID:12241,DOID:12241,SCTID_65959000,SCTID_65959000]	[beta thalassemia,beta thalassemia,beta Thalassemia,beta Thalassemia]
ENSPHENO:0000168	BETA-THALASSEMIA INTERMEDIA	[SCTID_191189009,SCTID_191189009]	[Beta thalassemia intermedia,Beta thalassemia intermedia]
ENSPHENO:0000169	BETA-ZERO-THALASSEMIA	[]	[]
ENSPHENO:0000170	BIPOLAR AFFECTIVE DISORDER SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000171	BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY	[]	[]
ENSPHENO:0000172	BLAU SYNDROME	[DOID:0050678,DOID:0050678,MIM:186580,MIM:186580]	[Blau syndrome,Blau syndrome,BLAU SYNDROME,BLAU SYNDROME]
ENSPHENO:0000173	BLEPHAROPHIMOSIS PTOSIS AND EPICANTHUS INVERSUS	[MIM:110100,MIM:110100]	[BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS,BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS]
ENSPHENO:0000174	BLOOD GROUP ERIK	[MIM:111300.0001,MIM:111300.0001]	[GPA.0001,GPA.0001]
ENSPHENO:0000175	BLOOD GROUP--LUTHERAN NULL	[]	[]
ENSPHENO:0000176	BLOOD GROUP--OK	[MIM:111380,MIM:111380]	[BLOOD GROUP--OK,BLOOD GROUP--OK]
ENSPHENO:0000177	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11	[MIM:300306,MIM:300306]	[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11]
ENSPHENO:0000178	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12	[MIM:612362,MIM:612362]	[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12]
ENSPHENO:0000179	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15	[MIM:612967,MIM:612967]	[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15]
ENSPHENO:0000180	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8	[MIM:603188,MIM:603188]	[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8]
ENSPHENO:0000181	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11	[MIM:612114,MIM:612114]	[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11]
ENSPHENO:0000182	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13	[MIM:612727,MIM:612727]	[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13]
ENSPHENO:0000183	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3	[MIM:606928,MIM:606928]	[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3]
ENSPHENO:0000184	BONE MINERAL DENSITY VARIATION QUANTITATIVE TRAIT LOCUS	[]	[]
ENSPHENO:0000185	BONE MORPHOGENETIC PROTEIN 15	[MIM:300247,MIM:300247]	[BONE MORPHOGENETIC PROTEIN 15,BONE MORPHOGENETIC PROTEIN 15]
ENSPHENO:0000186	BRANCHIOOTORENAL SYNDROME 2	[MIM:610896,MIM:610896]	[BRANCHIOOTORENAL SYNDROME 2,BRANCHIOOTORENAL SYNDROME 2]
ENSPHENO:0000187	BRCA2 GENE	[MIM:600185,MIM:600185]	[BRCA2 GENE,BRCA2 GENE]
ENSPHENO:0000188	BREAST-OVARIAN CANCER FAMILIAL SUSCEPTIBILITY TO 1	[MIM:604370,MIM:604370]	[BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1]
ENSPHENO:0000189	BREAST-OVARIAN CANCER FAMILIAL SUSCEPTIBILITY TO 2	[MIM:612555,MIM:612555]	[BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000190	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	[MIM:211400,MIM:211400]	[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1]
ENSPHENO:0000191	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	[MIM:613021,MIM:613021]	[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2]
ENSPHENO:0000192	BRUNNER SYNDROME	[MIM:300615,MIM:300615]	[BRUNNER SYNDROME,BRUNNER SYNDROME]
ENSPHENO:0000193	BURKITT LYMPHOMA	[DOID:8584,DOID:8584,MIM:113970,MIM:113970,SCTID_118617000,SCTID_118617000]	[Burkitt's lymphoma,Burkitt's lymphoma,BURKITT LYMPHOMA,BURKITT LYMPHOMA,Burkitt's lymphoma,Burkitt's lymphoma]
ENSPHENO:0000194	BURULI ULCER SUSCEPTIBILITY TO	[MIM:610446,MIM:610446]	[BURULI ULCER, SUSCEPTIBILITY TO,BURULI ULCER, SUSCEPTIBILITY TO]
ENSPHENO:0000195	Basal cell carcinoma (cutaneous)	[]	[]
ENSPHENO:0000196	Benign familial neonatal seizures type 1	[]	[]
ENSPHENO:0000197	Bernard-Soulier syndrome	[DOID:2217,DOID:2217,MIM:231200,MIM:231200,SCTID_54569005,SCTID_54569005]	[Bernard-Soulier syndrome,Bernard-Soulier syndrome,BERNARD-SOULIER SYNDROME,BERNARD-SOULIER SYNDROME,Bernard Soulier syndrome,Bernard Soulier syndrome]
ENSPHENO:0000198	Biliary atresia	[DOID:13608,DOID:13608,HP:0005912,HP:0005912]	[biliary atresia,biliary atresia,Biliary duct atresia,Biliary duct atresia]
ENSPHENO:0000199	Bilirubin levels	[]	[]
ENSPHENO:0000200	Biochemical measures	[]	[]
ENSPHENO:0000201	Biomarkers-TNFa	[]	[]
ENSPHENO:0000202	Biomedical quantitative traits	[]	[]
ENSPHENO:0000203	Bipolar disorder	[DOID:3312,DOID:3312,HP:0007302,HP:0007302,SCTID_13746004,SCTID_13746004]	[bipolar disorder,bipolar disorder,Bipolar affective disorder,Bipolar affective disorder,Bipolar disorder,Bipolar disorder]
ENSPHENO:0000204	Bipolar disorder and schizophrenia	[]	[]
ENSPHENO:0000205	Bladder cancer	[DOID:11054,DOID:11054,MIM:109800,MIM:109800]	[urinary bladder cancer,urinary bladder cancer,BLADDER CANCER,BLADDER CANCER]
ENSPHENO:0000206	Blood Lipids-MeanHDL-C	[]	[]
ENSPHENO:0000207	Blood Lipids-MeanLDL-C	[]	[]
ENSPHENO:0000208	Blood Lipids-MeanTG	[]	[]
ENSPHENO:0000209	Blood Phenotypes-FVII	[]	[]
ENSPHENO:0000210	Blood Phenotypes-Fibrinogen	[]	[]
ENSPHENO:0000211	Blood Phenotypes-Hematocrit	[]	[]
ENSPHENO:0000212	Blood Phenotypes-MCH	[]	[]
ENSPHENO:0000213	Blood Phenotypes-RBCC	[]	[]
ENSPHENO:0000214	Blood Pressure and Arterial Stiffness-Arterial Stiffness	[]	[]
ENSPHENO:0000215	Blood Pressure and Arterial Stiffness-Carotid-Brachial Pulse Wave Velocity	[]	[]
ENSPHENO:0000216	Blood Pressure and Arterial Stiffness-Carotid-Femoral Pulse Wave Velocity	[]	[]
ENSPHENO:0000217	Blood Pressure and Arterial Stiffness-Diastolic Blood Pressure	[]	[]
ENSPHENO:0000218	Blood Pressure and Arterial Stiffness-Forward Wave Amplitude	[]	[]
ENSPHENO:0000219	Blood Pressure and Arterial Stiffness-Mean Artierial Pressure	[]	[]
ENSPHENO:0000220	Blood Pressure and Arterial Stiffness-Reflected Wave Amplitude	[]	[]
ENSPHENO:0000221	Blood Pressure and Arterial Stiffness-Systolic Blood Pressure	[]	[]
ENSPHENO:0000222	Blood pressure	[]	[]
ENSPHENO:0000223	Blue vs. green eyes	[]	[]
ENSPHENO:0000224	Body mass index	[MIM:606641,MIM:606641]	[BODY MASS INDEX,BODY MASS INDEX]
ENSPHENO:0000225	Bone mass and geometry-Combined Bone Mineral Density phenotypes Femoral Neck Bone Mineral Density Trochanater Bone Mineral Density Lumbar Spine Bone Mineral Density	[]	[]
ENSPHENO:0000226	Bone mass and geometry-Combined Bone Mineral Density phenotypes Femoral Neck Bone Mineral Density Trochanater Bone Mineral Density Lumbar Spine Bone Mineral Density gender differentiated in females	[]	[]
ENSPHENO:0000227	Bone mass and geometry-Femoral Neck Bone Mineral Density	[]	[]
ENSPHENO:0000228	Bone mass and geometry-Femoral Neck Bone Mineral Density gender differentiated in females	[]	[]
ENSPHENO:0000229	Bone mass and geometry-Hip geometery neck shaft angle	[]	[]
ENSPHENO:0000230	Bone mass and geometry-Hip geometry neck section modulus	[]	[]
ENSPHENO:0000231	Bone mass and geometry-Hip geometry neck section modulus gender differentiated in females	[]	[]
ENSPHENO:0000232	Bone mass and geometry-Hip geometry shaft width	[]	[]
ENSPHENO:0000233	Bone mass and geometry-Quantitative broadband ultrasound attentuation of the calcaneus	[]	[]
ENSPHENO:0000234	Bone mass and geometry-Trochanter Bone Mineral Density	[]	[]
ENSPHENO:0000235	Bone mineral density	[]	[]
ENSPHENO:0000236	Bone mineral density (hip)	[]	[]
ENSPHENO:0000237	Bone mineral density (spine)	[]	[]
ENSPHENO:0000238	Brain aging MRI and cognition phenotypes-Brain MRI Frontal Brain Volume	[]	[]
ENSPHENO:0000239	Brain aging MRI and cognition phenotypes-Brain MRI Hippocampal Volume	[]	[]
ENSPHENO:0000240	Brain aging MRI and cognition phenotypes-Brain MRI Temporal Brain Volume	[]	[]
ENSPHENO:0000241	Brain aging MRI and cognition phenotypes-Brain MRI Total Cerebral Brain Volume	[]	[]
ENSPHENO:0000242	Brain aging MRI and cognition phenotypes-Brain MRI White Matter Hyperintensity Volume	[]	[]
ENSPHENO:0000243	Brain aging MRI and cognition phenotypes-Cognitive performance Similarities	[]	[]
ENSPHENO:0000244	Brain aging MRI and cognition phenotypes-Cognitive performance Wide-Range Achievement Test	[]	[]
ENSPHENO:0000245	Brain aging MRI and cognition phenotypes-Cognitive performance attention and executive function	[]	[]
ENSPHENO:0000246	Brain aging MRI and cognition phenotypes-Cognitive performance verbal memory	[]	[]
ENSPHENO:0000247	Brain aging MRI and cognition phenotypes-Cognitive performance visual memory and organization	[]	[]
ENSPHENO:0000248	Brain imaging	[]	[]
ENSPHENO:0000249	Brain structure	[]	[]
ENSPHENO:0000250	Breast cancer	[DOID:1612,DOID:1612,HP:0003002,HP:0003002,MIM:114480,MIM:114480]	[breast cancer,breast cancer,Breast carcinoma,Breast carcinoma,BREAST CANCER,BREAST CANCER]
ENSPHENO:0000251	Bronchiectasis with or without elevated sweat chloride type 2	[]	[]
ENSPHENO:0000252	Bullous congenital ichthyosiform erythroderma	[DOID:4603,DOID:4603]	[epidermolytic hyperkeratosis,epidermolytic hyperkeratosis]
ENSPHENO:0000253	C-REACTIVE PROTEIN PENTRAXIN-RELATED	[MIM:123260,MIM:123260]	[C-REACTIVE PROTEIN, PENTRAXIN-RELATED,C-REACTIVE PROTEIN, PENTRAXIN-RELATED]
ENSPHENO:0000254	C-reactive protein	[]	[]
ENSPHENO:0000255	CAMURATI-ENGELMANN DISEASE	[DOID:4997,DOID:4997,MIM:131300,MIM:131300]	[Camurati-Engelmann disease,Camurati-Engelmann disease,CAMURATI-ENGELMANN DISEASE,CAMURATI-ENGELMANN DISEASE]
ENSPHENO:0000256	CANCER PROGRESSION AND TUMOR CELL MOTILITY	[MIM:134935.0001,MIM:134935.0001]	[FGFR4.0001,FGFR4.0001]
ENSPHENO:0000257	CANDIDIASIS FAMILIAL 4	[MIM:613108,MIM:613108]	[CANDIDIASIS, FAMILIAL, 4,CANDIDIASIS, FAMILIAL, 4]
ENSPHENO:0000258	CARDIOENCEPHALOMYOPATHY FATAL INFANTILE DUE TO CYTOCHROME c OXIDASE DEFICIENCY	[]	[]
ENSPHENO:0000259	CARDIOFACIOCUTANEOUS SYNDROME	[MIM:115150,MIM:115150,SCTID_403770008,SCTID_403770008]	[CARDIOFACIOCUTANEOUS SYNDROME,CARDIOFACIOCUTANEOUS SYNDROME,Cardio-facio-cutaneous syndrome,Cardio-facio-cutaneous syndrome]
ENSPHENO:0000260	CARDIOMYOPATHY DILATED 1M	[MIM:607482,MIM:607482]	[CARDIOMYOPATHY, DILATED, 1M,CARDIOMYOPATHY, DILATED, 1M]
ENSPHENO:0000261	CARDIOMYOPATHY DILATED 1P	[MIM:609909,MIM:609909]	[CARDIOMYOPATHY, DILATED, 1P,CARDIOMYOPATHY, DILATED, 1P]
ENSPHENO:0000262	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC	[DOID:11986,DOID:11986]	[familial hypertrophic cardiomyopathy,familial hypertrophic cardiomyopathy]
ENSPHENO:0000263	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 1	[MIM:192600,MIM:192600]	[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1,CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1]
ENSPHENO:0000264	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 10	[MIM:608758,MIM:608758]	[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10,CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10]
ENSPHENO:0000265	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 3	[MIM:115196,MIM:115196]	[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3,CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3]
ENSPHENO:0000266	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 6	[MIM:600858,MIM:600858]	[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6,CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6]
ENSPHENO:0000267	CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 7	[MIM:613690,MIM:613690]	[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7,CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7]
ENSPHENO:0000268	CARDIOMYOPATHY FAMILIAL RESTRICTIVE 1	[MIM:115210,MIM:115210]	[CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1,CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1]
ENSPHENO:0000269	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	[MIM:255120,MIM:255120,SCTID_238001003,SCTID_238001003]	[CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,Carnitine palmitoyltransferase I deficiency,Carnitine palmitoyltransferase I deficiency]
ENSPHENO:0000270	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY INFANTILE	[MIM:600649,MIM:600649]	[CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE,CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE]
ENSPHENO:0000271	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY LATE-ONSET	[MIM:255110,MIM:255110]	[CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET,CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET]
ENSPHENO:0000272	CATARACT AGE-RELATED CORTICAL 2	[MIM:613020,MIM:613020]	[CATARACT, AGE-RELATED CORTICAL, 2,CATARACT, AGE-RELATED CORTICAL, 2]
ENSPHENO:0000273	CATARACT AUTOSOMAL DOMINANT NUCLEAR	[]	[]
ENSPHENO:0000274	CATARACT POSTERIOR POLAR 1	[MIM:116600,MIM:116600]	[CATARACT, POSTERIOR POLAR, 1,CATARACT, POSTERIOR POLAR, 1]
ENSPHENO:0000275	CATARACT PROGRESSIVE POLYMORPHIC CORTICAL	[MIM:123730.0001,MIM:123730.0001]	[CRYGS.0001,CRYGS.0001]
ENSPHENO:0000276	CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM	[MIM:116790.0001,MIM:116790.0001]	[COMT.0001,COMT.0001]
ENSPHENO:0000277	CD207 ANTIGEN	[MIM:604862,MIM:604862]	[CD207 ANTIGEN,CD207 ANTIGEN]
ENSPHENO:0000278	CENANI-LENZ SYNDACTYLY SYNDROME	[MIM:212780,MIM:212780]	[CENANI-LENZ SYNDACTYLY SYNDROME,CENANI-LENZ SYNDACTYLY SYNDROME]
ENSPHENO:0000279	CENTRAL CORE DISEASE	[DOID:3529,DOID:3529,SCTID_43152001,SCTID_43152001]	[central core myopathy,central core myopathy,Central core disease,Central core disease]
ENSPHENO:0000280	CENTRAL HYPOVENTILATION SYNDROME CONGENITAL WITH HIRSCHSPRUNG DISEASE	[]	[]
ENSPHENO:0000281	CEREBELLAR ATAXIA MENTAL RETARDATION AND DYSEQUILIBRIUM SYNDROME 1	[]	[]
ENSPHENO:0000282	CEREBRAL AMYLOID ANGIOPATHY APP-RELATED DUTCH VARIANT	[MIM:104760.0001,MIM:104760.0001]	[APP.0001,APP.0001]
ENSPHENO:0000283	CEREBRAL AMYLOID ANGIOPATHY APP-RELATED ITALIAN VARIANT	[]	[]
ENSPHENO:0000284	CEREBRAL ARTERIOPATHY AUTOSOMAL DOMINANT WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	[SCTID_390936003]	[Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy]
ENSPHENO:0000285	CEROID LIPOFUSCINOSIS NEURONAL 5	[MIM:256731,MIM:256731]	[CEROID LIPOFUSCINOSIS, NEURONAL, 5,CEROID LIPOFUSCINOSIS, NEURONAL, 5]
ENSPHENO:0000286	CHAR SYNDROME	[MIM:169100,MIM:169100]	[CHAR SYNDROME,CHAR SYNDROME]
ENSPHENO:0000287	CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2A2	[MIM:609260,MIM:609260]	[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2,CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2]
ENSPHENO:0000288	CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2B1	[MIM:605588,MIM:605588]	[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1,CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1]
ENSPHENO:0000289	CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2E	[MIM:607684,MIM:607684]	[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E,CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E]
ENSPHENO:0000290	CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2F	[MIM:606595,MIM:606595]	[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F,CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F]
ENSPHENO:0000291	CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	[MIM:601097.0001,MIM:601097.0001]	[PMP22.0001,PMP22.0001]
ENSPHENO:0000292	CHARCOT-MARIE-TOOTH DISEASE TYPE 4B1	[MIM:601382,MIM:601382]	[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1,CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1]
ENSPHENO:0000293	CHARCOT-MARIE-TOOTH DISEASE TYPE 4C	[MIM:601596,MIM:601596]	[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C,CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C]
ENSPHENO:0000294	CHARCOT-MARIE-TOOTH DISEASE TYPE 4J	[MIM:611228,MIM:611228]	[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J,CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J]
ENSPHENO:0000295	CHARCOT-MARIE-TOOTH DISEASE X-LINKED DOMINANT	[MIM:304040.0001,MIM:304040.0001]	[GJB1.0001,GJB1.0001]
ENSPHENO:0000296	CHARCOT-MARIE-TOOTH DISEASE X-LINKED DOMINANT 1	[MIM:302800,MIM:302800]	[CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1,CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1]
ENSPHENO:0000297	CHARCOT-MARIE-TOOTH DISEASE X-LINKED RECESSIVE 5	[MIM:311070,MIM:311070]	[CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5,CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5]
ENSPHENO:0000298	CHEDIAK-HIGASHI SYNDROME ADULT TYPE	[]	[]
ENSPHENO:0000299	CHIARI MALFORMATION TYPE I	[MIM:118420,MIM:118420,SCTID_253185002,SCTID_253185002]	[CHIARI MALFORMATION TYPE I,CHIARI MALFORMATION TYPE I,Chiari malformation type I,Chiari malformation type I]
ENSPHENO:0000300	CHILD SYNDROME	[MIM:300275.0001,MIM:300275.0001,SCTID_17608003,SCTID_17608003]	[NSDHL.0001,NSDHL.0001,Child syndrome,Child syndrome]
ENSPHENO:0000301	CHOLESTASIS INTRAHEPATIC OF PREGNANCY	[MIM:147480,MIM:147480]	[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY,CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY]
ENSPHENO:0000302	CHOLINERGIC RECEPTOR NEURONAL NICOTINIC ALPHA POLYPEPTIDE 4	[MIM:118504,MIM:118504]	[CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4,CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4]
ENSPHENO:0000303	CHONDRODYSPLASIA PUNCTATA 2 X-LINKED DOMINANT	[MIM:302960,MIM:302960]	[CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT,CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT]
ENSPHENO:0000304	CHOROIDAL DYSTROPHY CENTRAL AREOLAR 2	[MIM:613105,MIM:613105]	[CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2,CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2]
ENSPHENO:0000305	CHROMOSOME 6q24-q25 DELETION SYNDROME	[MIM:612863,MIM:612863]	[CHROMOSOME 6q24-q25 DELETION SYNDROME,CHROMOSOME 6q24-q25 DELETION SYNDROME]
ENSPHENO:0000306	CILIARY DYSKINESIA PRIMARY 11	[MIM:612649,MIM:612649]	[CILIARY DYSKINESIA, PRIMARY, 11,CILIARY DYSKINESIA, PRIMARY, 11]
ENSPHENO:0000307	CITRULLINEMIA TYPE II ADULT-ONSET	[MIM:603471,MIM:603471]	[CITRULLINEMIA, TYPE II, ADULT-ONSET,CITRULLINEMIA, TYPE II, ADULT-ONSET]
ENSPHENO:0000308	CITRULLINEMIA TYPE II NEONATAL-ONSET	[MIM:605814,MIM:605814]	[CITRULLINEMIA, TYPE II, NEONATAL-ONSET,CITRULLINEMIA, TYPE II, NEONATAL-ONSET]
ENSPHENO:0000309	CLEIDOCRANIAL DYSPLASIA	[DOID:13994,DOID:13994,MIM:119600,MIM:119600]	[cleidocranial dysplasia,cleidocranial dysplasia,CLEIDOCRANIAL DYSPLASIA,CLEIDOCRANIAL DYSPLASIA]
ENSPHENO:0000310	COCKAYNE SYNDROME TYPE A	[MIM:216400,MIM:216400]	[COCKAYNE SYNDROME, TYPE A,COCKAYNE SYNDROME, TYPE A]
ENSPHENO:0000311	CODON 72 POLYMORPHISM ({dbSNP rs1042522})	[]	[]
ENSPHENO:0000312	COENZYME Q10 DEFICIENCY	[MIM:607426,MIM:607426]	[COENZYME Q10 DEFICIENCY,COENZYME Q10 DEFICIENCY]
ENSPHENO:0000313	COLD-INDUCED SWEATING SYNDROME 2	[MIM:610313,MIM:610313]	[COLD-INDUCED SWEATING SYNDROME 2,COLD-INDUCED SWEATING SYNDROME 2]
ENSPHENO:0000314	COLON CANCER SOMATIC	[MIM:600925.0001,MIM:600925.0001]	[PTPRJ.0001,PTPRJ.0001]
ENSPHENO:0000315	COLORECTAL CANCER HEREDITARY NONPOLYPOSIS TYPE 2	[MIM:609310,MIM:609310]	[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2,COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2]
ENSPHENO:0000316	COLORECTAL CANCER SUSCEPTIBILITY TO 2	[MIM:611469,MIM:611469]	[COLORECTAL CANCER, SUSCEPTIBILITY TO, 2,COLORECTAL CANCER, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000317	COLORECTAL CANCER SUSCEPTIBILITY TO 6	[MIM:612231,MIM:612231]	[COLORECTAL CANCER, SUSCEPTIBILITY TO, 6,COLORECTAL CANCER, SUSCEPTIBILITY TO, 6]
ENSPHENO:0000318	COLORECTAL CANCER SUSCEPTIBILITY TO 7	[MIM:612232,MIM:612232]	[COLORECTAL CANCER, SUSCEPTIBILITY TO, 7,COLORECTAL CANCER, SUSCEPTIBILITY TO, 7]
ENSPHENO:0000319	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5	[MIM:611719,MIM:611719]	[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5]
ENSPHENO:0000320	CONE DYSTROPHY 3	[MIM:602093,MIM:602093]	[CONE DYSTROPHY 3,CONE DYSTROPHY 3]
ENSPHENO:0000321	CONE-ROD DYSTROPHY 2	[MIM:120970,MIM:120970]	[CONE-ROD DYSTROPHY 2,CONE-ROD DYSTROPHY 2]
ENSPHENO:0000322	CONE-ROD DYSTROPHY 5	[MIM:600977,MIM:600977]	[CONE-ROD DYSTROPHY 5,CONE-ROD DYSTROPHY 5]
ENSPHENO:0000323	CONE-ROD DYSTROPHY 6	[MIM:601777,MIM:601777]	[CONE-ROD DYSTROPHY 6,CONE-ROD DYSTROPHY 6]
ENSPHENO:0000324	CONGENITAL CATARACTS FACIAL DYSMORPHISM AND NEUROPATHY	[MIM:604168,MIM:604168]	[CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY,CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY]
ENSPHENO:0000325	CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIa	[MIM:212066,MIM:212066]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa]
ENSPHENO:0000326	CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ia	[MIM:212065,MIM:212065]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia]
ENSPHENO:0000327	CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ib	[MIM:602579,MIM:602579]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib]
ENSPHENO:0000328	CONGENITAL DISORDER OF GLYCOSYLATION TYPE If	[MIM:609180,MIM:609180]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If]
ENSPHENO:0000329	CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ik	[MIM:608540,MIM:608540]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik]
ENSPHENO:0000330	CONGENITAL DISORDER OF GLYCOSYLATION TYPE In	[MIM:612015,MIM:612015]	[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In,CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In]
ENSPHENO:0000331	CORNEAL DYSTROPHY CONGENITAL STROMAL	[MIM:610048,MIM:610048]	[CORNEAL DYSTROPHY, CONGENITAL STROMAL,CORNEAL DYSTROPHY, CONGENITAL STROMAL]
ENSPHENO:0000332	CORNEAL DYSTROPHY CRYSTALLINE OF SCHNYDER	[MIM:121800,MIM:121800,SCTID_420212002]	[CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER,CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER,Schnyder crystalline corneal dystrophy]
ENSPHENO:0000333	CORNELIA DE LANGE SYNDROME 1	[MIM:122470,MIM:122470]	[CORNELIA DE LANGE SYNDROME 1,CORNELIA DE LANGE SYNDROME 1]
ENSPHENO:0000334	CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA PROTECTION AGAINST	[]	[]
ENSPHENO:0000335	COWDEN-LIKE SYNDROME	[MIM:612359,MIM:612359]	[COWDEN-LIKE SYNDROME,COWDEN-LIKE SYNDROME]
ENSPHENO:0000336	CRANIOMETAPHYSEAL DYSPLASIA AUTOSOMAL DOMINANT	[MIM:123000,MIM:123000]	[CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT,CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT]
ENSPHENO:0000337	CRIGLER-NAJJAR SYNDROME TYPE I	[MIM:191740.0001,MIM:191740.0001,SCTID_8933000,SCTID_8933000]	[UGT1A1.0001,UGT1A1.0001,Crigler-Najjar syndrome, type I,Crigler-Najjar syndrome, type I]
ENSPHENO:0000338	CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIA	[MIM:219200,MIM:219200]	[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA,CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA]
ENSPHENO:0000339	CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIA;	[MIM:219200,MIM:219200]	[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA,CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA]
ENSPHENO:0000340	CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIB	[MIM:612940,MIM:612940]	[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB,CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB]
ENSPHENO:0000341	CVD outcomes-Atrial Fibrillation	[]	[]
ENSPHENO:0000342	CVD outcomes-Cardiovascular Disease including Myocardial Infarction Coronary Insufficiency CHD death Atherothrombotic stroke	[]	[]
ENSPHENO:0000343	CVD outcomes-Coronary Heart Disease including Myocardial Infarction Coronary Insufficiency CHD death	[]	[]
ENSPHENO:0000344	CYP2E1*5B ALLELE	[MIM:124040.0001,MIM:124040.0001]	[CYP2E1.0001,CYP2E1.0001]
ENSPHENO:0000345	CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR	[MIM:602421,MIM:602421]	[CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR,CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR]
ENSPHENO:0000346	CYSTINOSIS NEPHROPATHIC	[MIM:219800,MIM:219800]	[CYSTINOSIS, NEPHROPATHIC,CYSTINOSIS, NEPHROPATHIC]
ENSPHENO:0000347	CYSTINURIA	[DOID:9266,DOID:9266,HP:0003131,HP:0003131,MIM:220100,MIM:220100,SCTID_85020001,SCTID_85020001]	[cystinuria,cystinuria,Cystinuria,Cystinuria,CYSTINURIA,CYSTINURIA,Cystinuria,Cystinuria]
ENSPHENO:0000348	Ca/Tu ALLOANTIGEN POLYMORPHISM	[]	[]
ENSPHENO:0000349	Canavan disease	[DOID:3613,DOID:3613,MIM:271900,MIM:271900]	[Canavan disease,Canavan disease,CANAVAN DISEASE,CANAVAN DISEASE]
ENSPHENO:0000350	Cancer breast cancer and prostate cancer-Breast cancer	[]	[]
ENSPHENO:0000351	Cancer breast cancer and prostate cancer-Prostate cancer	[]	[]
ENSPHENO:0000352	Cannabis dependence	[DOID:1849,DOID:1849,SCTID_85005007,SCTID_85005007]	[cannabis dependence,cannabis dependence,Cannabis dependence,Cannabis dependence]
ENSPHENO:0000353	Cardiac hypertrophy	[MP:0001625,MP:0001625]	[cardiac hypertrophy,cardiac hypertrophy]
ENSPHENO:0000354	Cardiac repolarization (QT interval)	[]	[]
ENSPHENO:0000355	Cardiomyopathy dilated type 1A	[]	[]
ENSPHENO:0000356	Cardiomyopathy dilated type 1M	[]	[]
ENSPHENO:0000357	Cardiomyopathy familial hypertrophic type 1	[]	[]
ENSPHENO:0000358	Cardiomyopathy familial hypertrophic type 4	[]	[]
ENSPHENO:0000359	Cardiomyopathy familial hypertrophic with Wolff-Parkinson-White syndrome	[]	[]
ENSPHENO:0000360	Cardiovascular disease risk factors	[]	[]
ENSPHENO:0000361	Carotid atherosclerosis in HIV infection	[]	[]
ENSPHENO:0000362	Celiac disease	[DOID:10608,DOID:10608,HP:0002608,HP:0002608,MIM:212750,MIM:212750,SCTID_396331005,SCTID_396331005]	[celiac disease,celiac disease,Celiac disease,Celiac disease,CELIAC DISEASE,CELIAC DISEASE,Celiac disease,Celiac disease]
ENSPHENO:0000363	Celiac disease and Rheumatoid arthritis	[]	[]
ENSPHENO:0000364	Central core disease of muscle	[MIM:117000,MIM:117000]	[CENTRAL CORE DISEASE OF MUSCLE,CENTRAL CORE DISEASE OF MUSCLE]
ENSPHENO:0000365	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy	[SCTID_390936003,SCTID_390936003]	[Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy,Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy]
ENSPHENO:0000366	Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy	[]	[]
ENSPHENO:0000367	Chanarin-Dorfman syndrome	[MIM:275630,MIM:275630]	[CHANARIN-DORFMAN SYNDROME,CHANARIN-DORFMAN SYNDROME]
ENSPHENO:0000368	Charcot-Marie-Tooth disease type 2A2	[]	[]
ENSPHENO:0000369	Charcot-Marie-Tooth disease type 2E	[]	[]
ENSPHENO:0000370	Chediak-Higashi syndrome	[DOID:2935,DOID:2935,MIM:214500,MIM:214500]	[Chediak-Higashi syndrome,Chediak-Higashi syndrome,CHEDIAK-HIGASHI SYNDROME,CHEDIAK-HIGASHI SYNDROME]
ENSPHENO:0000371	Cherubism	[DOID:1856,DOID:1856,MIM:118400,MIM:118400,SCTID_53432004,SCTID_53432004]	[cherubism,cherubism,CHERUBISM,CHERUBISM,Cherubism,Cherubism]
ENSPHENO:0000372	Childhood asthma	[SCTID_233678006,SCTID_233678006]	[Childhood asthma,Childhood asthma]
ENSPHENO:0000373	Childhood asthma-ORMDL3 Gene Expression QTL for childhood asthma	[]	[]
ENSPHENO:0000374	Cholesterol total	[]	[]
ENSPHENO:0000375	Chronic granulomatous disease autosomal recessive cytochrome-b-negative	[MIM:233690,MIM:233690]	[GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE,GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE]
ENSPHENO:0000376	Chronic kidney disease	[]	[]
ENSPHENO:0000377	Chronic lymphocytic leukemia	[DOID:1040,DOID:1040,HP:0005550,HP:0005550,MIM:151400]	[chronic lymphocytic leukemia,chronic lymphocytic leukemia,Chronic lymphatic leukemia,Chronic lymphatic leukemia,LEUKEMIA, CHRONIC LYMPHOCYTIC]
ENSPHENO:0000378	Chronic obstructive pulmonary disease	[DOID:3083,DOID:3083,HP:0006510,HP:0006510,MIM:606963]	[chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,Chronic obstructive pulmonary disease,Chronic obstructive pulmonary disease,PULMONARY DISEASE, CHRONIC OBSTRUCTIVE]
ENSPHENO:0000379	Coffee consumption	[]	[]
ENSPHENO:0000380	Cognitive performance	[]	[]
ENSPHENO:0000381	Cognitive test performance	[]	[]
ENSPHENO:0000382	Colorectal cancer	[DOID:9256,DOID:9256,MIM:114500,MIM:114500]	[colorectal cancer,colorectal cancer,COLORECTAL CANCER,COLORECTAL CANCER]
ENSPHENO:0000383	Common traits (Other)	[]	[]
ENSPHENO:0000384	Conduct disorder (case status)	[]	[]
ENSPHENO:0000385	Conduct disorder (interaction)	[]	[]
ENSPHENO:0000386	Conduct disorder (symptom count)	[]	[]
ENSPHENO:0000387	Cone-rod dystrophy type 3	[]	[]
ENSPHENO:0000388	Congenital disorder of glycosylation type 1K	[]	[]
ENSPHENO:0000389	Congenital erythropoietic porphyria	[MIM:263700,SCTID_22935002,SCTID_22935002]	[PORPHYRIA, CONGENITAL ERYTHROPOIETIC,Congenital erythropoietic porphyria,Congenital erythropoietic porphyria]
ENSPHENO:0000390	Congenital hypothyroidism non-goitrous type 5	[]	[]
ENSPHENO:0000391	Coronary Artery Disease	[HP:0001677,HP:0001677,MP:0003024,MP:0003024,SCTID_414024009]	[Coronary artery disease,Coronary artery disease,coronary artery stenosis,coronary artery stenosis,Disorder of coronary artery]
ENSPHENO:0000392	Coronary heart disease	[DOID:3393,DOID:3393]	[coronary heart disease,coronary heart disease]
ENSPHENO:0000393	Coronary spasm-Coronary spasm gender differentiated in women	[]	[]
ENSPHENO:0000394	Coumarin resistance	[MIM:122700,MIM:122700]	[COUMARIN RESISTANCE,COUMARIN RESISTANCE]
ENSPHENO:0000395	Craniofrontonasal syndrome	[DOID:14737,DOID:14737,MIM:304110,MIM:304110]	[craniofrontonasal syndrome,craniofrontonasal syndrome,CRANIOFRONTONASAL SYNDROME,CRANIOFRONTONASAL SYNDROME]
ENSPHENO:0000396	Craniometaphyseal dysplasia Jackson type	[]	[]
ENSPHENO:0000397	Crigler-Najjar syndrome type 2	[]	[]
ENSPHENO:0000398	Crohn's disease	[DOID:8778,DOID:8778,HP:0100280,HP:0100280,SCTID_34000006,SCTID_34000006]	[Crohn's disease,Crohn's disease,Crohn's disease,Crohn's disease,Crohn's disease,Crohn's disease]
ENSPHENO:0000399	Crohn's disease and Celiac disease	[]	[]
ENSPHENO:0000400	Crouzon syndrome with acanthosis nigricans	[MIM:612247,MIM:612247]	[CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS,CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS]
ENSPHENO:0000401	Cryptorchidism	[DOID:11383,DOID:11383,HP:0000028,HP:0000028,MP:0002286,MP:0002286,MIM:146738.0001,MIM:146738.0001,MIM:606655.0001,MIM:606655.0001]	[cryptorchidism,cryptorchidism,Cryptorchidism,Cryptorchidism,cryptorchism,cryptorchism,INSL3.0001,INSL3.0001,LGR8.0001,LGR8.0001]
ENSPHENO:0000402	Cystic fibrosis	[DOID:1485,DOID:1485,MIM:219700,MIM:219700,SCTID_190905008,SCTID_190905008]	[cystic fibrosis,cystic fibrosis,CYSTIC FIBROSIS,CYSTIC FIBROSIS,Cystic fibrosis,Cystic fibrosis]
ENSPHENO:0000403	Cystic fibrosis severity	[]	[]
ENSPHENO:0000404	D-dimer levels	[]	[]
ENSPHENO:0000405	DAOA ANTISENSE RNA	[MIM:607415,MIM:607415]	[DAOA ANTISENSE RNA,DAOA ANTISENSE RNA]
ENSPHENO:0000406	DEAFNESS AUTOSOMAL DOMINANT 2A	[MIM:600101,MIM:600101]	[DEAFNESS, AUTOSOMAL DOMINANT 2A,DEAFNESS, AUTOSOMAL DOMINANT 2A]
ENSPHENO:0000407	DEAFNESS AUTOSOMAL DOMINANT 2B	[MIM:612644,MIM:612644]	[DEAFNESS, AUTOSOMAL DOMINANT 2B,DEAFNESS, AUTOSOMAL DOMINANT 2B]
ENSPHENO:0000408	DEAFNESS AUTOSOMAL DOMINANT 3A	[MIM:601544,MIM:601544]	[DEAFNESS, AUTOSOMAL DOMINANT 3A,DEAFNESS, AUTOSOMAL DOMINANT 3A]
ENSPHENO:0000409	DEAFNESS AUTOSOMAL DOMINANT 4	[MIM:600652,MIM:600652]	[DEAFNESS, AUTOSOMAL DOMINANT 4,DEAFNESS, AUTOSOMAL DOMINANT 4]
ENSPHENO:0000410	DEAFNESS AUTOSOMAL DOMINANT 47	[MIM:608652,MIM:608652]	[DEAFNESS, AUTOSOMAL DOMINANT 47,DEAFNESS, AUTOSOMAL DOMINANT 47]
ENSPHENO:0000411	DEAFNESS AUTOSOMAL DOMINANT 6	[MIM:600965,MIM:600965]	[DEAFNESS, AUTOSOMAL DOMINANT 6,DEAFNESS, AUTOSOMAL DOMINANT 6]
ENSPHENO:0000412	DEAFNESS AUTOSOMAL DOMINANT WITHOUT VESTIBULAR INVOLVEMENT	[]	[]
ENSPHENO:0000413	DEAFNESS AUTOSOMAL RECESSIVE 1A	[MIM:220290,MIM:220290]	[DEAFNESS, AUTOSOMAL RECESSIVE 1A,DEAFNESS, AUTOSOMAL RECESSIVE 1A]
ENSPHENO:0000414	DEAFNESS AUTOSOMAL RECESSIVE 29	[MIM:605608.0001,MIM:605608.0001]	[CLDN14.0001,CLDN14.0001]
ENSPHENO:0000415	DEAFNESS AUTOSOMAL RECESSIVE 9	[MIM:601071,MIM:601071]	[DEAFNESS, AUTOSOMAL RECESSIVE 9,DEAFNESS, AUTOSOMAL RECESSIVE 9]
ENSPHENO:0000416	DEAFNESS X-LINKED 2	[MIM:304400,MIM:304400]	[DEAFNESS, X-LINKED 2,DEAFNESS, X-LINKED 2]
ENSPHENO:0000417	DEJERINE-SOTTAS NEUROPATHY AUTOSOMAL RECESSIVE	[MIM:605725.0001,MIM:605725.0001]	[PRX.0001,PRX.0001]
ENSPHENO:0000418	DEMENTIA FRONTOTEMPORAL WITH PARKINSONISM	[MIM:157140.0001,MIM:157140.0001]	[MAPT.0001,MAPT.0001]
ENSPHENO:0000419	DIABETES INSIPIDUS NEPHROGENIC AUTOSOMAL RECESSIVE	[MIM:107777.0001,MIM:107777.0001]	[AQP2.0001,AQP2.0001]
ENSPHENO:0000420	DIABETES INSIPIDUS NEPHROGENIC X-LINKED	[MIM:304800,MIM:304800]	[DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED,DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED]
ENSPHENO:0000421	DIABETES MELLITUS INSULIN-DEPENDENT 5	[MIM:600320,MIM:600320]	[DIABETES MELLITUS, INSULIN-DEPENDENT, 5,DIABETES MELLITUS, INSULIN-DEPENDENT, 5]
ENSPHENO:0000422	DIABETES MELLITUS NONINSULIN-DEPENDENT	[DOID:9352,DOID:9352,HP:0005978,HP:0005978,MIM:125853,MIM:125853]	[type 2 diabetes mellitus,type 2 diabetes mellitus,Type II diabetes mellitus,Type II diabetes mellitus,DIABETES MELLITUS, NONINSULIN-DEPENDENT,DIABETES MELLITUS, NONINSULIN-DEPENDENT]
ENSPHENO:0000423	DIABETES MELLITUS NONINSULIN-DEPENDENT SUSCEPTIBILITY TO	[MIM:173335.0001,MIM:173335.0001,MIM:602228.0001,MIM:602228.0001,MIM:605286.0001,MIM:605286.0001,MIM:605565.0001,MIM:605565.0001,MIM:608289.0001,MIM:608289.0001,MIM:611145.0001,MIM:611145.0001,MIM:611259.0001,MIM:611259.0001]	[ENPP1.0001,ENPP1.0001,TCF7L2.0001,TCF7L2.0001,CAPN10.0001,CAPN10.0001,RETN.0001,RETN.0001,IGF2BP2.0001,IGF2BP2.0001,SLC30A8.0001,SLC30A8.0001,CDKAL1.0001,CDKAL1.0001]
ENSPHENO:0000424	DIABETES MELLITUS PERMANENT NEONATAL	[MIM:606176,MIM:606176]	[DIABETES MELLITUS, PERMANENT NEONATAL,DIABETES MELLITUS, PERMANENT NEONATAL]
ENSPHENO:0000425	DIABETES MELLITUS PERMANENT NEONATAL WITH NEUROLOGIC FEATURES	[]	[]
ENSPHENO:0000426	DIABETES MELLITUS TRANSIENT NEONATAL 1	[MIM:601410,MIM:601410]	[DIABETES MELLITUS, TRANSIENT NEONATAL, 1,DIABETES MELLITUS, TRANSIENT NEONATAL, 1]
ENSPHENO:0000427	DIARRHEA 2 WITH MICROVILLUS ATROPHY	[MIM:251850,MIM:251850]	[DIARRHEA 2, WITH MICROVILLUS ATROPHY,DIARRHEA 2, WITH MICROVILLUS ATROPHY]
ENSPHENO:0000428	DISRUPTED IN SCHIZOPHRENIA 1	[MIM:605210,MIM:605210]	[DISRUPTED IN SCHIZOPHRENIA 1,DISRUPTED IN SCHIZOPHRENIA 1]
ENSPHENO:0000429	DONOHUE SYNDROME	[DOID:0050470,DOID:0050470,MIM:246200,MIM:246200]	[Donohue Syndrome,Donohue Syndrome,DONOHUE SYNDROME,DONOHUE SYNDROME]
ENSPHENO:0000430	DYSLEXIA SUSCEPTIBILITY TO 2	[MIM:600202,MIM:600202]	[DYSLEXIA, SUSCEPTIBILITY TO, 2,DYSLEXIA, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000431	DYSTONIA 1 TORSION MODIFIER OF	[]	[]
ENSPHENO:0000432	DYSTONIA 12	[MIM:128235,MIM:128235]	[DYSTONIA 12,DYSTONIA 12]
ENSPHENO:0000433	Deafness autosomal dominant type 2A	[]	[]
ENSPHENO:0000434	Deafness autosomal dominant type 3A	[]	[]
ENSPHENO:0000435	Deafness autosomal dominant type 6	[]	[]
ENSPHENO:0000436	Depression--quantitative trait	[]	[]
ENSPHENO:0000437	Diabetes related insulin traits	[]	[]
ENSPHENO:0000438	Diabetic nephropathy	[]	[]
ENSPHENO:0000439	Diabetic retinopathy	[DOID:8947,DOID:8947,SCTID_4855003,SCTID_4855003]	[diabetic retinopathy,diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy]
ENSPHENO:0000440	Dialysis-related mortality	[]	[]
ENSPHENO:0000441	Diastolic blood pressure	[]	[]
ENSPHENO:0000442	Digit length ratio	[]	[]
ENSPHENO:0000443	Dilated cardiomyopathy	[DOID:12930,DOID:12930,HP:0001644,HP:0001644,MP:0002795,MP:0002795]	[dilated cardiomyopathy,dilated cardiomyopathy,Dilated cardiomyopathy,Dilated cardiomyopathy,dilated cardiomyopathy,dilated cardiomyopathy]
ENSPHENO:0000444	Distal arthrogryposis type 2B	[MIM:601680]	[ARTHROGRYPOSIS, DISTAL, TYPE 2B]
ENSPHENO:0000445	Distal renal tubular acidosis with preserved hearing	[]	[]
ENSPHENO:0000446	Drug-induced liver injury (flucloxacillin)	[]	[]
ENSPHENO:0000447	ECG and HR variability-Heart rate variability - SDNN - standard deviation of normal RR intervals	[]	[]
ENSPHENO:0000448	ECG and HR variability-Heart rate variability - TP - total power	[]	[]
ENSPHENO:0000449	ECG and HR variability-PR interval length	[]	[]
ENSPHENO:0000450	ECG and HR variability-QT interval length	[]	[]
ENSPHENO:0000451	ECG and HR variability-RR interval length	[]	[]
ENSPHENO:0000452	ECG dimensions brachial artery endothelial function treadmill exercise responses-Aortic root diameter	[]	[]
ENSPHENO:0000453	ECG dimensions brachial artery endothelial function treadmill exercise responses-Baseline brachial artery diameter	[]	[]
ENSPHENO:0000454	ECG dimensions brachial artery endothelial function treadmill exercise responses-Brachial artery flow-mediated dilation percent	[]	[]
ENSPHENO:0000455	ECG dimensions brachial artery endothelial function treadmill exercise responses-Brachial artery hyperemic flow velocity	[]	[]
ENSPHENO:0000456	ECG dimensions brachial artery endothelial function treadmill exercise responses-LV diastolic dimension	[]	[]
ENSPHENO:0000457	ECG dimensions brachial artery endothelial function treadmill exercise responses-LV systolic dimension	[]	[]
ENSPHENO:0000458	ECG dimensions brachial artery endothelial function treadmill exercise responses-LV wall thickness	[]	[]
ENSPHENO:0000459	ECG dimensions brachial artery endothelial function treadmill exercise responses-Left atrial diameter	[]	[]
ENSPHENO:0000460	ECG dimensions brachial artery endothelial function treadmill exercise responses-Mean Exercise Treadmill Test phenotypes	[]	[]
ENSPHENO:0000461	ECG dimensions brachial artery endothelial function treadmill exercise responses-Mean LV phenotypes	[]	[]
ENSPHENO:0000462	ECG dimensions brachial artery endothelial function treadmill exercise responses-Post-exercise 3 minute recovery systolic blood pressure	[]	[]
ENSPHENO:0000463	ECG dimensions brachial artery endothelial function treadmill exercise responses-Stage 2 exercise heart rate	[]	[]
ENSPHENO:0000464	ECTODERMAL DYSPLASIA ANHIDROTIC AUTOSOMAL RECESSIVE	[MIM:606603.0001,MIM:606603.0001]	[EDARADD.0001,EDARADD.0001]
ENSPHENO:0000465	ECTODERMAL DYSPLASIA HYPOHIDROTIC AUTOSOMAL DOMINANT	[MIM:129490,MIM:129490]	[ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT,ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT]
ENSPHENO:0000466	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	[MIM:613573,MIM:613573]	[ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1]
ENSPHENO:0000467	EHLERS-DANLOS SYNDROME AUTOSOMAL RECESSIVE CARDIAC VALVULAR FORM	[MIM:225320,MIM:225320]	[EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM,EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM]
ENSPHENO:0000468	EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE	[MIM:601776,MIM:601776]	[EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE,EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE]
ENSPHENO:0000469	EHLERS-DANLOS SYNDROME TYPE IV	[MIM:120180.0001,MIM:120180.0001]	[COL3A1.0001,COL3A1.0001]
ENSPHENO:0000470	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4	[MIM:612998,MIM:612998]	[EMERY-DREIFUSS MUSCULAR DYSTROPHY 4,EMERY-DREIFUSS MUSCULAR DYSTROPHY 4]
ENSPHENO:0000471	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5	[MIM:612999,MIM:612999]	[EMERY-DREIFUSS MUSCULAR DYSTROPHY 5,EMERY-DREIFUSS MUSCULAR DYSTROPHY 5]
ENSPHENO:0000472	EMERY-DREIFUSS MUSCULAR DYSTROPHY ATYPICAL AUTOSOMAL RECESSIVE	[]	[]
ENSPHENO:0000473	EMERY-DREIFUSS MUSCULAR DYSTROPHY AUTOSOMAL DOMINANT	[MIM:181350,MIM:181350]	[EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT,EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT]
ENSPHENO:0000474	ENDOMETRIAL CANCER	[DOID:1380,DOID:1380,MIM:608089,MIM:608089]	[endometrial cancer,endometrial cancer,ENDOMETRIAL CANCER,ENDOMETRIAL CANCER]
ENSPHENO:0000475	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	[MIM:603034,MIM:603034]	[ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY,ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY]
ENSPHENO:0000476	ENHANCED S-CONE SYNDROME	[MIM:268100,MIM:268100]	[ENHANCED S-CONE SYNDROME,ENHANCED S-CONE SYNDROME]
ENSPHENO:0000477	EPIDERMOLYSIS BULLOSA JUNCTIONAL HERLITZ TYPE	[MIM:226700,MIM:226700]	[EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE,EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE]
ENSPHENO:0000478	EPIDERMOLYSIS BULLOSA SIMPLEX AUTOSOMAL RECESSIVE	[MIM:601001,MIM:601001]	[EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE,EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE]
ENSPHENO:0000479	EPIDERMOLYSIS BULLOSA SIMPLEX DOWLING-MEARA TYPE	[MIM:131760,MIM:131760]	[EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE,EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE]
ENSPHENO:0000480	EPIDERMOLYSIS BULLOSA SIMPLEX GENERALIZED	[MIM:131900,MIM:131900,SCTID_90496008]	[EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED,EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED,Generalized epidermolysis bullosa simplex]
ENSPHENO:0000481	EPIDERMOLYSIS BULLOSA SIMPLEX LOCALIZED	[MIM:131800,MIM:131800]	[EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED,EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED]
ENSPHENO:0000482	EPIDERMOLYSIS BULLOSA SIMPLEX OGNA TYPE	[MIM:131950,MIM:131950,SCTID_398071000,SCTID_398071000]	[EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE,EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE,Epidermolysis bullosa simplex, Ogna type,Epidermolysis bullosa simplex, Ogna type]
ENSPHENO:0000483	EPIDERMOLYTIC HYPERKERATOSIS	[DOID:4603,DOID:4603,HP:0007475,HP:0007475,MIM:113800,MIM:113800]	[epidermolytic hyperkeratosis,epidermolytic hyperkeratosis,Epidermolytic hyperkeratosis,Epidermolytic hyperkeratosis,EPIDERMOLYTIC HYPERKERATOSIS,EPIDERMOLYTIC HYPERKERATOSIS]
ENSPHENO:0000484	EPILEPSY CHILDHOOD ABSENCE SUSCEPTIBILITY TO 6	[MIM:611942,MIM:611942]	[EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6,EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6]
ENSPHENO:0000485	EPILEPSY IDIOPATHIC GENERALIZED SUSCEPTIBILITY TO	[MIM:154270.0001,MIM:154270.0001]	[dbSNP rs649224.0001,dbSNP rs649224.0001]
ENSPHENO:0000486	EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 7	[MIM:613720,MIM:613720]	[EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7,EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7]
ENSPHENO:0000487	EPISODIC ATAXIA TYPE 2	[MIM:108500,MIM:108500,SCTID_420932006,SCTID_420932006]	[EPISODIC ATAXIA, TYPE 2,EPISODIC ATAXIA, TYPE 2,Episodic ataxia type 2,Episodic ataxia type 2]
ENSPHENO:0000488	EPOXIDE HYDROLASE POLYMORPHISM	[]	[]
ENSPHENO:0000489	ERYTHERMALGIA PRIMARY	[MIM:133020,MIM:133020]	[ERYTHERMALGIA, PRIMARY,ERYTHERMALGIA, PRIMARY]
ENSPHENO:0000490	ERYTHROCYTOSIS FAMILIAL 1	[MIM:133100,MIM:133100]	[ERYTHROCYTOSIS, FAMILIAL, 1,ERYTHROCYTOSIS, FAMILIAL, 1]
ENSPHENO:0000491	ERYTHROCYTOSIS FAMILIAL 3	[MIM:609820,MIM:609820]	[ERYTHROCYTOSIS, FAMILIAL, 3,ERYTHROCYTOSIS, FAMILIAL, 3]
ENSPHENO:0000492	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	[MIM:133200,MIM:133200]	[ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA]
ENSPHENO:0000493	ESTROGEN RECEPTOR 2	[MIM:601663,MIM:601663]	[ESTROGEN RECEPTOR 2,ESTROGEN RECEPTOR 2]
ENSPHENO:0000494	EXFOLIATION SYNDROME SUSCEPTIBILITY TO	[MIM:153456.0001,MIM:153456.0001]	[LOXL1.0001,LOXL1.0001]
ENSPHENO:0000495	EXOCRINE PANCREATIC INSUFFICIENCY DYSERYTHROPOIETIC ANEMIA AND CALVARIAL HYPEROSTOSIS	[]	[]
ENSPHENO:0000496	EXOSTOSES MULTIPLE TYPE I	[MIM:133700,MIM:133700]	[EXOSTOSES, MULTIPLE, TYPE I,EXOSTOSES, MULTIPLE, TYPE I]
ENSPHENO:0000497	EXUDATIVE VITREORETINOPATHY 1	[MIM:133780,MIM:133780]	[EXUDATIVE VITREORETINOPATHY 1,EXUDATIVE VITREORETINOPATHY 1]
ENSPHENO:0000498	EXUDATIVE VITREORETINOPATHY 2 X-LINKED	[MIM:305390,MIM:305390]	[EXUDATIVE VITREORETINOPATHY 2, X-LINKED,EXUDATIVE VITREORETINOPATHY 2, X-LINKED]
ENSPHENO:0000499	EXUDATIVE VITREORETINOPATHY 4	[MIM:601813,MIM:601813]	[EXUDATIVE VITREORETINOPATHY 4,EXUDATIVE VITREORETINOPATHY 4]
ENSPHENO:0000500	EXUDATIVE VITREORETINOPATHY 4 AUTOSOMAL DOMINANT	[]	[]
ENSPHENO:0000501	EXUDATIVE VITREORETINOPATHY 4 AUTOSOMAL RECESSIVE	[]	[]
ENSPHENO:0000502	Early onset extreme obesity	[]	[]
ENSPHENO:0000503	Echocardiographic traits	[]	[]
ENSPHENO:0000504	Electrocardiographic conduction measures	[]	[]
ENSPHENO:0000505	Electrocardiographic traits	[]	[]
ENSPHENO:0000506	Emery-Dreifuss muscular dystrophy type 2	[]	[]
ENSPHENO:0000507	Entorhinal cortical thickness	[]	[]
ENSPHENO:0000508	Eosinophilic esophagitis (pediatric)	[]	[]
ENSPHENO:0000509	Epidermolysis bullosa simplex Dowling-Meara type	[MIM:131760,MIM:131760]	[EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE,EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE]
ENSPHENO:0000510	Epidermolysis bullosa simplex Koebner type	[]	[]
ENSPHENO:0000511	Epidermolysis bullosa simplex Weber-Cockayne type	[]	[]
ENSPHENO:0000512	Episodic ataxia type 2	[MIM:108500,MIM:108500,SCTID_420932006,SCTID_420932006]	[EPISODIC ATAXIA, TYPE 2,EPISODIC ATAXIA, TYPE 2,Episodic ataxia type 2,Episodic ataxia type 2]
ENSPHENO:0000513	Erectile dysfunction and prostate cancer treatment	[]	[]
ENSPHENO:0000514	Erythrocyte sedimentation rate	[]	[]
ENSPHENO:0000515	Esophageal cancer	[DOID:5041,DOID:5041,MIM:133239,MIM:133239]	[esophageal cancer,esophageal cancer,ESOPHAGEAL CANCER,ESOPHAGEAL CANCER]
ENSPHENO:0000516	Esophageal cancer and gastric cancer	[]	[]
ENSPHENO:0000517	Event-related brain oscillations	[]	[]
ENSPHENO:0000518	Exercise treadmill test traits	[]	[]
ENSPHENO:0000519	Eye color	[]	[]
ENSPHENO:0000520	F-cell distribution	[]	[]
ENSPHENO:0000521	FABRY DISEASE CARDIAC VARIANT	[]	[]
ENSPHENO:0000522	FACTOR VII-ACTIVATING PROTEASE MARBURG I	[MIM:603924.0001,MIM:603924.0001]	[HABP2.0001,HABP2.0001]
ENSPHENO:0000523	FAMILIAL ADENOMATOUS POLYPOSIS 1 ATTENUATED	[]	[]
ENSPHENO:0000524	FAMILIAL ADENOMATOUS POLYPOSIS 1 SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000525	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	[MIM:120100,MIM:120100]	[FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1]
ENSPHENO:0000526	FAMILIAL MEDITERRANEAN FEVER	[DOID:2987,DOID:2987,MIM:249100,MIM:249100,SCTID_12579009,SCTID_12579009]	[familial Mediterranean fever,familial Mediterranean fever,FAMILIAL MEDITERRANEAN FEVER,FAMILIAL MEDITERRANEAN FEVER,Familial Mediterranean fever,Familial Mediterranean fever]
ENSPHENO:0000527	FANCONI ANEMIA COMPLEMENTATION GROUP C	[MIM:227645,MIM:227645]	[FANCONI ANEMIA, COMPLEMENTATION GROUP C,FANCONI ANEMIA, COMPLEMENTATION GROUP C]
ENSPHENO:0000528	FANCONI ANEMIA COMPLEMENTATION GROUP D1	[MIM:605724,MIM:605724]	[FANCONI ANEMIA, COMPLEMENTATION GROUP D1,FANCONI ANEMIA, COMPLEMENTATION GROUP D1]
ENSPHENO:0000529	FANCONI ANEMIA COMPLEMENTATION GROUP N	[MIM:610832,MIM:610832]	[FANCONI ANEMIA, COMPLEMENTATION GROUP N,FANCONI ANEMIA, COMPLEMENTATION GROUP N]
ENSPHENO:0000530	FANCONI RENOTUBULAR SYNDROME 2	[MIM:613388,MIM:613388]	[FANCONI RENOTUBULAR SYNDROME 2,FANCONI RENOTUBULAR SYNDROME 2]
ENSPHENO:0000531	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1	[MIM:612108,MIM:612108]	[FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1]
ENSPHENO:0000532	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2	[MIM:613219,MIM:613219]	[FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2]
ENSPHENO:0000533	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5	[MIM:613463,MIM:613463]	[FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5]
ENSPHENO:0000534	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5	[MIM:142335,MIM:142335]	[FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5]
ENSPHENO:0000535	FH FRENCH CANADIAN 2	[]	[]
ENSPHENO:0000536	FH KUWAIT	[]	[]
ENSPHENO:0000537	FIBROBLAST GROWTH FACTOR 20	[MIM:605558,MIM:605558]	[FIBROBLAST GROWTH FACTOR 20,FIBROBLAST GROWTH FACTOR 20]
ENSPHENO:0000538	FINGERS RELATIVE LENGTH OF	[MIM:136100,MIM:136100]	[FINGERS, RELATIVE LENGTH OF,FINGERS, RELATIVE LENGTH OF]
ENSPHENO:0000539	FMO3 ACTIVITY DECREASED	[]	[]
ENSPHENO:0000540	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	[MIM:603965,MIM:603965]	[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2]
ENSPHENO:0000541	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4 SUSCEPTIBILITY TO	[MIM:612551,MIM:612551]	[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO]
ENSPHENO:0000542	FORKHEAD BOX J1	[MIM:602291,MIM:602291]	[FORKHEAD BOX J1,FORKHEAD BOX J1]
ENSPHENO:0000543	FORKHEAD BOX O3A	[MIM:602681,MIM:602681]	[FORKHEAD BOX O3A,FORKHEAD BOX O3A]
ENSPHENO:0000544	FRASER SYNDROME	[MIM:219000,MIM:219000]	[FRASER SYNDROME,FRASER SYNDROME]
ENSPHENO:0000545	FRIEDREICH ATAXIA	[DOID:12705,DOID:12705,MIM:606829.0001,MIM:606829.0001,SCTID_10394003,SCTID_10394003]	[Friedreich ataxia,Friedreich ataxia,FXN.0001,FXN.0001,Friedreich's ataxia,Friedreich's ataxia]
ENSPHENO:0000546	FRONTOTEMPORAL DEMENTIA	[DOID:9255,DOID:9255,HP:0002145,HP:0002145,MIM:600274,MIM:600274,SCTID_230270009,SCTID_230270009]	[frontotemporal dementia,frontotemporal dementia,Frontotemporal dementia,Frontotemporal dementia,FRONTOTEMPORAL DEMENTIA,FRONTOTEMPORAL DEMENTIA,Frontotemporal dementia,Frontotemporal dementia]
ENSPHENO:0000547	FRONTOTEMPORAL DEMENTIA CHROMOSOME 3-LINKED	[MIM:600795,MIM:600795]	[FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED,FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED]
ENSPHENO:0000548	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	[MIM:138945.0001,MIM:138945.0001]	[GRN.0001,GRN.0001]
ENSPHENO:0000549	FUCOSIDOSIS	[DOID:14500,DOID:14500,MIM:230000,MIM:230000,SCTID_64716005,SCTID_64716005]	[fucosidosis,fucosidosis,FUCOSIDOSIS,FUCOSIDOSIS,Fucosidosis,Fucosidosis]
ENSPHENO:0000550	FUCOSYLTRANSFERASE 2	[MIM:182100,MIM:182100]	[FUCOSYLTRANSFERASE 2,FUCOSYLTRANSFERASE 2]
ENSPHENO:0000551	FUNDUS ALBIPUNCTATUS AUTOSOMAL RECESSIVE	[MIM:601617.0001,MIM:601617.0001]	[RDH5.0001,RDH5.0001]
ENSPHENO:0000552	FYVE RhoGEF AND PH DOMAIN-CONTAINING PROTEIN 6	[MIM:613520,MIM:613520]	[FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6,FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6]
ENSPHENO:0000553	Fabry disease	[DOID:14499,DOID:14499,MIM:301500,MIM:301500,SCTID_16652001,SCTID_16652001]	[Fabry disease,Fabry disease,FABRY DISEASE,FABRY DISEASE,Fabry's disease,Fabry's disease]
ENSPHENO:0000554	Factor XI deficiency	[DOID:2229,DOID:2229,HP:0001929,HP:0001929,MIM:612416,MIM:612416]	[factor XI deficiency,factor XI deficiency,Factor XI deficiency,Factor XI deficiency,FACTOR XI DEFICIENCY,FACTOR XI DEFICIENCY]
ENSPHENO:0000555	Familial Mediterranean fever autosomal dominant	[MIM:134610,MIM:134610]	[FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT,FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT]
ENSPHENO:0000556	Familial Mediterranean fever autosomal recessive	[]	[]
ENSPHENO:0000557	Familial arrhythmogenic right ventricular dysplasia type 8	[]	[]
ENSPHENO:0000558	Familial hypercholesterolemia	[DOID:13810,DOID:13810,SCTID_398036000,SCTID_398036000]	[familial hypercholesterolemia,familial hypercholesterolemia,Familial hypercholesterolemia,Familial hypercholesterolemia]
ENSPHENO:0000559	Familial hyperproinsulinemia	[]	[]
ENSPHENO:0000560	Familial juvenile hyperuricemic nephropathy type 1	[]	[]
ENSPHENO:0000561	Familial multiple endocrine neoplasia type I	[]	[]
ENSPHENO:0000562	Familial partial lipodystrophy type 2	[MIM:151660]	[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2]
ENSPHENO:0000563	Fanconi anemia	[DOID:13636,DOID:13636,MIM:227650,MIM:227650,SCTID_30575002,SCTID_30575002]	[Fanconi's anemia,Fanconi's anemia,FANCONI ANEMIA,FANCONI ANEMIA,Fanconi's anemia,Fanconi's anemia]
ENSPHENO:0000564	Fasting plasma glucose	[]	[]
ENSPHENO:0000565	Fetal hemoglobin levels	[]	[]
ENSPHENO:0000566	Folate pathway vitamin levels	[]	[]
ENSPHENO:0000567	Freckles	[HP:0001480]	[Freckling]
ENSPHENO:0000568	Freckling	[HP:0001480,HP:0001480]	[Freckling,Freckling]
ENSPHENO:0000569	Fundus flavimaculatus	[SCTID_47673003,SCTID_47673003]	[Fundus flavimaculatus,Fundus flavimaculatus]
ENSPHENO:0000570	G6PD MEDITERRANEAN	[]	[]
ENSPHENO:0000571	G6PD ORISSA	[]	[]
ENSPHENO:0000572	GALACTOKINASE DEFICIENCY	[DOID:14695,DOID:14695,MIM:230200,MIM:230200,SCTID_124302001]	[galactokinase deficiency,galactokinase deficiency,GALACTOKINASE DEFICIENCY,GALACTOKINASE DEFICIENCY,Deficiency of galactokinase]
ENSPHENO:0000573	GAUCHER DISEASE TYPE I	[MIM:230800,MIM:230800]	[GAUCHER DISEASE, TYPE I,GAUCHER DISEASE, TYPE I]
ENSPHENO:0000574	GC1/GC2 POLYMORPHISM	[MIM:139200.0001,MIM:139200.0001]	[GC.0001,GC.0001]
ENSPHENO:0000575	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS	[DOID:0060170,DOID:0060170,MIM:604233,MIM:604233]	[generalized epilepsy with febrile seizures plus,generalized epilepsy with febrile seizures plus,GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS,GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS]
ENSPHENO:0000576	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS TYPE 1	[]	[]
ENSPHENO:0000577	GERSTMANN-STRAUSSLER DISEASE	[DOID:4249,DOID:4249,MIM:137440,MIM:137440]	[Gerstmann-Straussler-Scheinker disease,Gerstmann-Straussler-Scheinker disease,GERSTMANN-STRAUSSLER DISEASE,GERSTMANN-STRAUSSLER DISEASE]
ENSPHENO:0000578	GLAUCOMA 1 OPEN ANGLE A	[MIM:137750,MIM:137750]	[GLAUCOMA 1, OPEN ANGLE, A,GLAUCOMA 1, OPEN ANGLE, A]
ENSPHENO:0000579	GLAUCOMA 1 OPEN ANGLE F	[MIM:603383,MIM:603383]	[GLAUCOMA 1, OPEN ANGLE, F,GLAUCOMA 1, OPEN ANGLE, F]
ENSPHENO:0000580	GLIOMA SUSCEPTIBILITY 5	[MIM:613030,MIM:613030]	[GLIOMA SUSCEPTIBILITY 5,GLIOMA SUSCEPTIBILITY 5]
ENSPHENO:0000581	GLIOMA SUSCEPTIBILITY 6	[MIM:613031,MIM:613031]	[GLIOMA SUSCEPTIBILITY 6,GLIOMA SUSCEPTIBILITY 6]
ENSPHENO:0000582	GLUCOCORTICOID DEFICIENCY 1	[MIM:202200,MIM:202200]	[GLUCOCORTICOID DEFICIENCY 1,GLUCOCORTICOID DEFICIENCY 1]
ENSPHENO:0000583	GLUT1 DEFICIENCY SYNDROME 1	[MIM:606777,MIM:606777]	[GLUT1 DEFICIENCY SYNDROME 1,GLUT1 DEFICIENCY SYNDROME 1]
ENSPHENO:0000584	GLUTAMINE DEFICIENCY CONGENITAL	[MIM:610015,MIM:610015]	[GLUTAMINE DEFICIENCY, CONGENITAL,GLUTAMINE DEFICIENCY, CONGENITAL]
ENSPHENO:0000585	GLUTARIC ACIDEMIA I	[MIM:231670,MIM:231670]	[GLUTARIC ACIDEMIA I,GLUTARIC ACIDEMIA I]
ENSPHENO:0000586	GLUTARIC ACIDEMIA IIB	[]	[]
ENSPHENO:0000587	GLUTARIC ACIDURIA IIB	[MIM:130410.0001,MIM:130410.0001]	[ETFB.0001,ETFB.0001]
ENSPHENO:0000588	GLYCOGEN STORAGE DISEASE III	[DOID:2748,DOID:2748,MIM:232400,MIM:232400]	[glycogen storage disease III,glycogen storage disease III,GLYCOGEN STORAGE DISEASE III,GLYCOGEN STORAGE DISEASE III]
ENSPHENO:0000589	GLYCOGEN STORAGE DISEASE IV COMBINED HEPATIC AND MYOPATHIC	[]	[]
ENSPHENO:0000590	GLYCOGEN STORAGE DISEASE IXb	[MIM:261750,MIM:261750]	[GLYCOGEN STORAGE DISEASE IXb,GLYCOGEN STORAGE DISEASE IXb]
ENSPHENO:0000591	GLYCOGEN STORAGE DISEASE Ia	[MIM:232200,MIM:232200]	[GLYCOGEN STORAGE DISEASE Ia,GLYCOGEN STORAGE DISEASE Ia]
ENSPHENO:0000592	GLYCOGEN STORAGE DISEASE Ib	[MIM:232220,MIM:232220]	[GLYCOGEN STORAGE DISEASE Ib,GLYCOGEN STORAGE DISEASE Ib]
ENSPHENO:0000593	GLYCOGEN STORAGE DISEASE VI	[DOID:2754,DOID:2754,MIM:232700,MIM:232700]	[glycogen storage disease VI,glycogen storage disease VI,GLYCOGEN STORAGE DISEASE VI,GLYCOGEN STORAGE DISEASE VI]
ENSPHENO:0000594	GLYCOGEN STORAGE DISEASE X	[MIM:261670,MIM:261670]	[GLYCOGEN STORAGE DISEASE X,GLYCOGEN STORAGE DISEASE X]
ENSPHENO:0000595	GM1-GANGLIOSIDOSIS TYPE I	[MIM:230500,MIM:230500]	[GM1-GANGLIOSIDOSIS, TYPE I,GM1-GANGLIOSIDOSIS, TYPE I]
ENSPHENO:0000596	GM2-GANGLIOSIDOSIS LATE ONSET	[]	[]
ENSPHENO:0000597	GM2-gangliosidosis type 1	[]	[]
ENSPHENO:0000598	GRANULOMATOUS DISEASE CHRONIC AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE	[MIM:233690,MIM:233690]	[GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE,GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE]
ENSPHENO:0000599	GRAVES DISEASE SUSCEPTIBILITY TO 4	[]	[]
ENSPHENO:0000600	GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES	[]	[]
ENSPHENO:0000601	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	[MIM:612736,MIM:612736,SCTID_124239003]	[GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY,GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY,Deficiency of guanidinoacetate methyltransferase]
ENSPHENO:0000602	Galactosialidosis	[MIM:256540,MIM:256540]	[GALACTOSIALIDOSIS,GALACTOSIALIDOSIS]
ENSPHENO:0000603	Gallstone disease	[]	[]
ENSPHENO:0000604	Gaucher disease	[DOID:1926,DOID:1926]	[Gaucher's disease,Gaucher's disease]
ENSPHENO:0000605	Gaucher disease type 1	[]	[]
ENSPHENO:0000606	General cognitive ability	[]	[]
ENSPHENO:0000607	Generalized thyroid hormone resistance	[SCTID_237560005,SCTID_237560005]	[Generalized thyroid hormone resistance,Generalized thyroid hormone resistance]
ENSPHENO:0000608	Gilbert syndrome	[DOID:2739,DOID:2739,MIM:143500,MIM:143500,SCTID_27503000,SCTID_27503000]	[Gilbert syndrome,Gilbert syndrome,GILBERT SYNDROME,GILBERT SYNDROME,Gilbert's syndrome,Gilbert's syndrome]
ENSPHENO:0000609	Glaucoma	[DOID:1686,DOID:1686,HP:0000501,HP:0000501,SCTID_23986001,SCTID_23986001]	[glaucoma,glaucoma,Glaucoma,Glaucoma,Glaucoma,Glaucoma]
ENSPHENO:0000610	Glaucoma (exfoliation)	[]	[]
ENSPHENO:0000611	Glaucoma (primary open-angle)	[]	[]
ENSPHENO:0000612	Glaucoma-Exfoliation glaucoma	[]	[]
ENSPHENO:0000613	Glioma	[DOID:3070,DOID:3070,HP:0009733,HP:0009733]	[malignant glioma,malignant glioma,Glioma,Glioma]
ENSPHENO:0000614	Glioma (high-grade)	[]	[]
ENSPHENO:0000615	Glutamate formiminotransferase deficiency	[MIM:606806.0001,MIM:606806.0001,SCTID_59761008,SCTID_59761008]	[FTCD.0001,FTCD.0001,Glutamate formiminotransferase deficiency,Glutamate formiminotransferase deficiency]
ENSPHENO:0000616	Glycated hemoglobin levels	[]	[]
ENSPHENO:0000617	Glycogen storage disease type 1A	[]	[]
ENSPHENO:0000618	Graves' disease	[DOID:12361,DOID:12361,HP:0100647,HP:0100647,MIM:275000,MIM:275000,SCTID_353295004,SCTID_353295004]	[Graves' disease,Graves' disease,Graves disease,Graves disease,GRAVES DISEASE,GRAVES DISEASE,Graves' disease,Graves' disease]
ENSPHENO:0000619	HBG1 POLYMORPHISM	[MIM:142200.0001,MIM:142200.0001]	[HBG1.0001,HBG1.0001]
ENSPHENO:0000620	HDL cholesterol	[]	[]
ENSPHENO:0000621	HEARING LOSS NOISE-INDUCED SUSCEPTIBILITY TO	[MIM:613035,MIM:613035]	[HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO,HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO]
ENSPHENO:0000622	HEMOCHROMATOSIS TYPE 2A	[MIM:602390,MIM:602390]	[HEMOCHROMATOSIS, TYPE 2A,HEMOCHROMATOSIS, TYPE 2A]
ENSPHENO:0000623	HEMOCHROMATOSIS TYPE 2B	[MIM:613313,MIM:613313]	[HEMOCHROMATOSIS, TYPE 2B,HEMOCHROMATOSIS, TYPE 2B]
ENSPHENO:0000624	HEMOCHROMATOSIS TYPE 3	[MIM:604250,MIM:604250]	[HEMOCHROMATOSIS, TYPE 3,HEMOCHROMATOSIS, TYPE 3]
ENSPHENO:0000625	HEMOCHROMATOSIS TYPE 4	[MIM:606069,MIM:606069]	[HEMOCHROMATOSIS, TYPE 4,HEMOCHROMATOSIS, TYPE 4]
ENSPHENO:0000626	HEMOGLOBIN A(2) LUCANIA	[]	[]
ENSPHENO:0000627	HEMOGLOBIN A(2) NYU	[]	[]
ENSPHENO:0000628	HEMOGLOBIN A(2) ZAGREB	[]	[]
ENSPHENO:0000629	HEMOGLOBIN ALESHA	[]	[]
ENSPHENO:0000630	HEMOGLOBIN ALTDORF	[]	[]
ENSPHENO:0000631	HEMOGLOBIN ANAMOSA	[]	[]
ENSPHENO:0000632	HEMOGLOBIN ATHENS-GEORGIA	[]	[]
ENSPHENO:0000633	HEMOGLOBIN BETHESDA	[]	[]
ENSPHENO:0000634	HEMOGLOBIN BRIE COMTE ROBERT	[]	[]
ENSPHENO:0000635	HEMOGLOBIN BRISTOL	[]	[]
ENSPHENO:0000636	HEMOGLOBIN BRYN MAWR	[]	[]
ENSPHENO:0000637	HEMOGLOBIN BURKE	[]	[]
ENSPHENO:0000638	HEMOGLOBIN BUSHWICK	[]	[]
ENSPHENO:0000639	HEMOGLOBIN CAEN	[]	[]
ENSPHENO:0000640	HEMOGLOBIN CAMPERDOWN	[]	[]
ENSPHENO:0000641	HEMOGLOBIN CASTILLA	[]	[]
ENSPHENO:0000642	HEMOGLOBIN CHAROLLES	[]	[]
ENSPHENO:0000643	HEMOGLOBIN CHRISTCHURCH	[]	[]
ENSPHENO:0000644	HEMOGLOBIN CONSTANT SPRING	[MIM:141850.0001,MIM:141850.0001]	[HBA2.0001,HBA2.0001]
ENSPHENO:0000645	HEMOGLOBIN DARTMOUTH	[]	[]
ENSPHENO:0000646	HEMOGLOBIN DEBROUSSE	[]	[]
ENSPHENO:0000647	HEMOGLOBIN DUINO	[]	[]
ENSPHENO:0000648	HEMOGLOBIN E	[]	[]
ENSPHENO:0000649	HEMOGLOBIN F (CARLTON)	[]	[]
ENSPHENO:0000650	HEMOGLOBIN F (DAMMAM)	[]	[]
ENSPHENO:0000651	HEMOGLOBIN F (MACEDONIA II)	[]	[]
ENSPHENO:0000652	HEMOGLOBIN F (MARIETTA)	[]	[]
ENSPHENO:0000653	HEMOGLOBIN F (ONODA)	[]	[]
ENSPHENO:0000654	HEMOGLOBIN F (PORDENONE)	[]	[]
ENSPHENO:0000655	HEMOGLOBIN F (PORTO TORRES)	[]	[]
ENSPHENO:0000656	HEMOGLOBIN F (SARDINIA)	[]	[]
ENSPHENO:0000657	HEMOGLOBIN F (SIENA)	[]	[]
ENSPHENO:0000658	HEMOGLOBIN F (TEXAS I)	[]	[]
ENSPHENO:0000659	HEMOGLOBIN F (VICTORIA JUBILEE)	[]	[]
ENSPHENO:0000660	HEMOGLOBIN F (WAYNESBORO)	[]	[]
ENSPHENO:0000661	HEMOGLOBIN F (YAMAGUCHI)	[]	[]
ENSPHENO:0000662	HEMOGLOBIN FUKUYAMA	[]	[]
ENSPHENO:0000663	HEMOGLOBIN G (COPENHAGEN)	[]	[]
ENSPHENO:0000664	HEMOGLOBIN G (FERRARA)	[]	[]
ENSPHENO:0000665	HEMOGLOBIN G (HONOLULU)	[]	[]
ENSPHENO:0000666	HEMOGLOBIN GRANGE-BLANCHE	[]	[]
ENSPHENO:0000667	HEMOGLOBIN HAMADAN	[]	[]
ENSPHENO:0000668	HEMOGLOBIN HAMMERSMITH	[]	[]
ENSPHENO:0000669	HEMOGLOBIN HOWICK	[]	[]
ENSPHENO:0000670	HEMOGLOBIN ICARIA	[]	[]
ENSPHENO:0000671	HEMOGLOBIN J (BUDA)	[]	[]
ENSPHENO:0000672	HEMOGLOBIN J (CHICAGO)	[]	[]
ENSPHENO:0000673	HEMOGLOBIN J (EUROPA)	[]	[]
ENSPHENO:0000674	HEMOGLOBIN J (IRAN)	[]	[]
ENSPHENO:0000675	HEMOGLOBIN J (RAMBAM)	[]	[]
ENSPHENO:0000676	HEMOGLOBIN J (SICILIA)	[]	[]
ENSPHENO:0000677	HEMOGLOBIN J (TAICHUNG)	[]	[]
ENSPHENO:0000678	HEMOGLOBIN J (TONGARIKI)	[]	[]
ENSPHENO:0000679	HEMOGLOBIN JAMAICA PLAIN	[]	[]
ENSPHENO:0000680	HEMOGLOBIN JOHNSTOWN	[]	[]
ENSPHENO:0000681	HEMOGLOBIN KOCHI	[]	[]
ENSPHENO:0000682	HEMOGLOBIN LA DESIRADE	[]	[]
ENSPHENO:0000683	HEMOGLOBIN LINKOPING	[]	[]
ENSPHENO:0000684	HEMOGLOBIN M (SASKATOON)	[]	[]
ENSPHENO:0000685	HEMOGLOBIN MAPUTO	[]	[]
ENSPHENO:0000686	HEMOGLOBIN MEDICINE LAKE	[]	[]
ENSPHENO:0000687	HEMOGLOBIN MELUSINE	[]	[]
ENSPHENO:0000688	HEMOGLOBIN MONTEFIORE	[]	[]
ENSPHENO:0000689	HEMOGLOBIN MOSCVA	[]	[]
ENSPHENO:0000690	HEMOGLOBIN NAGASAKI	[]	[]
ENSPHENO:0000691	HEMOGLOBIN NIKOSIA	[]	[]
ENSPHENO:0000692	HEMOGLOBIN NORTH CHICAGO	[]	[]
ENSPHENO:0000693	HEMOGLOBIN O (PADOVA)	[]	[]
ENSPHENO:0000694	HEMOGLOBIN OLOMOUC	[]	[]
ENSPHENO:0000695	HEMOGLOBIN OSLER	[]	[]
ENSPHENO:0000696	HEMOGLOBIN OWARI	[]	[]
ENSPHENO:0000697	HEMOGLOBIN PAVIE	[]	[]
ENSPHENO:0000698	HEMOGLOBIN PERTH	[]	[]
ENSPHENO:0000699	HEMOGLOBIN PETERBOROUGH	[]	[]
ENSPHENO:0000700	HEMOGLOBIN POISSY	[]	[]
ENSPHENO:0000701	HEMOGLOBIN POTOMAC	[]	[]
ENSPHENO:0000702	HEMOGLOBIN PRESBYTERIAN	[]	[]
ENSPHENO:0000703	HEMOGLOBIN QUESTEMBERT	[]	[]
ENSPHENO:0000704	HEMOGLOBIN RENERT	[]	[]
ENSPHENO:0000705	HEMOGLOBIN ROCKFORD	[]	[]
ENSPHENO:0000706	HEMOGLOBIN ROTHSCHILD	[]	[]
ENSPHENO:0000707	HEMOGLOBIN SAKI	[]	[]
ENSPHENO:0000708	HEMOGLOBIN SAN DIEGO	[]	[]
ENSPHENO:0000709	HEMOGLOBIN SAVANNAH	[]	[]
ENSPHENO:0000710	HEMOGLOBIN SEAL ROCK	[]	[]
ENSPHENO:0000711	HEMOGLOBIN SHEPHERDS BUSH	[]	[]
ENSPHENO:0000712	HEMOGLOBIN SILVER SPRINGS	[]	[]
ENSPHENO:0000713	HEMOGLOBIN SOGN	[]	[]
ENSPHENO:0000714	HEMOGLOBIN STANMORE	[]	[]
ENSPHENO:0000715	HEMOGLOBIN T (CAMBODIA)	[]	[]
ENSPHENO:0000716	HEMOGLOBIN TACOMA	[]	[]
ENSPHENO:0000717	HEMOGLOBIN TARRANT	[]	[]
ENSPHENO:0000718	HEMOGLOBIN TIZI-OUZOU	[]	[]
ENSPHENO:0000719	HEMOGLOBIN TUNIS	[]	[]
ENSPHENO:0000720	HEMOGLOBIN VAL DE MARNE	[]	[]
ENSPHENO:0000721	HEMOGLOBIN VOLGA	[]	[]
ENSPHENO:0000722	HEMOGLOBIN WARWICKSHIRE	[]	[]
ENSPHENO:0000723	HEMOGLOBIN WIEN	[]	[]
ENSPHENO:0000724	HEMOGLOBIN WINDSOR	[]	[]
ENSPHENO:0000725	HEMOGLOBIN--BETA LOCUS	[MIM:141900,MIM:141900]	[HEMOGLOBIN--BETA LOCUS,HEMOGLOBIN--BETA LOCUS]
ENSPHENO:0000726	HEMOLYTIC ANEMIA NONSPHEROCYTIC DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	[]	[]
ENSPHENO:0000727	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FAMILIAL 2	[MIM:603553,MIM:603553]	[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2]
ENSPHENO:0000728	HEMOPHILIA B	[DOID:12259,DOID:12259,MIM:306900,MIM:306900]	[hemophilia B,hemophilia B,HEMOPHILIA B,HEMOPHILIA B]
ENSPHENO:0000729	HEPATITIS A VIRUS CELLULAR RECEPTOR 1	[MIM:606518,MIM:606518]	[HEPATITIS A VIRUS CELLULAR RECEPTOR 1,HEPATITIS A VIRUS CELLULAR RECEPTOR 1]
ENSPHENO:0000730	HEPATOBLASTOMA SOMATIC	[]	[]
ENSPHENO:0000731	HERMANSKY-PUDLAK SYNDROME 7	[MIM:607145.0001,MIM:607145.0001]	[DTNBP1.0001,DTNBP1.0001]
ENSPHENO:0000732	HERPES SIMPLEX ENCEPHALITIS SUSCEPTIBILITY TO 2	[MIM:613002,MIM:613002]	[HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2,HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000733	HETEROTAXY VISCERAL 1 X-LINKED	[MIM:306955,MIM:306955]	[HETEROTAXY, VISCERAL, 1, X-LINKED,HETEROTAXY, VISCERAL, 1, X-LINKED]
ENSPHENO:0000734	HHH SYNDROME	[MIM:603861.0001,MIM:603861.0001]	[SLC25A15.0001,SLC25A15.0001]
ENSPHENO:0000735	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10	[]	[]
ENSPHENO:0000736	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 11	[]	[]
ENSPHENO:0000737	HIRSCHSPRUNG DISEASE PROTECTION AGAINST	[]	[]
ENSPHENO:0000738	HIRSCHSPRUNG DISEASE SUSCEPTIBILITY TO 1	[MIM:142623,MIM:142623]	[HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1,HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1]
ENSPHENO:0000739	HIRSCHSPRUNG DISEASE SUSCEPTIBILITY TO 2	[MIM:600155,MIM:600155]	[HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2,HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000740	HIRSCHSPRUNG DISEASE SUSCEPTIBILITY TO 4	[MIM:613712,MIM:613712]	[HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4,HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4]
ENSPHENO:0000741	HISTIDINEMIA	[DOID:0060168,DOID:0060168,HP:0010906,HP:0010906,MIM:235800,MIM:235800,SCTID_410058007,SCTID_410058007]	[histidinemia,histidinemia,Hyperhistidinemia,Hyperhistidinemia,HISTIDINEMIA,HISTIDINEMIA,Histidinemia,Histidinemia]
ENSPHENO:0000742	HIV-1 control	[]	[]
ENSPHENO:0000743	HIV-1 disease progression-HIV-1 viral load at set point	[]	[]
ENSPHENO:0000744	HIV-1 susceptibility	[]	[]
ENSPHENO:0000745	HMG-CoA synthase deficiency	[]	[]
ENSPHENO:0000746	HOLOPROSENCEPHALY 3	[MIM:142945,MIM:142945]	[HOLOPROSENCEPHALY 3,HOLOPROSENCEPHALY 3]
ENSPHENO:0000747	HOLT-ORAM SYNDROME	[MIM:142900,MIM:142900,SCTID_19092004,SCTID_19092004]	[HOLT-ORAM SYNDROME,HOLT-ORAM SYNDROME,Holt-Oram syndrome,Holt-Oram syndrome]
ENSPHENO:0000748	HOMOCYSTINURIA cblD TYPE VARIANT 1	[MIM:611935.0001,MIM:611935.0001]	[C2ORF25.0001,C2ORF25.0001]
ENSPHENO:0000749	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 RESISTANCE TO	[MIM:158105.0001,MIM:158105.0001,MIM:600835.0001,MIM:600835.0001,MIM:601156.0001,MIM:601156.0001,MIM:601267.0001,MIM:601267.0001,MIM:601373.0001,MIM:601373.0001]	[CCL2.0001,CCL2.0001,CXCL12.0001,CXCL12.0001,CCL11.0001,CCL11.0001,CCR2.0001,CCR2.0001,CCR5.0001,CCR5.0001]
ENSPHENO:0000750	HUNTINGTIN-ASSOCIATED PROTEIN 1	[MIM:600947,MIM:600947]	[HUNTINGTIN-ASSOCIATED PROTEIN 1,HUNTINGTIN-ASSOCIATED PROTEIN 1]
ENSPHENO:0000751	HUNTINGTON DISEASE	[DOID:12858,DOID:12858,MIM:143100,MIM:143100]	[Huntington's disease,Huntington's disease,HUNTINGTON DISEASE,HUNTINGTON DISEASE]
ENSPHENO:0000752	HYDATIDIFORM MOLE RECURRENT	[MIM:231090,MIM:231090]	[HYDATIDIFORM MOLE, RECURRENT,HYDATIDIFORM MOLE, RECURRENT]
ENSPHENO:0000753	HYDATIDIFORM MOLE RECURRENT 1	[]	[]
ENSPHENO:0000754	HYPER-IgD SYNDROME	[MIM:260920,MIM:260920]	[HYPER-IgD SYNDROME,HYPER-IgD SYNDROME]
ENSPHENO:0000755	HYPER-IgE RECURRENT INFECTION SYNDROME AUTOSOMAL DOMINANT	[MIM:147060,MIM:147060]	[HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT,HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT]
ENSPHENO:0000756	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY AUTOSOMAL DOMINANT	[MIM:115300,MIM:115300]	[HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT,HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT]
ENSPHENO:0000757	HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 2	[MIM:601820,MIM:601820]	[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2,HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2]
ENSPHENO:0000758	HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 3	[MIM:602485,MIM:602485]	[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3,HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3]
ENSPHENO:0000759	HYPERLIPIDEMIA FAMILIAL COMBINED SUSCEPTIBILITY TO	[MIM:191523.0001,MIM:191523.0001]	[USF1.0001,USF1.0001]
ENSPHENO:0000760	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	[MIM:607393.0001,MIM:607393.0001]	[CDC73.0001,CDC73.0001]
ENSPHENO:0000761	HYPERPHENYLALANINEMIA BH4-DEFICIENT A	[MIM:261640,MIM:261640]	[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A,HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A]
ENSPHENO:0000762	HYPERPHENYLALANINEMIA BH4-DEFICIENT A DUE TO PARTIAL PTS DEFICIENCY	[]	[]
ENSPHENO:0000763	HYPERPHENYLALANINEMIA BH4-DEFICIENT B	[MIM:233910,MIM:233910]	[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B,HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B]
ENSPHENO:0000764	HYPERPHENYLALANINEMIA BH4-DEFICIENT C	[MIM:261630,MIM:261630]	[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C,HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C]
ENSPHENO:0000765	HYPERPHENYLALANINEMIA BH4-DEFICIENT D	[MIM:264070,MIM:264070]	[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D,HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D]
ENSPHENO:0000766	HYPERPROINSULINEMIA FAMILIAL	[]	[]
ENSPHENO:0000767	HYPERPROLINEMIA TYPE I	[MIM:239500,MIM:239500]	[HYPERPROLINEMIA, TYPE I,HYPERPROLINEMIA, TYPE I]
ENSPHENO:0000768	HYPERURICEMIC NEPHROPATHY FAMILIAL JUVENILE 1	[MIM:162000,MIM:162000]	[HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1,HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1]
ENSPHENO:0000769	HYPOCALCIURIC HYPERCALCEMIA FAMILIAL	[MIM:601199.0001,MIM:601199.0001,SCTID_237885008]	[CASR.0001,CASR.0001,Familial hypocalciuric hypercalcemia]
ENSPHENO:0000770	HYPOGONADOTROPIC HYPOGONADISM	[DOID:1921,DOID:1921,HP:0000044,MIM:146110,MIM:146110,SCTID_33927004,SCTID_33927004]	[Klinefelter's syndrome,Klinefelter's syndrome,Hypogonadotrophic hypogonadism,HYPOGONADOTROPIC HYPOGONADISM,HYPOGONADOTROPIC HYPOGONADISM,Hypogonadotropic hypogonadism,Hypogonadotropic hypogonadism]
ENSPHENO:0000771	HYPOKALEMIC PERIODIC PARALYSIS TYPE 1	[MIM:170400,MIM:170400]	[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1,HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1]
ENSPHENO:0000772	HYPOMAGNESEMIA 3 RENAL	[MIM:248250,MIM:248250]	[HYPOMAGNESEMIA 3, RENAL,HYPOMAGNESEMIA 3, RENAL]
ENSPHENO:0000773	HYPOMAGNESEMIA PRIMARY	[MIM:603959.0001,MIM:603959.0001,SCTID_80710001,SCTID_80710001]	[CLDN16.0001,CLDN16.0001,Primary hypomagnesemia,Primary hypomagnesemia]
ENSPHENO:0000774	HYPOPARATHYROIDISM FAMILIAL ISOLATED	[MIM:146200,MIM:146200]	[HYPOPARATHYROIDISM, FAMILIAL ISOLATED,HYPOPARATHYROIDISM, FAMILIAL ISOLATED]
ENSPHENO:0000775	HYPOPARATHYROIDISM SPORADIC	[]	[]
ENSPHENO:0000776	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	[MIM:241410,MIM:241410]	[HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME,HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME]
ENSPHENO:0000777	HYPOPHOSPHATEMIC RICKETS AUTOSOMAL RECESSIVE 2	[MIM:613312,MIM:613312]	[HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2,HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2]
ENSPHENO:0000778	HYPOTHYROIDISM CONGENITAL NONGOITROUS 2	[MIM:218700,MIM:218700]	[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2,HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2]
ENSPHENO:0000779	HYPOTHYROIDISM THYROIDAL WITH SPIKY HAIR AND CLEFT PALATE	[]	[]
ENSPHENO:0000780	HYPOURICEMIA RENAL 1	[MIM:220150,MIM:220150]	[HYPOURICEMIA, RENAL, 1,HYPOURICEMIA, RENAL, 1]
ENSPHENO:0000781	HYPOURICEMIA RENAL 2	[MIM:612076,MIM:612076]	[HYPOURICEMIA, RENAL, 2,HYPOURICEMIA, RENAL, 2]
ENSPHENO:0000782	Haemotological (blood) traits-Fetal hemoglobin (HbF)	[]	[]
ENSPHENO:0000783	Haemotological (blood) traits-Hemoglobin (Hb)	[]	[]
ENSPHENO:0000784	Haemotological (blood) traits-Hemoglobin A2 (HbA2)	[]	[]
ENSPHENO:0000785	Haemotological (blood) traits-Mean corpuscular hemoglobin (MCH)	[]	[]
ENSPHENO:0000786	Hair eye and skin pigmentation-Blue versus brown eye pigmentation	[]	[]
ENSPHENO:0000787	Hair eye and skin pigmentation-Blue versus green eye pigmentation	[]	[]
ENSPHENO:0000788	Hair eye and skin pigmentation-Freckles	[]	[]
ENSPHENO:0000789	Hair eye and skin pigmentation-Red hair pigmentation	[]	[]
ENSPHENO:0000790	Hair morphology	[]	[]
ENSPHENO:0000791	Heart failure	[DOID:6000,DOID:6000,HP:0001635,HP:0001635,SCTID_84114007,SCTID_84114007]	[heart failure,heart failure,Congestive heart failure,Congestive heart failure,Heart failure,Heart failure]
ENSPHENO:0000792	Height	[]	[]
ENSPHENO:0000793	Hematocrit	[]	[]
ENSPHENO:0000794	Hematological and biochemical traits	[]	[]
ENSPHENO:0000795	Hematological parameters	[]	[]
ENSPHENO:0000796	Hemochromatosis type 2A	[MIM:602390,MIM:602390]	[HEMOCHROMATOSIS, TYPE 2A,HEMOCHROMATOSIS, TYPE 2A]
ENSPHENO:0000797	Hemoglobin	[]	[]
ENSPHENO:0000798	Hemophilia A	[MIM:306700,MIM:306700]	[HEMOPHILIA A,HEMOPHILIA A]
ENSPHENO:0000799	Hemostatic factors and hematological phenotypes	[]	[]
ENSPHENO:0000800	Hennekam lymphangiectasia-lymphedema syndrome	[MIM:235510,MIM:235510,SCTID_234146006,SCTID_234146006]	[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME,Hennekam lymphangiectasia-lymphedema syndrome,Hennekam lymphangiectasia-lymphedema syndrome]
ENSPHENO:0000801	Hepatic adverse events with thrombin inhibitor ximelagatran-Serum alanine aminotransferase levels	[]	[]
ENSPHENO:0000802	Hepatitis B	[DOID:2043,DOID:2043]	[hepatitis B,hepatitis B]
ENSPHENO:0000803	Hepatocellular carcinoma	[DOID:684,DOID:684,HP:0001402,HP:0001402,MP:0003331,MP:0003331,MIM:114550,MIM:114550]	[hepatocellular carcinoma,hepatocellular carcinoma,Hepatocellular carcinoma,Hepatocellular carcinoma,hepatocellular carcinoma,hepatocellular carcinoma,HEPATOCELLULAR CARCINOMA,HEPATOCELLULAR CARCINOMA]
ENSPHENO:0000804	Hereditary hemorrhagic telangiectasia type 2	[MIM:600376]	[TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2]
ENSPHENO:0000805	Hereditary non-polyposis colorectal cancer type 2	[MIM:609310]	[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2]
ENSPHENO:0000806	Hip geometry	[]	[]
ENSPHENO:0000807	Hippocampal atrophy	[]	[]
ENSPHENO:0000808	Hirschsprung disease type 2	[]	[]
ENSPHENO:0000809	Hirschsprung disease type 4	[]	[]
ENSPHENO:0000810	Holocarboxylase synthetase deficiency	[DOID:859,DOID:859,MIM:253270,MIM:253270]	[holocarboxylase synthetase deficiency,holocarboxylase synthetase deficiency,HOLOCARBOXYLASE SYNTHETASE DEFICIENCY,HOLOCARBOXYLASE SYNTHETASE DEFICIENCY]
ENSPHENO:0000811	Hoyeraal-Hreidarsson syndrome	[MIM:300240,MIM:300240]	[HOYERAAL-HREIDARSSON SYNDROME,HOYERAAL-HREIDARSSON SYNDROME]
ENSPHENO:0000812	Human episodic memory	[]	[]
ENSPHENO:0000813	Hutchinson-Gilford progeria syndrome	[DOID:3911,DOID:3911,MIM:176670,MIM:176670]	[progeria,progeria,HUTCHINSON-GILFORD PROGERIA SYNDROME,HUTCHINSON-GILFORD PROGERIA SYNDROME]
ENSPHENO:0000814	Hypertension	[DOID:10763,DOID:10763,HP:0000822,HP:0000822,MP:0000231,MP:0000231]	[hypertension,hypertension,Hypertension,Hypertension,hypertension,hypertension]
ENSPHENO:0000815	Hypertriglyceridemia	[HP:0002155,HP:0002155,MP:0001552,MP:0001552,SCTID_302870006,SCTID_302870006]	[Hypertriglyceridemia,Hypertriglyceridemia,increased circulating triglyceride level,increased circulating triglyceride level,Hypertriglyceridemia,Hypertriglyceridemia]
ENSPHENO:0000816	Hypochondroplasia	[DOID:0080041,DOID:0080041,MIM:146000,MIM:146000,SCTID_205468002,SCTID_205468002]	[hypochondroplasia,hypochondroplasia,HYPOCHONDROPLASIA,HYPOCHONDROPLASIA,Hypochondroplasia,Hypochondroplasia]
ENSPHENO:0000817	Hypophosphatemic nephrolithiasis/osteoporosis type 2	[]	[]
ENSPHENO:0000818	Hypoplastic left heart syndrome	[DOID:9955,DOID:9955,MIM:241550,MIM:241550,SCTID_62067003,SCTID_62067003]	[hypoplastic left heart syndrome,hypoplastic left heart syndrome,HYPOPLASTIC LEFT HEART SYNDROME,HYPOPLASTIC LEFT HEART SYNDROME,Hypoplastic left heart syndrome,Hypoplastic left heart syndrome]
ENSPHENO:0000819	Hypospadias	[DOID:10892,DOID:10892,HP:0000047,HP:0000047,MP:0003124,SCTID_416010008,SCTID_416010008]	[hypospadias,hypospadias,Hypospadias,Hypospadias,hypospadia,Hypospadias,Hypospadias]
ENSPHENO:0000820	Hypotrichosis-lymphedema-telangiectasia syndrome	[MIM:607823,MIM:607823]	[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME]
ENSPHENO:0000821	ICHTHYOSIS LAMELLAR 3	[MIM:604777,MIM:604777]	[ICHTHYOSIS, LAMELLAR, 3,ICHTHYOSIS, LAMELLAR, 3]
ENSPHENO:0000822	IMMUNITY-RELATED GTPase FAMILY M	[MIM:608212,MIM:608212]	[IMMUNITY-RELATED GTPase FAMILY, M,IMMUNITY-RELATED GTPase FAMILY, M]
ENSPHENO:0000823	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY	[MIM:604973.0001,MIM:604973.0001]	[FCN3.0001,FCN3.0001]
ENSPHENO:0000824	IMMUNODEFICIENCY WITH HYPER-IgM TYPE 2	[MIM:605258,MIM:605258]	[IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2,IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2]
ENSPHENO:0000825	IMMUNODEFICIENCY WITH HYPER-IgM TYPE 3	[MIM:606843,MIM:606843]	[IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3,IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3]
ENSPHENO:0000826	IMMUNODEFICIENCY WITH HYPER-IgM TYPE 5	[MIM:608106,MIM:608106]	[IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5,IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5]
ENSPHENO:0000827	INFERTILITY MALE AND FEMALE	[]	[]
ENSPHENO:0000828	INFLAMMATORY BOWEL DISEASE 1	[MIM:266600,MIM:266600]	[INFLAMMATORY BOWEL DISEASE 1,INFLAMMATORY BOWEL DISEASE 1]
ENSPHENO:0000829	INFLAMMATORY BOWEL DISEASE 1 SUSCEPTIBILITY TO	[MIM:605956.0001,MIM:605956.0001]	[NOD2.0001,NOD2.0001]
ENSPHENO:0000830	INFLAMMATORY BOWEL DISEASE 10	[MIM:611081,MIM:611081]	[INFLAMMATORY BOWEL DISEASE 10,INFLAMMATORY BOWEL DISEASE 10]
ENSPHENO:0000831	INFLAMMATORY BOWEL DISEASE 17	[MIM:612261,MIM:612261]	[INFLAMMATORY BOWEL DISEASE 17,INFLAMMATORY BOWEL DISEASE 17]
ENSPHENO:0000832	INFLAMMATORY BOWEL DISEASE 19	[MIM:612278,MIM:612278]	[INFLAMMATORY BOWEL DISEASE 19,INFLAMMATORY BOWEL DISEASE 19]
ENSPHENO:0000833	INFLAMMATORY BOWEL DISEASE 20	[MIM:612288,MIM:612288]	[INFLAMMATORY BOWEL DISEASE 20,INFLAMMATORY BOWEL DISEASE 20]
ENSPHENO:0000834	INFLAMMATORY BOWEL DISEASE 22	[MIM:612380,MIM:612380]	[INFLAMMATORY BOWEL DISEASE 22,INFLAMMATORY BOWEL DISEASE 22]
ENSPHENO:0000835	INFLAMMATORY BOWEL DISEASE 24	[MIM:612566,MIM:612566]	[INFLAMMATORY BOWEL DISEASE 24,INFLAMMATORY BOWEL DISEASE 24]
ENSPHENO:0000836	INFLAMMATORY BOWEL DISEASE 26	[MIM:612639,MIM:612639]	[INFLAMMATORY BOWEL DISEASE 26,INFLAMMATORY BOWEL DISEASE 26]
ENSPHENO:0000837	INFLAMMATORY BOWEL DISEASE 27	[MIM:612796,MIM:612796]	[INFLAMMATORY BOWEL DISEASE 27,INFLAMMATORY BOWEL DISEASE 27]
ENSPHENO:0000838	INFLAMMATORY BOWEL DISEASE 3	[MIM:604519,MIM:604519]	[INFLAMMATORY BOWEL DISEASE 3,INFLAMMATORY BOWEL DISEASE 3]
ENSPHENO:0000839	INFLAMMATORY BOWEL DISEASE 8	[MIM:606668,MIM:606668]	[INFLAMMATORY BOWEL DISEASE 8,INFLAMMATORY BOWEL DISEASE 8]
ENSPHENO:0000840	INSENSITIVITY TO PAIN CONGENITAL WITH ANHIDROSIS	[MIM:256800,MIM:256800]	[INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS,INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS]
ENSPHENO:0000841	INSULIN-LIKE GROWTH FACTOR I	[MIM:147440,MIM:147440]	[INSULIN-LIKE GROWTH FACTOR I,INSULIN-LIKE GROWTH FACTOR I]
ENSPHENO:0000842	INTERFERON REGULATORY FACTOR 1	[MIM:147575,MIM:147575]	[INTERFERON REGULATORY FACTOR 1,INTERFERON REGULATORY FACTOR 1]
ENSPHENO:0000843	INTERFERON REGULATORY FACTOR 6	[MIM:607199,MIM:607199]	[INTERFERON REGULATORY FACTOR 6,INTERFERON REGULATORY FACTOR 6]
ENSPHENO:0000844	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1	[MIM:603502,MIM:603502]	[INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1,INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1]
ENSPHENO:0000845	INTERLEUKIN 23 RECEPTOR	[MIM:607562,MIM:607562]	[INTERLEUKIN 23 RECEPTOR,INTERLEUKIN 23 RECEPTOR]
ENSPHENO:0000846	INTERLEUKIN 6	[MIM:147620,MIM:147620]	[INTERLEUKIN 6,INTERLEUKIN 6]
ENSPHENO:0000847	INTERVERTEBRAL DISC DISEASE SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000848	INTRINSIC FACTOR DEFICIENCY	[MIM:261000,MIM:261000]	[INTRINSIC FACTOR DEFICIENCY,INTRINSIC FACTOR DEFICIENCY]
ENSPHENO:0000849	ISOVALERIC ACIDEMIA	[DOID:14753,DOID:14753,MIM:243500,MIM:243500]	[isovaleric acidemia,isovaleric acidemia,ISOVALERIC ACIDEMIA,ISOVALERIC ACIDEMIA]
ENSPHENO:0000850	ISOVALERIC ACIDEMIA TYPE I	[MIM:607036.0001,MIM:607036.0001]	[IVD.0001,IVD.0001]
ENSPHENO:0000851	Ichthyosis lamellar type 2	[]	[]
ENSPHENO:0000852	Immunodeficiency with hyper-IgM type 3	[MIM:606843,MIM:606843]	[IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3,IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3]
ENSPHENO:0000853	Immunoglobulin A	[]	[]
ENSPHENO:0000854	Immunoglobulin A nephropathy	[]	[]
ENSPHENO:0000855	Inflammatory bowel disease	[DOID:0050589,DOID:0050589,HP:0002037,HP:0002037,SCTID_24526004,SCTID_24526004]	[inflammatory bowel disease,inflammatory bowel disease,Inflammatory bowel disease,Inflammatory bowel disease,Inflammatory bowel disease,Inflammatory bowel disease]
ENSPHENO:0000856	Inflammatory bowel disease (early onset)	[]	[]
ENSPHENO:0000857	Information processing speed	[]	[]
ENSPHENO:0000858	Insulin resistance/response	[]	[]
ENSPHENO:0000859	Intracranial aneurysm	[DOID:10941,DOID:10941,HP:0004944,HP:0004944,MP:0010478,MP:0010478,SCTID_128609009,SCTID_128609009]	[intracranial aneurysm,intracranial aneurysm,Cerebral aneurysm,Cerebral aneurysm,intracranial aneurysm,intracranial aneurysm,Intracranial aneurysm,Intracranial aneurysm]
ENSPHENO:0000860	Iris color	[]	[]
ENSPHENO:0000861	Ischemic stroke	[HP:0002140,HP:0002140,MIM:601367,SCTID_422504002,SCTID_422504002]	[Ischemic stroke,Ischemic stroke,STROKE, ISCHEMIC,Ischemic stroke,Ischemic stroke]
ENSPHENO:0000862	Ischemic stroke-Large vessel stroke	[]	[]
ENSPHENO:0000863	Ischemic stroke-Small vessel stroke	[]	[]
ENSPHENO:0000864	Ischemic stroke-Stroke cardioembolism	[]	[]
ENSPHENO:0000865	JANUS KINASE 2	[MIM:147796,MIM:147796]	[JANUS KINASE 2,JANUS KINASE 2]
ENSPHENO:0000866	JERVELL AND LANGE-NIELSEN SYNDROME 2	[MIM:612347,MIM:612347]	[JERVELL AND LANGE-NIELSEN SYNDROME 2,JERVELL AND LANGE-NIELSEN SYNDROME 2]
ENSPHENO:0000867	JOUBERT SYNDROME 3	[MIM:608629,MIM:608629]	[JOUBERT SYNDROME 3,JOUBERT SYNDROME 3]
ENSPHENO:0000868	Jervell and Lange-Nielsen syndrome type 2	[]	[]
ENSPHENO:0000869	KALLMANN SYNDROME 3	[MIM:244200,MIM:244200]	[KALLMANN SYNDROME 3,KALLMANN SYNDROME 3]
ENSPHENO:0000870	KELOID FORMATION	[MIM:148100,MIM:148100]	[KELOID FORMATION,KELOID FORMATION]
ENSPHENO:0000871	KIAA0319 GENE	[MIM:609269,MIM:609269]	[KIAA0319 GENE,KIAA0319 GENE]
ENSPHENO:0000872	KLIPPEL-FEIL SYNDROME 1 AUTOSOMAL DOMINANT	[MIM:118100,MIM:118100]	[KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT,KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT]
ENSPHENO:0000873	KNOBLOCH SYNDROME 1	[]	[]
ENSPHENO:0000874	KNOBLOCH SYNDROME TYPE I	[MIM:267750,MIM:267750]	[KNOBLOCH SYNDROME, TYPE I,KNOBLOCH SYNDROME, TYPE I]
ENSPHENO:0000875	KNUCKLE PADS LEUKONYCHIA AND SENSORINEURAL DEAFNESS	[DOID:0050658,DOID:0050658,MIM:149200,MIM:149200]	[Bart-Pumphrey syndrome,Bart-Pumphrey syndrome,KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS,KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS]
ENSPHENO:0000876	Keloid	[HP:0010562]	[Keloids]
ENSPHENO:0000877	Keratitis-ichthyosis-deafness syndrome	[]	[]
ENSPHENO:0000878	Kidney function and endocine traits-GFR	[]	[]
ENSPHENO:0000879	Kidney function and endocine traits-TSH	[]	[]
ENSPHENO:0000880	Kidney function and endocine traits-UAE	[]	[]
ENSPHENO:0000881	Kidney function and endocine traits-meanTSH	[]	[]
ENSPHENO:0000882	LACTASE PERSISTENCE	[MIM:601806.0001,MIM:601806.0001]	[MCM6.0001,MCM6.0001]
ENSPHENO:0000883	LADD SYNDROME	[DOID:0050331,DOID:0050331]	[LADD syndrome,LADD syndrome]
ENSPHENO:0000884	LARSEN SYNDROME AUTOSOMAL DOMINANT	[MIM:150250,MIM:150250]	[LARSEN SYNDROME, AUTOSOMAL DOMINANT,LARSEN SYNDROME, AUTOSOMAL DOMINANT]
ENSPHENO:0000885	LDL cholesterol	[]	[]
ENSPHENO:0000886	LEBER CONGENITAL AMAUROSIS 13	[MIM:612712,MIM:612712]	[LEBER CONGENITAL AMAUROSIS 13,LEBER CONGENITAL AMAUROSIS 13]
ENSPHENO:0000887	LEBER CONGENITAL AMAUROSIS 3	[MIM:604232,MIM:604232]	[LEBER CONGENITAL AMAUROSIS 3,LEBER CONGENITAL AMAUROSIS 3]
ENSPHENO:0000888	LEBER CONGENITAL AMAUROSIS 8	[]	[]
ENSPHENO:0000889	LEIGH SYNDROME FRENCH-CANADIAN TYPE	[MIM:220111,MIM:220111]	[LEIGH SYNDROME, FRENCH-CANADIAN TYPE,LEIGH SYNDROME, FRENCH-CANADIAN TYPE]
ENSPHENO:0000890	LEPROSY SUSCEPTIBILITY TO 1	[MIM:609888,MIM:609888]	[LEPROSY, SUSCEPTIBILITY TO, 1,LEPROSY, SUSCEPTIBILITY TO, 1]
ENSPHENO:0000891	LEUKEMIA ACUTE LYMPHOBLASTIC	[HP:0006721,MIM:613065,MIM:613065]	[Acute lymphatic leukemia,LEUKEMIA, ACUTE LYMPHOBLASTIC,LEUKEMIA, ACUTE LYMPHOBLASTIC]
ENSPHENO:0000892	LEUKEMIA ACUTE LYMPHOBLASTIC SUSCEPTIBILITY TO 2	[MIM:613067,MIM:613067]	[LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2,LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000893	LEUKEMIA ACUTE MYELOID SOMATIC	[MIM:116897.0001,MIM:116897.0001,MIM:600618.0001,MIM:600618.0001]	[CEBPA.0001,CEBPA.0001,ETV6.0001,ETV6.0001]
ENSPHENO:0000894	LEUKODYSTROPHY HYPOMYELINATING 2	[MIM:608804,MIM:608804]	[LEUKODYSTROPHY, HYPOMYELINATING, 2,LEUKODYSTROPHY, HYPOMYELINATING, 2]
ENSPHENO:0000895	LEUKODYSTROPHY HYPOMYELINATING 5	[MIM:610532,MIM:610532]	[LEUKODYSTROPHY, HYPOMYELINATING, 5,LEUKODYSTROPHY, HYPOMYELINATING, 5]
ENSPHENO:0000896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	[MIM:603896,MIM:603896]	[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER]
ENSPHENO:0000897	LEUKOTRIENE A4 HYDROLASE	[MIM:151570,MIM:151570]	[LEUKOTRIENE A4 HYDROLASE,LEUKOTRIENE A4 HYDROLASE]
ENSPHENO:0000898	LIPODYSTROPHY FAMILIAL PARTIAL TYPE 2	[MIM:151660,MIM:151660]	[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2,LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2]
ENSPHENO:0000899	LIPODYSTROPHY FAMILIAL PARTIAL TYPE 3	[MIM:604367,MIM:604367]	[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3,LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3]
ENSPHENO:0000900	LIPOPROTEIN LIPASE	[MIM:609708,MIM:609708]	[LIPOPROTEIN LIPASE,LIPOPROTEIN LIPASE]
ENSPHENO:0000901	LISSENCEPHALY 1	[MIM:607432,MIM:607432]	[LISSENCEPHALY 1,LISSENCEPHALY 1]
ENSPHENO:0000902	LISSENCEPHALY X-LINKED 1	[MIM:300067,MIM:300067]	[LISSENCEPHALY, X-LINKED, 1,LISSENCEPHALY, X-LINKED, 1]
ENSPHENO:0000903	LISSENCEPHALY X-LINKED 2	[MIM:300215,MIM:300215]	[LISSENCEPHALY, X-LINKED, 2,LISSENCEPHALY, X-LINKED, 2]
ENSPHENO:0000904	LIVER FIBROSIS SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000905	LOC387715 GENE	[MIM:611313,MIM:611313]	[LOC387715 GENE,LOC387715 GENE]
ENSPHENO:0000906	LOEYS-DIETZ SYNDROME TYPE 1B	[MIM:610168,MIM:610168]	[LOEYS-DIETZ SYNDROME, TYPE 1B,LOEYS-DIETZ SYNDROME, TYPE 1B]
ENSPHENO:0000907	LOEYS-DIETZ SYNDROME TYPE 2B	[MIM:610380,MIM:610380]	[LOEYS-DIETZ SYNDROME, TYPE 2B,LOEYS-DIETZ SYNDROME, TYPE 2B]
ENSPHENO:0000908	LONG QT SYNDROME 1	[MIM:192500,MIM:192500]	[LONG QT SYNDROME 1,LONG QT SYNDROME 1]
ENSPHENO:0000909	LONG QT SYNDROME 2	[MIM:613688,MIM:613688]	[LONG QT SYNDROME 2,LONG QT SYNDROME 2]
ENSPHENO:0000910	LONG QT SYNDROME 3/6 DIGENIC	[]	[]
ENSPHENO:0000911	LONG QT SYNDROME 5 ACQUIRED SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0000912	LONGEVITY 2	[MIM:606460,MIM:606460]	[LONGEVITY 2,LONGEVITY 2]
ENSPHENO:0000913	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	[]	[]
ENSPHENO:0000914	LUNG CANCER SUSCEPTIBILITY 2	[MIM:118503.0001,MIM:118503.0001,MIM:118505.0001,MIM:118505.0001]	[CHRNA3.0001,CHRNA3.0001,CHRNA5.0001,CHRNA5.0001]
ENSPHENO:0000915	LUNG CANCER SUSCEPTIBILITY 4	[MIM:612593,MIM:612593]	[LUNG CANCER SUSCEPTIBILITY 4,LUNG CANCER SUSCEPTIBILITY 4]
ENSPHENO:0000916	LYMPHOPROLIFERATIVE SYNDROME X-LINKED 1	[MIM:308240,MIM:308240]	[LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1,LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1]
ENSPHENO:0000917	LYMPHOPROLIFERATIVE SYNDROME X-LINKED 2	[MIM:300635,MIM:300635]	[LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2,LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2]
ENSPHENO:0000918	Large B-cell lymphoma	[]	[]
ENSPHENO:0000919	Late-onset Alzheimer's disease	[]	[]
ENSPHENO:0000920	Leber congenital amaurosis type 13	[]	[]
ENSPHENO:0000921	Left ventricular mass	[]	[]
ENSPHENO:0000922	Leprechaunism	[DOID:0050470,DOID:0050470]	[Donohue Syndrome,Donohue Syndrome]
ENSPHENO:0000923	Leprosy	[DOID:1024,DOID:1024,SCTID_81004002,SCTID_81004002]	[leprosy,leprosy,Leprosy,Leprosy]
ENSPHENO:0000924	Leukodystrophy globoid cell	[DOID:10587,DOID:10587]	[Krabbe disease,Krabbe disease]
ENSPHENO:0000925	Leukodystrophy metachromatic	[DOID:10581,DOID:10581,MIM:250100]	[metachromatic leukodystrophy,metachromatic leukodystrophy,METACHROMATIC LEUKODYSTROPHY]
ENSPHENO:0000926	Li-Fraumeni syndrome	[DOID:3012,DOID:3012,SCTID_428850001,SCTID_428850001]	[Li-Fraumeni syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome]
ENSPHENO:0000927	Limb-girdle muscular dystrophy type 2A	[MIM:253600]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A]
ENSPHENO:0000928	Limb-girdle muscular dystrophy type 2B	[MIM:253601]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B]
ENSPHENO:0000929	Limb-girdle muscular dystrophy type 2D	[MIM:608099]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D]
ENSPHENO:0000930	Lipid level measurements-HDL cholesterol levels	[]	[]
ENSPHENO:0000931	Lipid level measurements-LDL cholesterol levels	[]	[]
ENSPHENO:0000932	Lipid level measurements-Triglyceride levels	[]	[]
ENSPHENO:0000933	Lipid measurements-HDL cholesterol	[]	[]
ENSPHENO:0000934	Lipid measurements-Triglycerides	[]	[]
ENSPHENO:0000935	Lipoprotein lipase deficiency	[MIM:609708.0001,MIM:609708.0001]	[LPL.0001,LPL.0001]
ENSPHENO:0000936	Lipoprotein-associated phospholipase A2 activity and mass	[]	[]
ENSPHENO:0000937	Long QT syndrome type 2	[]	[]
ENSPHENO:0000938	Long QT syndrome type 6	[]	[]
ENSPHENO:0000939	Longevity	[]	[]
ENSPHENO:0000940	Longevity and age-related phenotypes-Age at death	[]	[]
ENSPHENO:0000941	Longevity and age-related phenotypes-Age at death morbidity-free survival at age 65	[]	[]
ENSPHENO:0000942	Longevity and age-related phenotypes-Age at natural menopause	[]	[]
ENSPHENO:0000943	Longevity and age-related phenotypes-Biologic age by osseographic scoring system	[]	[]
ENSPHENO:0000944	Longevity and age-related phenotypes-Biologic age by osseographic scoring system walking speed at advanced age	[]	[]
ENSPHENO:0000945	Longevity and age-related phenotypes-Morbidity-free survival at age 65	[]	[]
ENSPHENO:0000946	Longevity and age-related phenotypes-Walking speed at advanced age	[]	[]
ENSPHENO:0000947	Lung cancer	[DOID:1324,DOID:1324,DOID:3905,DOID:3905,MIM:211980,MIM:211980]	[lung cancer,lung cancer,lung carcinoma,lung carcinoma,LUNG CANCER,LUNG CANCER]
ENSPHENO:0000948	Lung cancer smokers with versus smokers without	[]	[]
ENSPHENO:0000949	Lung carcinoma	[DOID:3905,DOID:3905,MP:0008714,MP:0008714]	[lung carcinoma,lung carcinoma,lung carcinoma,lung carcinoma]
ENSPHENO:0000950	MACULAR CORNEAL DYSTROPHY TYPE I	[MIM:605294.0001,MIM:605294.0001,SCTID_418054005,SCTID_418054005]	[CHST6.0001,CHST6.0001,Macular corneal dystrophy Type I,Macular corneal dystrophy Type I]
ENSPHENO:0000951	MACULAR DEGENERATION AGE-RELATED 1	[MIM:603075,MIM:603075]	[MACULAR DEGENERATION, AGE-RELATED, 1,MACULAR DEGENERATION, AGE-RELATED, 1]
ENSPHENO:0000952	MACULAR DEGENERATION AGE-RELATED 11	[MIM:611953,MIM:611953]	[MACULAR DEGENERATION, AGE-RELATED, 11,MACULAR DEGENERATION, AGE-RELATED, 11]
ENSPHENO:0000953	MACULAR DEGENERATION AGE-RELATED 3	[MIM:608895,MIM:608895]	[MACULAR DEGENERATION, AGE-RELATED, 3,MACULAR DEGENERATION, AGE-RELATED, 3]
ENSPHENO:0000954	MACULAR DEGENERATION AGE-RELATED 7	[MIM:610149,MIM:610149]	[MACULAR DEGENERATION, AGE-RELATED, 7,MACULAR DEGENERATION, AGE-RELATED, 7]
ENSPHENO:0000955	MACULAR DEGENERATION AGE-RELATED 7 SUSCEPTIBILITY TO	[MIM:602194.0001,MIM:602194.0001]	[HTRA1.0001,HTRA1.0001]
ENSPHENO:0000956	MAJOR AFFECTIVE DISORDER 4	[MIM:611247,MIM:611247]	[MAJOR AFFECTIVE DISORDER 4,MAJOR AFFECTIVE DISORDER 4]
ENSPHENO:0000957	MALARIA SUSCEPTIBILITY TO	[MIM:611162,MIM:611162]	[MALARIA, SUSCEPTIBILITY TO,MALARIA, SUSCEPTIBILITY TO]
ENSPHENO:0000958	MALATTIA LEVENTINESE	[MIM:601548.0001,MIM:601548.0001]	[EFEMP1.0001,EFEMP1.0001]
ENSPHENO:0000959	MALIGNANT HYPERTHERMIA SUSCEPTIBILITY TO 1	[MIM:145600,MIM:145600]	[MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1,MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1]
ENSPHENO:0000960	MALT lymphoma	[MIM:603517.0001,MIM:603517.0001]	[BCL10.0001,BCL10.0001]
ENSPHENO:0000961	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	[MIM:248370,MIM:248370]	[MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY,MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY]
ENSPHENO:0000962	MANNOSIDOSIS ALPHA B LYSOSOMAL	[MIM:248500,MIM:248500]	[MANNOSIDOSIS, ALPHA B, LYSOSOMAL,MANNOSIDOSIS, ALPHA B, LYSOSOMAL]
ENSPHENO:0000963	MANTLE CELL LYMPHOMA SOMATIC	[]	[]
ENSPHENO:0000964	MARINESCO-SJOGREN SYNDROME	[MIM:248800,MIM:248800]	[MARINESCO-SJOGREN SYNDROME,MARINESCO-SJOGREN SYNDROME]
ENSPHENO:0000965	MATRIX METALLOPROTEINASE 1	[MIM:120353,MIM:120353]	[MATRIX METALLOPROTEINASE 1,MATRIX METALLOPROTEINASE 1]
ENSPHENO:0000966	MATURITY-ONSET DIABETES OF THE YOUNG TYPE 7	[MIM:610508,MIM:610508]	[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7,MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7]
ENSPHENO:0000967	MATURITY-ONSET DIABETES OF THE YOUNG TYPE II	[MIM:138079.0001,MIM:138079.0001]	[GCK.0001,GCK.0001]
ENSPHENO:0000968	MCKUSICK-KAUFMAN SYNDROME	[MIM:236700,MIM:236700]	[MCKUSICK-KAUFMAN SYNDROME,MCKUSICK-KAUFMAN SYNDROME]
ENSPHENO:0000969	MDR1 POLYMORPHISM	[]	[]
ENSPHENO:0000970	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS	[MIM:604004,MIM:604004]	[MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS]
ENSPHENO:0000971	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	[]	[]
ENSPHENO:0000972	MELANOMA CUTANEOUS MALIGNANT 2	[MIM:600160.0001,MIM:600160.0001]	[CDKN2A.0001,CDKN2A.0001]
ENSPHENO:0000973	MELANOMA CUTANEOUS MALIGNANT 3	[MIM:123829.0001,MIM:123829.0001]	[CDK4.0001,CDK4.0001]
ENSPHENO:0000974	MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 2	[MIM:155601,MIM:155601]	[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2,MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2]
ENSPHENO:0000975	MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 3	[MIM:609048,MIM:609048]	[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3,MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3]
ENSPHENO:0000976	MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 5	[MIM:613099,MIM:613099]	[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5,MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5]
ENSPHENO:0000977	MENARCHE AGE AT QUANTITATIVE TRAIT LOCUS 2	[MIM:612882,MIM:612882]	[MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2,MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2]
ENSPHENO:0000978	MENINGIOMA SOMATIC	[]	[]
ENSPHENO:0000979	MENKES DISEASE	[DOID:1838,DOID:1838,MIM:309400,MIM:309400]	[Menkes disease,Menkes disease,MENKES DISEASE,MENKES DISEASE]
ENSPHENO:0000980	MENOPAUSE NATURAL AGE AT QUANTITATIVE TRAIT LOCUS 4	[MIM:612886,MIM:612886]	[MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4,MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4]
ENSPHENO:0000981	MENTAL RETARDATION AUTOSOMAL DOMINANT 3	[MIM:612580,MIM:612580]	[MENTAL RETARDATION, AUTOSOMAL DOMINANT 3,MENTAL RETARDATION, AUTOSOMAL DOMINANT 3]
ENSPHENO:0000982	MENTAL RETARDATION AUTOSOMAL RECESSIVE 10	[MIM:611096,MIM:611096]	[MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10]
ENSPHENO:0000983	MENTAL RETARDATION AUTOSOMAL RECESSIVE 11	[MIM:611097,MIM:611097]	[MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11]
ENSPHENO:0000984	MENTAL RETARDATION AUTOSOMAL RECESSIVE 12	[MIM:611090,MIM:611090]	[MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12]
ENSPHENO:0000985	MENTAL RETARDATION AUTOSOMAL RECESSIVE 5	[MIM:611091,MIM:611091]	[MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5]
ENSPHENO:0000986	MENTAL RETARDATION X-LINKED 30	[MIM:300558,MIM:300558]	[MENTAL RETARDATION, X-LINKED 30,MENTAL RETARDATION, X-LINKED 30]
ENSPHENO:0000987	MENTAL RETARDATION X-LINKED 58	[MIM:300210,MIM:300210]	[MENTAL RETARDATION, X-LINKED 58,MENTAL RETARDATION, X-LINKED 58]
ENSPHENO:0000988	MENTAL RETARDATION X-LINKED 59	[MIM:300630,MIM:300630]	[MENTAL RETARDATION, X-LINKED 59,MENTAL RETARDATION, X-LINKED 59]
ENSPHENO:0000989	MENTAL RETARDATION X-LINKED 88	[MIM:300034.0001,MIM:300034.0001]	[AGTR2.0001,AGTR2.0001]
ENSPHENO:0000990	MENTAL RETARDATION X-LINKED WITH OR WITHOUT SEIZURES ARX-RELATED	[MIM:300419,MIM:300419]	[MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED,MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED]
ENSPHENO:0000991	METACHROMATIC LEUKODYSTROPHY	[DOID:10581,DOID:10581,MIM:250100,MIM:250100]	[metachromatic leukodystrophy,metachromatic leukodystrophy,METACHROMATIC LEUKODYSTROPHY,METACHROMATIC LEUKODYSTROPHY]
ENSPHENO:0000992	METACHROMATIC LEUKODYSTROPHY ADULT	[]	[]
ENSPHENO:0000993	METACHROMATIC LEUKODYSTROPHY LATE INFANTILE	[]	[]
ENSPHENO:0000994	METACHROMATIC LEUKODYSTROPHY LATE-ONSET	[]	[]
ENSPHENO:0000995	METACHROMATIC LEUKODYSTROPHY MILD	[]	[]
ENSPHENO:0000996	METAPHYSEAL CHONDRODYSPLASIA SCHMID TYPE	[MIM:156500,MIM:156500,SCTID_29248006,SCTID_29248006]	[METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE,METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE,Metaphyseal chondrodysplasia, Schmid type,Metaphyseal chondrodysplasia, Schmid type]
ENSPHENO:0000997	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY AUTOSOMAL RECESSIVE	[MIM:610550.0001,MIM:610550.0001]	[MAT1A.0001,MAT1A.0001]
ENSPHENO:0000998	MICRO RNA 433	[MIM:611711,MIM:611711]	[MICRO RNA 433,MICRO RNA 433]
ENSPHENO:0000999	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	[MIM:210720,MIM:210720]	[MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II,MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II]
ENSPHENO:0001000	MICROCEPHALY 1 PRIMARY AUTOSOMAL RECESSIVE	[MIM:251200]	[MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1]
ENSPHENO:0001001	MICROCEPHALY AMISH TYPE	[MIM:607196,MIM:607196]	[MICROCEPHALY, AMISH TYPE,MICROCEPHALY, AMISH TYPE]
ENSPHENO:0001002	MICROCEPHALY PRIMARY AUTOSOMAL RECESSIVE 1	[MIM:251200,MIM:251200]	[MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1,MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1]
ENSPHENO:0001003	MICROPHTHALMIA SYNDROMIC 3	[MIM:206900,MIM:206900]	[MICROPHTHALMIA, SYNDROMIC 3,MICROPHTHALMIA, SYNDROMIC 3]
ENSPHENO:0001004	MICROPHTHALMIA SYNDROMIC 9	[MIM:601186,MIM:601186]	[MICROPHTHALMIA, SYNDROMIC 9,MICROPHTHALMIA, SYNDROMIC 9]
ENSPHENO:0001005	MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 1	[MIM:603933,MIM:603933]	[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1,MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1]
ENSPHENO:0001006	MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 2	[MIM:612623,MIM:612623]	[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2,MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2]
ENSPHENO:0001007	MIGRAINE FAMILIAL HEMIPLEGIC 2	[MIM:602481,MIM:602481]	[MIGRAINE, FAMILIAL HEMIPLEGIC, 2,MIGRAINE, FAMILIAL HEMIPLEGIC, 2]
ENSPHENO:0001008	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	[MIM:255320,MIM:255320]	[MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA,MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA]
ENSPHENO:0001009	MISMATCH REPAIR CANCER SYNDROME	[MIM:276300,MIM:276300]	[MISMATCH REPAIR CANCER SYNDROME,MISMATCH REPAIR CANCER SYNDROME]
ENSPHENO:0001010	MITOCHONDRIAL COMPLEX I DEFICIENCY	[MIM:252010,MIM:252010]	[MITOCHONDRIAL COMPLEX I DEFICIENCY,MITOCHONDRIAL COMPLEX I DEFICIENCY]
ENSPHENO:0001011	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	[MIM:613662,MIM:613662]	[MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE),MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)]
ENSPHENO:0001012	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	[MIM:600234.0001,MIM:600234.0001]	[HMGCS2.0001,HMGCS2.0001]
ENSPHENO:0001013	MOVED TO 141900.0452	[]	[]
ENSPHENO:0001014	MRI atrophy measures	[]	[]
ENSPHENO:0001015	MUCOPOLYSACCHARIDOSIS TYPE IIIB	[DOID:12801,DOID:12801,MIM:252920,MIM:252920]	[mucopolysaccharidosis III,mucopolysaccharidosis III,MUCOPOLYSACCHARIDOSIS TYPE IIIB,MUCOPOLYSACCHARIDOSIS TYPE IIIB]
ENSPHENO:0001016	MUCOPOLYSACCHARIDOSIS TYPE IIIC	[MIM:252930,MIM:252930]	[MUCOPOLYSACCHARIDOSIS TYPE IIIC,MUCOPOLYSACCHARIDOSIS TYPE IIIC]
ENSPHENO:0001017	MUCOPOLYSACCHARIDOSIS TYPE IIID	[MIM:252940,MIM:252940]	[MUCOPOLYSACCHARIDOSIS TYPE IIID,MUCOPOLYSACCHARIDOSIS TYPE IIID]
ENSPHENO:0001018	MUCOPOLYSACCHARIDOSIS TYPE IVA	[DOID:12804,DOID:12804,MIM:253000,MIM:253000]	[mucopolysaccharidosis IV,mucopolysaccharidosis IV,MUCOPOLYSACCHARIDOSIS TYPE IVA,MUCOPOLYSACCHARIDOSIS TYPE IVA]
ENSPHENO:0001019	MUCOPOLYSACCHARIDOSIS TYPE IVB	[MIM:253010,MIM:253010,SCTID_238044004,SCTID_238044004]	[MUCOPOLYSACCHARIDOSIS TYPE IVB,MUCOPOLYSACCHARIDOSIS TYPE IVB,Mucopolysaccharidosis type IVB,Mucopolysaccharidosis type IVB]
ENSPHENO:0001020	MUCOPOLYSACCHARIDOSIS TYPE VI	[MIM:253200,MIM:253200]	[MUCOPOLYSACCHARIDOSIS TYPE VI,MUCOPOLYSACCHARIDOSIS TYPE VI]
ENSPHENO:0001021	MULTIPLE ENDOCRINE NEOPLASIA TYPE I	[MIM:131100,MIM:131100]	[MULTIPLE ENDOCRINE NEOPLASIA, TYPE I,MULTIPLE ENDOCRINE NEOPLASIA, TYPE I]
ENSPHENO:0001022	MULTIPLE ENDOCRINE NEOPLASIA TYPE IIA	[MIM:171400,MIM:171400]	[MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA,MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA]
ENSPHENO:0001023	MULTIPLE ENDOCRINE NEOPLASIA TYPE IIB	[MIM:162300,MIM:162300]	[MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB,MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB]
ENSPHENO:0001024	MULTIPLE SCLEROSIS SUSCEPTIBILITY TO	[MIM:126200,MIM:126200]	[MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO,MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO]
ENSPHENO:0001025	MULTIPLE SYNOSTOSES SYNDROME 1	[MIM:186500,MIM:186500]	[MULTIPLE SYNOSTOSES SYNDROME 1,MULTIPLE SYNOSTOSES SYNDROME 1]
ENSPHENO:0001026	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 1B	[MIM:159001,MIM:159001]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B]
ENSPHENO:0001027	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 1C	[MIM:607801,MIM:607801]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C]
ENSPHENO:0001028	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 2A AMISH	[MIM:114240.0001,MIM:114240.0001]	[CAPN3.0001,CAPN3.0001]
ENSPHENO:0001029	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 2C	[MIM:253700,MIM:253700]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C]
ENSPHENO:0001030	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 2D	[MIM:608099,MIM:608099]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D]
ENSPHENO:0001031	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 2E	[MIM:604286,MIM:604286]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E]
ENSPHENO:0001032	MUSCULAR DYSTROPHY LIMB-GIRDLE TYPE 2G	[MIM:601954,MIM:601954]	[MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G,MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G]
ENSPHENO:0001033	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES) TYPE A 5	[]	[]
ENSPHENO:0001034	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION) TYPE B 1	[]	[]
ENSPHENO:0001035	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION) TYPE B 5	[]	[]
ENSPHENO:0001036	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION) TYPE B 5	[]	[]
ENSPHENO:0001037	MUSICAL PERFECT PITCH	[MIM:159300,MIM:159300]	[MUSICAL PERFECT PITCH,MUSICAL PERFECT PITCH]
ENSPHENO:0001038	MYASTHENIC SYNDROME CONGENITAL ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	[]	[]
ENSPHENO:0001039	MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO	[MIM:607948,MIM:607948]	[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO,MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
ENSPHENO:0001040	MYELOMA MULTIPLE	[DOID:9538,HP:0006775,MIM:254500,MIM:254500,SCTID_109989006]	[multiple myeloma,Multiple myeloma,MYELOMA, MULTIPLE,MYELOMA, MULTIPLE,Multiple myeloma]
ENSPHENO:0001041	MYOCARDIAL INFARCTION PROTECTION AGAINST	[]	[]
ENSPHENO:0001042	MYOCARDIAL INFARCTION SUSCEPTIBILITY TO	[MIM:150571.0001,MIM:150571.0001,MIM:153440.0001,MIM:153440.0001,MIM:601176.0001,MIM:601176.0001,MIM:602601.0001,MIM:602601.0001,MIM:602855.0001,MIM:602855.0001,MIM:611082.0001,MIM:611082.0001]	[LGALS2.0001,LGALS2.0001,LTA.0001,LTA.0001,GCLM.0001,GCLM.0001,LOX1.0001,LOX1.0001,PSMA6.0001,PSMA6.0001,MIAT.0001,MIAT.0001]
ENSPHENO:0001043	MYOCILIN	[MIM:601652,MIM:601652]	[MYOCILIN,MYOCILIN]
ENSPHENO:0001044	MYOCLONIC EPILEPSY JUVENILE SUSCEPTIBILITY TO 1	[MIM:608815.0001,MIM:608815.0001]	[EFHC1.0001,EFHC1.0001]
ENSPHENO:0001045	MYOCLONUS-DYSTONIA SYNDROME	[MIM:126450.0001,MIM:126450.0001,MIM:604149.0001,MIM:604149.0001]	[DRD2.0001,DRD2.0001,SGCE.0001,SGCE.0001]
ENSPHENO:0001046	MYOKYMIA 1	[]	[]
ENSPHENO:0001047	MYOPATHY DISTAL WITH DECREASED CAVEOLIN 3	[]	[]
ENSPHENO:0001048	MYOTONIA CONGENITA AUTOSOMAL DOMINANT	[MIM:160800,MIM:160800]	[MYOTONIA CONGENITA, AUTOSOMAL DOMINANT,MYOTONIA CONGENITA, AUTOSOMAL DOMINANT]
ENSPHENO:0001049	Macular corneal dystrophy	[DOID:2565,DOID:2565,SCTID_60258001,SCTID_60258001]	[macular corneal dystrophy,macular corneal dystrophy,Macular corneal dystrophy,Macular corneal dystrophy]
ENSPHENO:0001050	Major CVD	[]	[]
ENSPHENO:0001051	Major depressive disorder	[DOID:1470,DOID:1470,MIM:608516,MIM:608516,SCTID_370143000,SCTID_370143000]	[major depressive disorder,major depressive disorder,MAJOR DEPRESSIVE DISORDER,MAJOR DEPRESSIVE DISORDER,Major depressive disorder,Major depressive disorder]
ENSPHENO:0001052	Major depressive disorder (broad)	[]	[]
ENSPHENO:0001053	Male-pattern baldness	[]	[]
ENSPHENO:0001054	Malignant hyperthermia susceptibility type 1	[]	[]
ENSPHENO:0001055	Marfan syndrome	[DOID:14323,DOID:14323,MIM:154700,MIM:154700,SCTID_19346006,SCTID_19346006]	[Marfan syndrome,Marfan syndrome,MARFAN SYNDROME,MARFAN SYNDROME,Marfan's syndrome,Marfan's syndrome]
ENSPHENO:0001056	Maturity-onset diabetes of the young type 7	[MIM:610508,MIM:610508]	[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7,MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7]
ENSPHENO:0001057	McLeod syndrome	[MIM:314850.0001,MIM:314850.0001]	[XK.0001,XK.0001]
ENSPHENO:0001058	Mean corpuscular hemoglobin	[MP:0001589,MP:0001589]	[abnormal mean corpuscular hemoglobin,abnormal mean corpuscular hemoglobin]
ENSPHENO:0001059	Mean corpuscular volume	[]	[]
ENSPHENO:0001060	Mean platelet volume	[]	[]
ENSPHENO:0001061	Meesmann corneal dystrophy	[MIM:122100,MIM:122100]	[CORNEAL DYSTROPHY, MEESMANN,CORNEAL DYSTROPHY, MEESMANN]
ENSPHENO:0001062	Melanoma	[DOID:1909,DOID:1909,HP:0002861,HP:0002861]	[melanoma,melanoma,Malignant melanoma,Malignant melanoma]
ENSPHENO:0001063	Menarche (age at onset)	[]	[]
ENSPHENO:0001064	Menarche and menopause (age at onset)	[]	[]
ENSPHENO:0001065	Menopause (age at onset)	[]	[]
ENSPHENO:0001066	Metabolic syndrome	[DOID:0014667,SCTID_75934005]	[disease of metabolism,Metabolic disease]
ENSPHENO:0001067	Metabolic syndrome (bivariate traits)	[]	[]
ENSPHENO:0001068	Metabolic traits	[]	[]
ENSPHENO:0001069	Methylmalonic aciduria type cblB	[DOID:14749,DOID:14749,MIM:251110,MIM:251110]	[methylmalonic acidemia,methylmalonic acidemia,METHYLMALONIC ACIDURIA, cblB TYPE,METHYLMALONIC ACIDURIA, cblB TYPE]
ENSPHENO:0001070	Migraine	[DOID:6364,DOID:6364,HP:0002076,HP:0002076,SCTID_37796009,SCTID_37796009]	[migraine,migraine,Migraine,Migraine,Migraine,Migraine]
ENSPHENO:0001071	Migraine familial hemiplegic type 2	[]	[]
ENSPHENO:0001072	Minor histocompatibility antigenicity-Cytotoxicity of lymphoblastoid cell lines (BLCLs) to CTL-1B9	[]	[]
ENSPHENO:0001073	Minor histocompatibility antigenicity-Cytotoxicity of lymphoblastoid cell lines (BLCLs) to CTL-2A12	[]	[]
ENSPHENO:0001074	Mitochondrial complex IV deficiency	[DOID:3762,DOID:3762,MIM:220110,MIM:220110]	[cytochrome-c oxidase deficiency,cytochrome-c oxidase deficiency,MITOCHONDRIAL COMPLEX IV DEFICIENCY,MITOCHONDRIAL COMPLEX IV DEFICIENCY]
ENSPHENO:0001075	Miyoshi muscular dystrophy type	[]	[]
ENSPHENO:0001076	Morbidity-free survival	[]	[]
ENSPHENO:0001077	Moyamoya disease	[DOID:13099,DOID:13099,SCTID_69116000,SCTID_69116000]	[Moyamoya disease,Moyamoya disease,Moyamoya disease,Moyamoya disease]
ENSPHENO:0001078	Muenke syndrome	[MIM:602849,MIM:602849]	[MUENKE SYNDROME,MUENKE SYNDROME]
ENSPHENO:0001079	Multiple complex diseases-Bipolar disorder	[]	[]
ENSPHENO:0001080	Multiple complex diseases-Bipolar disorder combined control dataset	[]	[]
ENSPHENO:0001081	Multiple complex diseases-Bipolar disorder combined control dataset gender differentiated	[]	[]
ENSPHENO:0001082	Multiple complex diseases-Bipolar disorder gender differentiated	[]	[]
ENSPHENO:0001083	Multiple complex diseases-Coronary Artery Disease	[]	[]
ENSPHENO:0001084	Multiple complex diseases-Coronary Artery Disease combined control dataset	[]	[]
ENSPHENO:0001085	Multiple complex diseases-Coronary Artery Disease combined control dataset gender differentiated	[]	[]
ENSPHENO:0001086	Multiple complex diseases-Coronary Artery Disease gender differentiated	[]	[]
ENSPHENO:0001087	Multiple complex diseases-Crohn's disease	[]	[]
ENSPHENO:0001088	Multiple complex diseases-Crohn's disease combined control dataset	[]	[]
ENSPHENO:0001089	Multiple complex diseases-Crohn's disease combined control dataset gender differentiated	[]	[]
ENSPHENO:0001090	Multiple complex diseases-Crohn's disease gender differentiated	[]	[]
ENSPHENO:0001091	Multiple complex diseases-Hypertension	[]	[]
ENSPHENO:0001092	Multiple complex diseases-Hypertension combined control dataset	[]	[]
ENSPHENO:0001093	Multiple complex diseases-Hypertension combined control dataset gender differentiated	[]	[]
ENSPHENO:0001094	Multiple complex diseases-Hypertension gender differentiated	[]	[]
ENSPHENO:0001095	Multiple complex diseases-Population differentiation markers among Great Britain	[]	[]
ENSPHENO:0001096	Multiple complex diseases-Rheumatoid Arthritis	[]	[]
ENSPHENO:0001097	Multiple complex diseases-Rheumatoid Arthritis combined control dataset	[]	[]
ENSPHENO:0001098	Multiple complex diseases-Rheumatoid Arthritis combined control dataset gender differentiated	[]	[]
ENSPHENO:0001099	Multiple complex diseases-Rheumatoid Arthritis gender differentiated	[]	[]
ENSPHENO:0001100	Multiple complex diseases-Type I Diabetes	[]	[]
ENSPHENO:0001101	Multiple complex diseases-Type I Diabetes Rheumatoid Arthritis Crohn's disease combined case analysis	[]	[]
ENSPHENO:0001102	Multiple complex diseases-Type I Diabetes Rheumatoid Arthritis Crohn's disease combined case analysis gender differentiated	[]	[]
ENSPHENO:0001103	Multiple complex diseases-Type I Diabetes Rheumatoid Arthritis combined case analysis	[]	[]
ENSPHENO:0001104	Multiple complex diseases-Type I Diabetes Rheumatoid Arthritis combined case analysis gender differentiated	[]	[]
ENSPHENO:0001105	Multiple complex diseases-Type I Diabetes combined control dataset	[]	[]
ENSPHENO:0001106	Multiple complex diseases-Type I Diabetes combined control dataset gender differentiated	[]	[]
ENSPHENO:0001107	Multiple complex diseases-Type I Diabetes gender differentiated	[]	[]
ENSPHENO:0001108	Multiple complex diseases-Type II Diabetes Mellitus	[]	[]
ENSPHENO:0001109	Multiple complex diseases-Type II Diabetes Mellitus Hypertension Coronary Artery Disease combined case analysis	[]	[]
ENSPHENO:0001110	Multiple complex diseases-Type II Diabetes Mellitus Hypertension Coronary Artery Disease combined case analysis gender differentiated	[]	[]
ENSPHENO:0001111	Multiple complex diseases-Type II Diabetes Mellitus combined control dataset	[]	[]
ENSPHENO:0001112	Multiple complex diseases-Type II Diabetes Mellitus combined control dataset gender differentiated	[]	[]
ENSPHENO:0001113	Multiple complex diseases-Type II Diabetes Mellitus gender differentiated	[]	[]
ENSPHENO:0001114	Multiple continuous traits in DGI samples-2 hour Insulin	[]	[]
ENSPHENO:0001115	Multiple continuous traits in DGI samples-2 hour glucose	[]	[]
ENSPHENO:0001116	Multiple continuous traits in DGI samples-ApoAI	[]	[]
ENSPHENO:0001117	Multiple continuous traits in DGI samples-ApoAII	[]	[]
ENSPHENO:0001118	Multiple continuous traits in DGI samples-ApoB	[]	[]
ENSPHENO:0001119	Multiple continuous traits in DGI samples-BMI Type II Diabetes Mellitus Cases	[]	[]
ENSPHENO:0001120	Multiple continuous traits in DGI samples-BMI Type II Diabetes Mellitus Controls	[]	[]
ENSPHENO:0001121	Multiple continuous traits in DGI samples-Diastolic Blood Pressure	[]	[]
ENSPHENO:0001122	Multiple continuous traits in DGI samples-Fasting glucose	[]	[]
ENSPHENO:0001123	Multiple continuous traits in DGI samples-Fasting insulin	[]	[]
ENSPHENO:0001124	Multiple continuous traits in DGI samples-Fat mass	[]	[]
ENSPHENO:0001125	Multiple continuous traits in DGI samples-HDL cholesterol	[]	[]
ENSPHENO:0001126	Multiple continuous traits in DGI samples-HOMA-IR	[]	[]
ENSPHENO:0001127	Multiple continuous traits in DGI samples-Height in Type II Diabetes Mellitus Cases	[]	[]
ENSPHENO:0001128	Multiple continuous traits in DGI samples-Height in Type II Diabetes Mellitus Controls	[]	[]
ENSPHENO:0001129	Multiple continuous traits in DGI samples-Hypertension	[]	[]
ENSPHENO:0001130	Multiple continuous traits in DGI samples-Insulinogenic index	[]	[]
ENSPHENO:0001131	Multiple continuous traits in DGI samples-LDL cholesterol	[]	[]
ENSPHENO:0001132	Multiple continuous traits in DGI samples-Systolic Blood Pressure	[]	[]
ENSPHENO:0001133	Multiple continuous traits in DGI samples-Total cholesterol	[]	[]
ENSPHENO:0001134	Multiple continuous traits in DGI samples-Triglyceride/HDL ratio	[]	[]
ENSPHENO:0001135	Multiple continuous traits in DGI samples-Triglycerides	[]	[]
ENSPHENO:0001136	Multiple continuous traits in DGI samples-Type II Diabetes Mellitus	[]	[]
ENSPHENO:0001137	Multiple continuous traits in DGI samples-Waist circumference in Type II Diabetes Mellitus Cases	[]	[]
ENSPHENO:0001138	Multiple continuous traits in DGI samples-Waist circumference in Type II Diabetes Mellitus Controls	[]	[]
ENSPHENO:0001139	Multiple continuous traits in DGI samples-Waist/height ratio squared	[]	[]
ENSPHENO:0001140	Multiple continuous traits in DGI samples-Waist/hip ratio in Type II Diabetes Mellitus Cases	[]	[]
ENSPHENO:0001141	Multiple continuous traits in DGI samples-Waist/hip ratio in Type II Diabetes Mellitus Controls	[]	[]
ENSPHENO:0001142	Multiple continuous traits in DGI samples-Weight in Type II Diabetes Mellitus Cases	[]	[]
ENSPHENO:0001143	Multiple continuous traits in DGI samples-Weight in Type II Diabetes Mellitus Controls	[]	[]
ENSPHENO:0001144	Multiple sclerosis	[DOID:2377,DOID:2377,SCTID_24700007,SCTID_24700007]	[multiple sclerosis,multiple sclerosis,Multiple sclerosis,Multiple sclerosis]
ENSPHENO:0001145	Multiple sclerosis (age of onset)	[]	[]
ENSPHENO:0001146	Multiple sclerosis (severity)	[]	[]
ENSPHENO:0001147	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Serum calcium levels	[]	[]
ENSPHENO:0001148	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Serum total cholesterol levels	[]	[]
ENSPHENO:0001149	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Serum triglyceride levels	[]	[]
ENSPHENO:0001150	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Serum urea levels	[]	[]
ENSPHENO:0001151	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Urine alubumin levels	[]	[]
ENSPHENO:0001152	Multiple serum and urine biomarkers in WTCCC BRIGHT samples-Urine potassium levels	[]	[]
ENSPHENO:0001153	Muscular dystrophy congenital LMNA-related	[MIM:613205,MIM:613205]	[MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED,MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED]
ENSPHENO:0001154	Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5	[]	[]
ENSPHENO:0001155	Myeloperoxidase deficiency	[MIM:254600,MIM:254600,SCTID_234433009,SCTID_234433009]	[MYELOPEROXIDASE DEFICIENCY,MYELOPEROXIDASE DEFICIENCY,Myeloperoxidase deficiency,Myeloperoxidase deficiency]
ENSPHENO:0001156	Myocardial infarction	[DOID:5844,DOID:5844,HP:0001658,HP:0001658,SCTID_22298006,SCTID_22298006]	[myocardial infarction,myocardial infarction,Myocardial infarction,Myocardial infarction,Myocardial infarction,Myocardial infarction]
ENSPHENO:0001157	Myokymia isolated type 1	[]	[]
ENSPHENO:0001158	Myopathy myofibrillar type 1	[]	[]
ENSPHENO:0001159	NAIL DISORDER NONSYNDROMIC CONGENITAL 4	[]	[]
ENSPHENO:0001160	NANCE-HORAN SYNDROME	[MIM:302350,MIM:302350]	[NANCE-HORAN SYNDROME,NANCE-HORAN SYNDROME]
ENSPHENO:0001161	NARCOLEPSY 5	[MIM:612851,MIM:612851]	[NARCOLEPSY 5,NARCOLEPSY 5]
ENSPHENO:0001162	NASOPHARYNGEAL CARCINOMA SUSCEPTIBILITY TO 2	[MIM:161550,MIM:161550]	[NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2,NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2]
ENSPHENO:0001163	NEONATAL ADRENOLEUKODYSTROPHY	[MIM:600414.0001,MIM:608666.0001,MIM:608666.0001]	[PEX5.0001,PEX26.0001,PEX26.0001]
ENSPHENO:0001164	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS	[MIM:300539,MIM:300539]	[NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS,NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS]
ENSPHENO:0001165	NEPHROLITHIASIS CALCIUM OXALATE	[DOID:585,DOID:585,HP:0008672,MIM:167030,MIM:167030]	[nephrolithiasis,nephrolithiasis,Calcium oxalate nephrolithiasis,NEPHROLITHIASIS, CALCIUM OXALATE,NEPHROLITHIASIS, CALCIUM OXALATE]
ENSPHENO:0001166	NEPHROLITHIASIS/OSTEOPOROSIS HYPOPHOSPHATEMIC 2	[MIM:612287,MIM:612287]	[NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2,NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2]
ENSPHENO:0001167	NEPHRONOPHTHISIS 3	[MIM:604387,MIM:604387]	[NEPHRONOPHTHISIS 3,NEPHRONOPHTHISIS 3]
ENSPHENO:0001168	NEUROFIBROMATOSIS TYPE II	[MIM:101000,MIM:101000]	[NEUROFIBROMATOSIS, TYPE II,NEUROFIBROMATOSIS, TYPE II]
ENSPHENO:0001169	NEURONOPATHY DISTAL HEREDITARY MOTOR TYPE IIB	[MIM:608634,MIM:608634]	[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB,NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB]
ENSPHENO:0001170	NEUROPATHY AXONAL WITH VOCAL CORD PARESIS AUTOSOMAL RECESSIVE	[]	[]
ENSPHENO:0001171	NEUROPATHY CONGENITAL HYPOMYELINATING AUTOSOMAL DOMINANT	[]	[]
ENSPHENO:0001172	NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 3	[MIM:191316,MIM:191316]	[NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3,NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3]
ENSPHENO:0001173	NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2	[MIM:146740.0001,MIM:146740.0001]	[FCGR3A.0001,FCGR3A.0001]
ENSPHENO:0001174	NICOTINE ADDICTION PROTECTION AGAINST	[]	[]
ENSPHENO:0001175	NIEMANN-PICK DISEASE INTERMEDIATE PROTRACTED NEUROVISCERAL	[]	[]
ENSPHENO:0001176	NIEMANN-PICK DISEASE TYPE A	[DOID:14504,DOID:14504,MIM:257200,MIM:257200,SCTID_52165006,SCTID_52165006]	[Niemann-Pick disease,Niemann-Pick disease,NIEMANN-PICK DISEASE, TYPE A,NIEMANN-PICK DISEASE, TYPE A,Niemann-Pick disease, type A,Niemann-Pick disease, type A]
ENSPHENO:0001177	NIEMANN-PICK DISEASE TYPE B	[DOID:14504,DOID:14504,MIM:607616,MIM:607616,SCTID_39390005,SCTID_39390005]	[Niemann-Pick disease,Niemann-Pick disease,NIEMANN-PICK DISEASE, TYPE B,NIEMANN-PICK DISEASE, TYPE B,Niemann-Pick disease, type B,Niemann-Pick disease, type B]
ENSPHENO:0001178	NIEMANN-PICK DISEASE TYPE C1	[MIM:257220,MIM:257220]	[NIEMANN-PICK DISEASE, TYPE C1,NIEMANN-PICK DISEASE, TYPE C1]
ENSPHENO:0001179	NIEMANN-PICK DISEASE TYPE C2	[MIM:607625,MIM:607625]	[NIEMANN-PICK DISEASE, TYPE C2,NIEMANN-PICK DISEASE, TYPE C2]
ENSPHENO:0001180	NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 1A	[MIM:310500,MIM:310500]	[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A,NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A]
ENSPHENO:0001181	NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 1B	[MIM:257270,MIM:257270]	[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B,NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B]
ENSPHENO:0001182	NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 1C	[MIM:613216,MIM:613216]	[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C,NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C]
ENSPHENO:0001183	NONAKA MYOPATHY	[MIM:605820,MIM:605820]	[NONAKA MYOPATHY,NONAKA MYOPATHY]
ENSPHENO:0001184	NOONAN SYNDROME 5	[MIM:611553,MIM:611553]	[NOONAN SYNDROME 5,NOONAN SYNDROME 5]
ENSPHENO:0001185	NORRIE DISEASE	[MIM:310600,MIM:310600]	[NORRIE DISEASE,NORRIE DISEASE]
ENSPHENO:0001186	Narcolepsy	[DOID:8986,DOID:8986,MP:0005279,MP:0005279,MIM:602358.0001,MIM:602358.0001,SCTID_60380001,SCTID_60380001]	[narcolepsy,narcolepsy,narcolepsy,narcolepsy,HCRT.0001,HCRT.0001,Narcolepsy,Narcolepsy]
ENSPHENO:0001187	Nasopharyngeal carcinoma	[DOID:9261,DOID:9261,MIM:607107,MIM:607107]	[nasopharynx carcinoma,nasopharynx carcinoma,NASOPHARYNGEAL CARCINOMA,NASOPHARYNGEAL CARCINOMA]
ENSPHENO:0001188	Natriuretic peptide levels	[]	[]
ENSPHENO:0001189	Nephronophthisis type 4	[]	[]
ENSPHENO:0001190	Nephropathy	[HP:0000112,HP:0000112]	[Nephropathy,Nephropathy]
ENSPHENO:0001191	Nephrotic syndrome (acquired)	[]	[]
ENSPHENO:0001192	Neuroticism	[]	[]
ENSPHENO:0001193	Neutrophil count	[]	[]
ENSPHENO:0001194	Nicotine dependence	[SCTID_56294008,SCTID_56294008]	[Nicotine dependence,Nicotine dependence]
ENSPHENO:0001195	Nicotine dependence cigarettes per day	[]	[]
ENSPHENO:0001196	Nicotine dependence-Nicotine dependence gender-differentiated	[]	[]
ENSPHENO:0001197	Non-alcoholic fatty liver disease histology (AST)	[]	[]
ENSPHENO:0001198	Non-alcoholic fatty liver disease histology (lobular)	[]	[]
ENSPHENO:0001199	Non-alcoholic fatty liver disease histology (other)	[]	[]
ENSPHENO:0001200	Non-small cell lung cancer	[SCTID_254637007,SCTID_254637007]	[Non-small cell lung cancer,Non-small cell lung cancer]
ENSPHENO:0001201	Nonsyndromic cleft lip with or without cleft palate	[]	[]
ENSPHENO:0001202	Noonan syndrome type 1	[]	[]
ENSPHENO:0001203	Normalized brain volume	[]	[]
ENSPHENO:0001204	OAT POLYMORPHISM	[]	[]
ENSPHENO:0001205	OBESITY AGE AT ONSET OF	[]	[]
ENSPHENO:0001206	OBESITY ASSOCIATION WITH	[MIM:186357.0001,MIM:186357.0001]	[SDC3.0001,SDC3.0001]
ENSPHENO:0001207	OBESITY LATE-ONSET	[MIM:602311.0001,MIM:602311.0001]	[AGRP.0001,AGRP.0001]
ENSPHENO:0001208	OBESITY SEVERE	[DOID:11981,DOID:11981,MIM:601487.0001,MIM:601487.0001]	[morbid obesity,morbid obesity,PPARG.0001,PPARG.0001]
ENSPHENO:0001209	OBESITY SUSCEPTIBILITY TO	[MIM:109691.0001,MIM:109691.0001,MIM:155540.0001,MIM:155540.0001,MIM:600781.0001,MIM:600781.0001,MIM:601693.0001,MIM:601693.0001,MIM:602606.0001,MIM:602606.0001,MIM:605353.0001,MIM:605353.0001]	[ADRB3.0001,ADRB3.0001,MC3R.0001,MC3R.0001,PYY.0001,PYY.0001,UCP2.0001,UCP2.0001,CART.0001,CART.0001,GHRL.0001,GHRL.0001]
ENSPHENO:0001210	OBESITY VARIATION IN	[MIM:608886.0001,MIM:608886.0001]	[PPARBC1B.0001,PPARBC1B.0001]
ENSPHENO:0001211	OCA2 GENE	[MIM:611409,MIM:611409]	[OCA2 GENE,OCA2 GENE]
ENSPHENO:0001212	OCULOPHARYNGEAL MUSCULAR DYSTROPHY	[DOID:11719,DOID:11719,MIM:164300,MIM:164300,SCTID_77097004,SCTID_77097004]	[oculopharyngeal muscular dystrophy,oculopharyngeal muscular dystrophy,OCULOPHARYNGEAL MUSCULAR DYSTROPHY,OCULOPHARYNGEAL MUSCULAR DYSTROPHY,Oculopharyngeal muscular dystrophy,Oculopharyngeal muscular dystrophy]
ENSPHENO:0001213	ODONTOONYCHODERMAL DYSPLASIA	[MIM:257980,MIM:257980,SCTID_403762003,SCTID_403762003]	[ODONTOONYCHODERMAL DYSPLASIA,ODONTOONYCHODERMAL DYSPLASIA,Odonto-onycho-dermal dysplasia,Odonto-onycho-dermal dysplasia]
ENSPHENO:0001214	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2	[MIM:606386,MIM:606386]	[OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2]
ENSPHENO:0001215	OMENN SYNDROME	[DOID:0060010,DOID:0060010,MIM:603554,MIM:603554]	[Omenn syndrome,Omenn syndrome,OMENN SYNDROME,OMENN SYNDROME]
ENSPHENO:0001216	OPIOID DEPENDENCE SUSCEPTIBILITY TO 1	[MIM:610064,MIM:610064]	[OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1,OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1]
ENSPHENO:0001217	OPTIC ATROPHY 1 WITH DEAFNESS	[]	[]
ENSPHENO:0001218	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS OPHTHALMOPLEGIA MYOPATHY ATAXIA AND NEUROPATHY	[]	[]
ENSPHENO:0001219	ORNITHINE CARBAMOYLTRANSFERASE	[MIM:300461,MIM:300461]	[ORNITHINE CARBAMOYLTRANSFERASE,ORNITHINE CARBAMOYLTRANSFERASE]
ENSPHENO:0001220	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	[DOID:9271,DOID:9271,MIM:300461.0001,MIM:300461.0001]	[ornithine carbamoyltransferase deficiency,ornithine carbamoyltransferase deficiency,OTC.0001,OTC.0001]
ENSPHENO:0001221	OROFACIAL CLEFT 6 SUSCEPTIBILITY TO	[MIM:608864,MIM:608864]	[OROFACIAL CLEFT 6, SUSCEPTIBILITY TO,OROFACIAL CLEFT 6, SUSCEPTIBILITY TO]
ENSPHENO:0001222	OSTEOARTHRITIS SUSCEPTIBILITY 1	[MIM:165720,MIM:165720]	[OSTEOARTHRITIS SUSCEPTIBILITY 1,OSTEOARTHRITIS SUSCEPTIBILITY 1]
ENSPHENO:0001223	OSTEOARTHRITIS SUSCEPTIBILITY 5	[MIM:612400,MIM:612400]	[OSTEOARTHRITIS SUSCEPTIBILITY 5,OSTEOARTHRITIS SUSCEPTIBILITY 5]
ENSPHENO:0001224	OSTEOGENESIS IMPERFECTA	[DOID:12347,DOID:12347,SCTID_78314001,SCTID_78314001]	[osteogenesis imperfecta,osteogenesis imperfecta,Osteogenesis imperfecta,Osteogenesis imperfecta]
ENSPHENO:0001225	OSTEOGENESIS IMPERFECTA TYPE II	[MIM:120150.0001,MIM:120150.0001,SCTID_205496008,SCTID_205496008]	[COL1A1.0001,COL1A1.0001,Osteogenesis imperfecta type II,Osteogenesis imperfecta type II]
ENSPHENO:0001226	OSTEOGENESIS IMPERFECTA TYPE III	[MIM:259420,MIM:259420,SCTID_385483009,SCTID_385483009]	[OSTEOGENESIS IMPERFECTA, TYPE III,OSTEOGENESIS IMPERFECTA, TYPE III,Osteogenesis imperfecta type III,Osteogenesis imperfecta type III]
ENSPHENO:0001227	OSTEOGENESIS IMPERFECTA TYPE III/IV	[]	[]
ENSPHENO:0001228	OSTEOGENESIS IMPERFECTA TYPE IV	[MIM:166220,MIM:166220,SCTID_205497004,SCTID_205497004]	[OSTEOGENESIS IMPERFECTA, TYPE IV,OSTEOGENESIS IMPERFECTA, TYPE IV,Osteogenesis imperfecta type IV,Osteogenesis imperfecta type IV]
ENSPHENO:0001229	OSTEOGENESIS IMPERFECTA TYPE VIII	[MIM:610915,MIM:610915]	[OSTEOGENESIS IMPERFECTA, TYPE VIII,OSTEOGENESIS IMPERFECTA, TYPE VIII]
ENSPHENO:0001230	OSTEOPETROSIS AUTOSOMAL RECESSIVE 3	[MIM:259730,MIM:259730]	[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3,OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3]
ENSPHENO:0001231	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	[MIM:259770,MIM:259770]	[OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME,OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME]
ENSPHENO:0001232	Obesity	[DOID:9970,DOID:9970,HP:0001513,HP:0001513,MP:0001261,MP:0001261,MIM:601665,MIM:601665,SCTID_414916001,SCTID_414916001]	[obesity,obesity,Obesity,Obesity,obese,obese,OBESITY,OBESITY,Obesity,Obesity]
ENSPHENO:0001233	Obesity (extreme)	[]	[]
ENSPHENO:0001234	Obesity and osteoporosis	[]	[]
ENSPHENO:0001235	Obesity-related traits-8 Combined BMI traits	[]	[]
ENSPHENO:0001236	Obesity-related traits-BMI	[]	[]
ENSPHENO:0001237	Obesity-related traits-Hip circumference	[]	[]
ENSPHENO:0001238	Obesity-related traits-Mean BMI	[]	[]
ENSPHENO:0001239	Obesity-related traits-Mean Waist Circumference	[]	[]
ENSPHENO:0001240	Obesity-related traits-Mean waist circumference Mean BMI	[]	[]
ENSPHENO:0001241	Obesity-related traits-Weight	[]	[]
ENSPHENO:0001242	Optic disc parameters	[]	[]
ENSPHENO:0001243	Osteoporosis	[DOID:11476,DOID:11476,HP:0000939,HP:0000939,MP:0000066,MP:0000066,MIM:166710,MIM:166710,SCTID_281387004,SCTID_64859006,SCTID_64859006]	[osteoporosis,osteoporosis,Osteoporosis,Osteoporosis,osteoporosis,osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,Regional osteoporosis,Osteoporosis,Osteoporosis]
ENSPHENO:0001244	Other erythrocyte phenotypes	[]	[]
ENSPHENO:0001245	Ovarian cancer	[DOID:2394,DOID:2394,MIM:167000,MIM:167000]	[ovarian cancer,ovarian cancer,OVARIAN CANCER,OVARIAN CANCER]
ENSPHENO:0001246	Ovarian hyperstimulation syndrome	[DOID:5425,DOID:5425,MIM:608115,MIM:608115,SCTID_129635004,SCTID_129635004]	[ovarian hyperstimulation syndrome,ovarian hyperstimulation syndrome,OVARIAN HYPERSTIMULATION SYNDROME,OVARIAN HYPERSTIMULATION SYNDROME,Ovarian hyperstimulation syndrome,Ovarian hyperstimulation syndrome]
ENSPHENO:0001247	PACHYONYCHIA CONGENITA TYPE 1	[DOID:0050449,DOID:0050449,MIM:167200,MIM:167200]	[pachyonychia congenita,pachyonychia congenita,PACHYONYCHIA CONGENITA, TYPE 1,PACHYONYCHIA CONGENITA, TYPE 1]
ENSPHENO:0001248	PACHYONYCHIA CONGENITA TYPE 2	[MIM:167210,MIM:167210]	[PACHYONYCHIA CONGENITA, TYPE 2,PACHYONYCHIA CONGENITA, TYPE 2]
ENSPHENO:0001249	PAGET DISEASE OF BONE	[DOID:5408,DOID:5408,MIM:602080,MIM:602080]	[Paget's disease of bone,Paget's disease of bone,PAGET DISEASE OF BONE,PAGET DISEASE OF BONE]
ENSPHENO:0001250	PALLISTER-HALL SYNDROME	[DOID:9248,DOID:9248,MIM:146510,MIM:146510,SCTID_56677004,SCTID_56677004]	[Pallister-Hall syndrome,Pallister-Hall syndrome,PALLISTER-HALL SYNDROME,PALLISTER-HALL SYNDROME,Pallister-Hall syndrome,Pallister-Hall syndrome]
ENSPHENO:0001251	PALMOPLANTAR KERATODERMA EPIDERMOLYTIC	[MIM:144200,MIM:144200]	[PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC,PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC]
ENSPHENO:0001252	PANCREATIC AGENESIS	[MIM:600733.0001,MIM:600733.0001]	[PDX1.0001,PDX1.0001]
ENSPHENO:0001253	PAPA syndrome	[]	[]
ENSPHENO:0001254	PAPILLON-LEFEVRE SYNDROME	[DOID:3389,DOID:3389,MIM:245000,MIM:245000]	[Papillon-Lefevre disease,Papillon-Lefevre disease,PAPILLON-LEFEVRE SYNDROME,PAPILLON-LEFEVRE SYNDROME]
ENSPHENO:0001255	PARAGANGLIOMAS 1	[MIM:168000,MIM:168000]	[PARAGANGLIOMAS 1,PARAGANGLIOMAS 1]
ENSPHENO:0001256	PARAGANGLIOMAS 2	[MIM:601650,MIM:601650]	[PARAGANGLIOMAS 2,PARAGANGLIOMAS 2]
ENSPHENO:0001257	PARATHYROID CARCINOMA SOMATIC	[]	[]
ENSPHENO:0001258	PARIETAL FORAMINA 2	[MIM:609597,MIM:609597]	[PARIETAL FORAMINA 2,PARIETAL FORAMINA 2]
ENSPHENO:0001259	PARKINSON DISEASE 10	[MIM:606852,MIM:606852]	[PARKINSON DISEASE 10,PARKINSON DISEASE 10]
ENSPHENO:0001260	PARKINSON DISEASE 16	[MIM:613164,MIM:613164]	[PARKINSON DISEASE 16,PARKINSON DISEASE 16]
ENSPHENO:0001261	PARKINSON DISEASE 6 AUTOSOMAL RECESSIVE EARLY-ONSET	[MIM:605909,MIM:605909]	[PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET,PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET]
ENSPHENO:0001262	PARKINSON DISEASE 6 EARLY-ONSET	[]	[]
ENSPHENO:0001263	PARKINSON DISEASE 6 LATE-ONSET SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0001264	PARKINSON DISEASE 8 SUSCEPTIBILITY TO	[]	[]
ENSPHENO:0001265	PARKINSON DISEASE LATE-ONSET	[MIM:168600,MIM:168600]	[PARKINSON DISEASE, LATE-ONSET,PARKINSON DISEASE, LATE-ONSET]
ENSPHENO:0001266	PELVIC ORGAN PROLAPSE SUSCEPTIBILITY TO 2	[MIM:613088,MIM:613088]	[PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2,PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2]
ENSPHENO:0001267	PEPTIDE TRANSPORTER PSF2 POLYMORPHISM	[MIM:170261.0001,MIM:170261.0001]	[TAP2.0001,TAP2.0001]
ENSPHENO:0001268	PERIODIC FEVER FAMILIAL AUTOSOMAL DOMINANT	[MIM:142680,MIM:142680]	[PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT,PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT]
ENSPHENO:0001269	PERIPHERAL DEMYELINATING NEUROPATHY CENTRAL DYSMYELINATION WAARDENBURG SYNDROME AND HIRSCHSPRUNG DISEASE	[]	[]
ENSPHENO:0001270	PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 3	[MIM:601758.0001,MIM:601758.0001]	[PEX12.0001,PEX12.0001]
ENSPHENO:0001271	PI NULL(LUDWIGSHAFEN)	[]	[]
ENSPHENO:0001272	PI P(ST. ALBANS)	[]	[]
ENSPHENO:0001273	PI S(IIYAMA)	[]	[]
ENSPHENO:0001274	PI Z	[]	[]
ENSPHENO:0001275	PILOMATRICOMA SOMATIC	[]	[]
ENSPHENO:0001276	PITUITARY ADENOMA GROWTH HORMONE-SECRETING	[DOID:6255,MIM:102200,MIM:102200]	[growth hormone secreting pituitary adenoma,PITUITARY ADENOMA, GROWTH HORMONE-SECRETING,PITUITARY ADENOMA, GROWTH HORMONE-SECRETING]
ENSPHENO:0001277	PITUITARY HORMONE DEFICIENCY COMBINED 1	[MIM:613038,MIM:613038]	[PITUITARY HORMONE DEFICIENCY, COMBINED, 1,PITUITARY HORMONE DEFICIENCY, COMBINED, 1]
ENSPHENO:0001278	POIKILODERMA WITH NEUTROPENIA	[MIM:604173,MIM:604173]	[POIKILODERMA WITH NEUTROPENIA,POIKILODERMA WITH NEUTROPENIA]
ENSPHENO:0001279	PONTOCEREBELLAR HYPOPLASIA TYPE 4	[MIM:225753,MIM:225753]	[PONTOCEREBELLAR HYPOPLASIA TYPE 4,PONTOCEREBELLAR HYPOPLASIA TYPE 4]
ENSPHENO:0001280	POPLITEAL PTERYGIUM SYNDROME	[MIM:119500,MIM:119500,SCTID_66783006,SCTID_66783006]	[POPLITEAL PTERYGIUM SYNDROME,POPLITEAL PTERYGIUM SYNDROME,Popliteal pterygium syndrome,Popliteal pterygium syndrome]
ENSPHENO:0001281	PORENCEPHALY FAMILIAL	[MIM:175780,MIM:175780]	[PORENCEPHALY, FAMILIAL,PORENCEPHALY, FAMILIAL]
ENSPHENO:0001282	PORPHYRIA ACUTE INTERMITTENT	[DOID:3890,MIM:176000,MIM:176000,SCTID_234422006]	[acute intermittent porphyria,PORPHYRIA, ACUTE INTERMITTENT,PORPHYRIA, ACUTE INTERMITTENT,Acute intermittent porphyria]
ENSPHENO:0001283	PORPHYRIA CONGENITAL ERYTHROPOIETIC	[MIM:263700,MIM:263700,SCTID_22935002]	[PORPHYRIA, CONGENITAL ERYTHROPOIETIC,PORPHYRIA, CONGENITAL ERYTHROPOIETIC,Congenital erythropoietic porphyria]
ENSPHENO:0001284	PRETERM PREMATURE RUPTURE OF THE MEMBRANES	[MIM:610504,MIM:610504,SCTID_312974005,SCTID_312974005]	[PRETERM PREMATURE RUPTURE OF THE MEMBRANES,PRETERM PREMATURE RUPTURE OF THE MEMBRANES,Preterm premature rupture of membranes,Preterm premature rupture of membranes]
ENSPHENO:0001285	PROALBUMIN JAFFNA	[]	[]
ENSPHENO:0001286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS AUTOSOMAL DOMINANT 3	[]	[]
ENSPHENO:0001287	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS AUTOSOMAL DOMINANT 4	[]	[]
ENSPHENO:0001288	PROPROTEIN CONVERTASE SUBTILISIN/KEXIN-TYPE 1	[MIM:162150,MIM:162150]	[PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1,PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1]
ENSPHENO:0001289	PROSTATE CANCER HEREDITARY 10	[MIM:611100,MIM:611100]	[PROSTATE CANCER, HEREDITARY, 10,PROSTATE CANCER, HEREDITARY, 10]
ENSPHENO:0001290	PROSTATE CANCER HEREDITARY 15	[MIM:611959,MIM:611959]	[PROSTATE CANCER, HEREDITARY, 15,PROSTATE CANCER, HEREDITARY, 15]
ENSPHENO:0001291	PSEUDOHERMAPHRODITISM FEMALE WITH HYPOKALEMIA DUE TO GLUCOCORTICOID RESISTANCE	[]	[]
ENSPHENO:0001292	PSORIASIS SUSCEPTIBILITY 1	[MIM:177900,MIM:177900]	[PSORIASIS SUSCEPTIBILITY 1,PSORIASIS SUSCEPTIBILITY 1]
ENSPHENO:0001293	PSORIASIS SUSCEPTIBILITY 11	[MIM:612599,MIM:612599]	[PSORIASIS SUSCEPTIBILITY 11,PSORIASIS SUSCEPTIBILITY 11]
ENSPHENO:0001294	PSORIASIS SUSCEPTIBILITY 13	[]	[]
ENSPHENO:0001295	PSORIASIS SUSCEPTIBILITY 7	[MIM:605606,MIM:605606]	[PSORIASIS SUSCEPTIBILITY 7,PSORIASIS SUSCEPTIBILITY 7]
ENSPHENO:0001296	PULMONARY ARTERIAL HYPERTENSION HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED	[MIM:601284.0001,MIM:601284.0001]	[ACVRL1.0001,ACVRL1.0001]
ENSPHENO:0001297	PYOGENIC STERILE ARTHRITIS PYODERMA GANGRENOSUM AND ACNE	[MIM:604416,MIM:604416]	[PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE,PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE]
ENSPHENO:0001298	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	[MIM:300502.0001,MIM:300502.0001]	[PDHA1.0001,PDHA1.0001]
ENSPHENO:0001299	PYRUVATE KINASE DEFICIENCY	[MIM:609712.0001,MIM:609712.0001,SCTID_124331002]	[PKLR.0001,PKLR.0001,Deficiency of pyruvate kinase]
ENSPHENO:0001300	PYRUVATE KINASE DEFICIENCY AMISH TYPE	[]	[]
ENSPHENO:0001301	Pachyonychia congenita type 1	[DOID:0050449,DOID:0050449,MIM:167200,MIM:167200]	[pachyonychia congenita,pachyonychia congenita,PACHYONYCHIA CONGENITA, TYPE 1,PACHYONYCHIA CONGENITA, TYPE 1]
ENSPHENO:0001302	Paget's disease	[DOID:3443,DOID:3443]	[mammary Paget's disease,mammary Paget's disease]
ENSPHENO:0001303	Pain	[]	[]
ENSPHENO:0001304	Palmoplantar keratoderma epidermolytic	[MIM:144200,MIM:144200]	[PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC,PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC]
ENSPHENO:0001305	Pancreatic cancer	[DOID:1793,DOID:1793,HP:0002894,HP:0002894,MP:0009153,MP:0009153,MIM:260350,MIM:260350]	[pancreatic cancer,pancreatic cancer,Neoplasm of the pancreas,Neoplasm of the pancreas,increased pancreas tumor incidence,increased pancreas tumor incidence,PANCREATIC CANCER,PANCREATIC CANCER]
ENSPHENO:0001306	Panic disorder	[DOID:594,DOID:594,SCTID_371631005,SCTID_371631005]	[panic disorder,panic disorder,Panic disorder,Panic disorder]
ENSPHENO:0001307	Parkinson disease	[DOID:14330,DOID:14330,SCTID_49049000,SCTID_49049000]	[Parkinson's disease,Parkinson's disease,Parkinson's disease,Parkinson's disease]
ENSPHENO:0001308	Parkinson disease type 8	[]	[]
ENSPHENO:0001309	Parkinson's disease	[DOID:14330,DOID:14330,SCTID_49049000,SCTID_49049000]	[Parkinson's disease,Parkinson's disease,Parkinson's disease,Parkinson's disease]
ENSPHENO:0001310	Paroxysmal nocturnal hemoglobinuria	[HP:0004818,HP:0004818,MIM:300818,MIM:300818,SCTID_1963002,SCTID_1963002]	[paroxysmal nocturnal hemoglobinuria,paroxysmal nocturnal hemoglobinuria,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA,Paroxysmal nocturnal hemoglobinuria,Paroxysmal nocturnal hemoglobinuria]
ENSPHENO:0001311	Partial acquired lipodystrophy	[MIM:608709,SCTID_75659004,SCTID_75659004]	[LIPODYSTROPHY, PARTIAL, ACQUIRED,Acquired partial lipodystrophy,Acquired partial lipodystrophy]
ENSPHENO:0001312	Pendred syndrome	[MIM:274600,MIM:274600,SCTID_70348004,SCTID_70348004]	[PENDRED SYNDROME,PENDRED SYNDROME,Pendred's syndrome,Pendred's syndrome]
ENSPHENO:0001313	Personality dimensions	[]	[]
ENSPHENO:0001314	Phenylketonuria	[DOID:9281,DOID:9281,MIM:261600,MIM:261600]	[phenylketonuria,phenylketonuria,PHENYLKETONURIA,PHENYLKETONURIA]
ENSPHENO:0001315	Phospholipid levels (plasma)	[]	[]
ENSPHENO:0001316	Plasma E-selectin levels	[]	[]
ENSPHENO:0001317	Plasma carotenoid and tocopherol levels	[]	[]
ENSPHENO:0001318	Plasma chemerin levels	[]	[]
ENSPHENO:0001319	Plasma eosinophil count	[]	[]
ENSPHENO:0001320	Plasma homocysteine	[]	[]
ENSPHENO:0001321	Plasma level of vitamin B12	[]	[]
ENSPHENO:0001322	Plasma levels of liver enzymes	[]	[]
ENSPHENO:0001323	Plasma vWF and FVIII levels	[]	[]
ENSPHENO:0001324	Platelet aggregation	[]	[]
ENSPHENO:0001325	Platelet counts	[]	[]
ENSPHENO:0001326	Platelet-activating factor acetylhydrolase deficiency	[MIM:601690.0001,MIM:601690.0001]	[PLA2G7.0001,PLA2G7.0001]
ENSPHENO:0001327	Polycystic kidney disease autosomal dominant type 1	[]	[]
ENSPHENO:0001328	Polysubstance addiction	[]	[]
ENSPHENO:0001329	Primary biliary cirrhosis	[DOID:12236,DOID:12236,HP:0002613,HP:0002613,SCTID_31712002,SCTID_31712002]	[primary biliary cirrhosis,primary biliary cirrhosis,Biliary cirrhosis,Biliary cirrhosis,Primary biliary cirrhosis,Primary biliary cirrhosis]
ENSPHENO:0001330	Primary congenital glaucoma type 3A	[]	[]
ENSPHENO:0001331	Primary tooth development (number of teeth)	[]	[]
ENSPHENO:0001332	Progressive Supranuclear Palsy	[DOID:678,DOID:678]	[progressive supranuclear palsy,progressive supranuclear palsy]
ENSPHENO:0001333	Progressive familial intrahepatic cholestasis type 3	[]	[]
ENSPHENO:0001334	Prostate cancer	[DOID:10283,DOID:10283,DOID:10286,DOID:10286,MIM:176807,MIM:176807]	[prostate cancer,prostate cancer,prostate carcinoma,prostate carcinoma,PROSTATE CANCER,PROSTATE CANCER]
ENSPHENO:0001335	Protein quantitative trait loci	[]	[]
ENSPHENO:0001336	Pseudovaginal perineoscrotal hypospadias	[MIM:264600,MIM:264600]	[PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS,PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS]
ENSPHENO:0001337	Pseudoxanthoma elasticum	[DOID:2738,DOID:2738,MIM:264800,MIM:264800,SCTID_252246005,SCTID_252246005]	[pseudoxanthoma elasticum,pseudoxanthoma elasticum,PSEUDOXANTHOMA ELASTICUM,PSEUDOXANTHOMA ELASTICUM,Pseudoxanthoma elasticum,Pseudoxanthoma elasticum]
ENSPHENO:0001338	Psoriasis	[DOID:8893,DOID:8893,HP:0003765,HP:0003765,MP:0001193,MP:0001193,SCTID_9014002,SCTID_9014002]	[psoriasis,psoriasis,Psoriasis,Psoriasis,psoriasis,psoriasis,Psoriasis,Psoriasis]
ENSPHENO:0001339	Psoriatic arthritis	[DOID:9008,DOID:9008]	[psoriatic arthritis,psoriatic arthritis]
ENSPHENO:0001340	Pulmonary function	[MIM:608852,MIM:608852]	[PULMONARY FUNCTION,PULMONARY FUNCTION]
ENSPHENO:0001341	Pulmonary function phenotypes-meanfev1	[]	[]
ENSPHENO:0001342	Pulmonary function phenotypes-meanratio	[]	[]
ENSPHENO:0001343	Pulmonary function phenotypes-ppfef	[]	[]
ENSPHENO:0001344	Pulmonary function phenotypes-ppfefrat	[]	[]
ENSPHENO:0001345	Pulmonary function phenotypes-ppfvc	[]	[]
ENSPHENO:0001346	Pulmonary function phenotypes-ppratio	[]	[]
ENSPHENO:0001347	Pulmonary function traits (other)	[]	[]
ENSPHENO:0001348	Pycnodysostosis	[DOID:0080038,DOID:0080038,MIM:265800,MIM:265800]	[pycnodysostosis,pycnodysostosis,PYCNODYSOSTOSIS,PYCNODYSOSTOSIS]
ENSPHENO:0001349	Pyruvate carboxylase deficiency	[DOID:3651,MIM:266150,MIM:266150,SCTID_87694001,SCTID_87694001]	[pyruvate carboxylase deficiency disease,PYRUVATE CARBOXYLASE DEFICIENCY,PYRUVATE CARBOXYLASE DEFICIENCY,Pyruvate carboxylase deficiency,Pyruvate carboxylase deficiency]
ENSPHENO:0001350	QT INTERVAL VARIATION IN	[MIM:610141,MIM:610141]	[QT INTERVAL, VARIATION IN,QT INTERVAL, VARIATION IN]
ENSPHENO:0001351	QT interval	[]	[]
ENSPHENO:0001352	Quantitative traits	[]	[]
ENSPHENO:0001353	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	[MIM:138750.0001,MIM:138750.0001,MIM:163731.0001,MIM:163731.0001,MIM:600018.0001,MIM:600018.0001,MIM:600532.0001,MIM:600532.0001,MIM:600570.0001,MIM:600570.0001,MIM:601828.0001,MIM:601828.0001,MIM:603779.0001,MIM:603779.0001,MIM:604433.0001,MIM:604433.0001,MIM:605558.0001,MIM:605558.0001,MIM:609526.0001,MIM:609526.0001]	[GLO1.0001,GLO1.0001,NOS1.0001,NOS1.0001,OPRM1.0001,OPRM1.0001,NDUFV2.0001,NDUFV2.0001,CLCN2.0001,CLCN2.0001,NR4A2.0001,NR4A2.0001,SNCAIP.0001,SNCAIP.0001,KCNE3.0001,KCNE3.0001,FGF20.0001,FGF20.0001,PLEKHG4.0001,PLEKHG4.0001]
ENSPHENO:0001354	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1	[MIM:612042,MIM:612042]	[RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1]
ENSPHENO:0001355	REFSUM DISEASE INFANTILE FORM	[MIM:266510,MIM:266510]	[REFSUM DISEASE, INFANTILE FORM,REFSUM DISEASE, INFANTILE FORM]
ENSPHENO:0001356	RENAL AGENESIS	[DOID:14766,DOID:14766,HP:0000104,HP:0000104,MP:0000520,MP:0000520,SCTID_204942005,SCTID_204942005]	[renal agenesis,renal agenesis,Renal agenesis,Renal agenesis,absent kidney,absent kidney,Renal agenesis,Renal agenesis]
ENSPHENO:0001357	RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS	[]	[]
ENSPHENO:0001358	RENAL TUBULAR ACIDOSIS DISTAL AUTOSOMAL RECESSIVE	[MIM:602722,MIM:602722]	[RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE,RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE]
ENSPHENO:0001359	RESTING HEART RATE VARIATION IN	[MIM:607276,MIM:607276]	[RESTING HEART RATE, VARIATION IN,RESTING HEART RATE, VARIATION IN]
ENSPHENO:0001360	RESTLESS LEGS SYNDROME SUSCEPTIBILITY TO 6	[MIM:611185,MIM:611185]	[RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6,RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6]
ENSPHENO:0001361	RESTLESS LEGS SYNDROME SUSCEPTIBILITY TO 7	[MIM:612853,MIM:612853]	[RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7,RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7]
ENSPHENO:0001362	RETINAL CONE DYSTROPHY 3B	[MIM:610356,MIM:610356]	[RETINAL CONE DYSTROPHY 3B,RETINAL CONE DYSTROPHY 3B]
ENSPHENO:0001363	RETINAL DEGENERATION AUTOSOMAL RECESSIVE CLUMPED PIGMENT TYPE	[]	[]
ENSPHENO:0001364	RETINAL DYSTROPHY EARLY-ONSET SEVERE LRAT-RELATED	[MIM:604863.0001,MIM:604863.0001]	[LRAT.0001,LRAT.0001]
ENSPHENO:0001365	RETINITIS PIGMENTOSA 11	[MIM:600138,MIM:600138]	[RETINITIS PIGMENTOSA 11,RETINITIS PIGMENTOSA 11]
ENSPHENO:0001366	RETINITIS PIGMENTOSA 12	[MIM:600105,MIM:600105]	[RETINITIS PIGMENTOSA 12,RETINITIS PIGMENTOSA 12]
ENSPHENO:0001367	RETINITIS PIGMENTOSA 13	[MIM:600059,MIM:600059]	[RETINITIS PIGMENTOSA 13,RETINITIS PIGMENTOSA 13]
ENSPHENO:0001368	RETINITIS PIGMENTOSA 17	[MIM:600852,MIM:600852]	[RETINITIS PIGMENTOSA 17,RETINITIS PIGMENTOSA 17]
ENSPHENO:0001369	RETINITIS PIGMENTOSA 18	[MIM:601414,MIM:601414]	[RETINITIS PIGMENTOSA 18,RETINITIS PIGMENTOSA 18]
ENSPHENO:0001370	RETINITIS PIGMENTOSA 2	[MIM:312600,MIM:312600]	[RETINITIS PIGMENTOSA 2,RETINITIS PIGMENTOSA 2]
ENSPHENO:0001371	RETINITIS PIGMENTOSA 3	[MIM:300029,MIM:300029]	[RETINITIS PIGMENTOSA 3,RETINITIS PIGMENTOSA 3]
ENSPHENO:0001372	RETINITIS PIGMENTOSA 39	[]	[]
ENSPHENO:0001373	RETINITIS PIGMENTOSA 4	[MIM:613731,MIM:613731]	[RETINITIS PIGMENTOSA 4,RETINITIS PIGMENTOSA 4]
ENSPHENO:0001374	RETINITIS PIGMENTOSA 42	[MIM:612943,MIM:612943]	[RETINITIS PIGMENTOSA 42,RETINITIS PIGMENTOSA 42]
ENSPHENO:0001375	RETINITIS PIGMENTOSA 49	[MIM:613756,MIM:613756]	[RETINITIS PIGMENTOSA 49,RETINITIS PIGMENTOSA 49]
ENSPHENO:0001376	RETINITIS PIGMENTOSA 50	[MIM:613194,MIM:613194]	[RETINITIS PIGMENTOSA 50,RETINITIS PIGMENTOSA 50]
ENSPHENO:0001377	RETINITIS PIGMENTOSA 54	[MIM:613428,MIM:613428]	[RETINITIS PIGMENTOSA 54,RETINITIS PIGMENTOSA 54]
ENSPHENO:0001378	RETINITIS PIGMENTOSA 7 WITH BULL'S-EYE MACULOPATHY	[]	[]
ENSPHENO:0001379	RETINOBLASTOMA	[DOID:768,DOID:768,HP:0009919,HP:0009919,MP:0006310,MP:0006310,MIM:180200,MIM:180200,SCTID_370967009,SCTID_370967009]	[retinoblastoma,retinoblastoma,Retinoblastoma,Retinoblastoma,retinoblastoma,retinoblastoma,RETINOBLASTOMA,RETINOBLASTOMA,Retinoblastoma,Retinoblastoma]
ENSPHENO:0001380	RETINOBLASTOMA-BINDING PROTEIN 8	[MIM:604124,MIM:604124]	[RETINOBLASTOMA-BINDING PROTEIN 8,RETINOBLASTOMA-BINDING PROTEIN 8]
ENSPHENO:0001381	RETINOSCHISIS 1 X-LINKED JUVENILE	[MIM:312700,MIM:312700]	[RETINOSCHISIS 1, X-LINKED, JUVENILE,RETINOSCHISIS 1, X-LINKED, JUVENILE]
ENSPHENO:0001382	RETT SYNDROME ZAPPELLA VARIANT	[MIM:300005.0001,MIM:300005.0001]	[MECP2.0001,MECP2.0001]
ENSPHENO:0001383	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA TYPE 3	[MIM:600121,MIM:600121]	[RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3,RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3]
ENSPHENO:0001384	RIEGER ANOMALY	[DOID:14686,DOID:14686,HP:0000558,HP:0000558,MIM:601090.0001,MIM:601090.0001]	[Axenfeld-Rieger syndrome,Axenfeld-Rieger syndrome,Rieger anomaly,Rieger anomaly,FOXC1.0001,FOXC1.0001]
ENSPHENO:0001385	RIGID SPINE MUSCULAR DYSTROPHY 1	[MIM:602771,MIM:602771]	[RIGID SPINE MUSCULAR DYSTROPHY 1,RIGID SPINE MUSCULAR DYSTROPHY 1]
ENSPHENO:0001386	RING DERMOID OF CORNEA	[MIM:180550,MIM:180550]	[RING DERMOID OF CORNEA,RING DERMOID OF CORNEA]
ENSPHENO:0001387	RIPPLING MUSCLE DISEASE 2	[]	[]
ENSPHENO:0001388	ROBERTS SYNDROME	[DOID:5325,DOID:5325,MIM:268300,MIM:268300]	[Roberts syndrome,Roberts syndrome,ROBERTS SYNDROME,ROBERTS SYNDROME]
ENSPHENO:0001389	ROD MONOCHROMACY	[MIM:600053.0001,MIM:600053.0001]	[CNGA3.0001,CNGA3.0001]
ENSPHENO:0001390	RR interval (heart rate)	[]	[]
ENSPHENO:0001391	Reasoning	[]	[]
ENSPHENO:0001392	Recombination rate (males)	[]	[]
ENSPHENO:0001393	Recombination rate-Recombination rate gender specific in males	[]	[]
ENSPHENO:0001394	Red blood cell traits	[]	[]
ENSPHENO:0001395	Renal cell carcinoma	[DOID:4450,DOID:4450,HP:0005584,HP:0005584]	[renal cell carcinoma,renal cell carcinoma,Renal cell carcinoma,Renal cell carcinoma]
ENSPHENO:0001396	Response to TNF antagonist treatment	[]	[]
ENSPHENO:0001397	Response to antidepressants	[]	[]
ENSPHENO:0001398	Response to antineoplastic agents	[]	[]
ENSPHENO:0001399	Response to antipsychotic therapy (extrapyramidal side effects)	[]	[]
ENSPHENO:0001400	Response to antipsychotic treatment	[]	[]
ENSPHENO:0001401	Response to diuretic therapy	[]	[]
ENSPHENO:0001402	Response to statin therapy	[]	[]
ENSPHENO:0001403	Response to treatment for acute lymphoblastic leukemia	[]	[]
ENSPHENO:0001404	Restless Leg Syndrome	[DOID:0050425]	[restless legs syndrome]
ENSPHENO:0001405	Restless Leg Syndrome-Periodic Leg Movements	[]	[]
ENSPHENO:0001406	Restless legs syndrome	[DOID:0050425,DOID:0050425]	[restless legs syndrome,restless legs syndrome]
ENSPHENO:0001407	Retinal vascular caliber	[]	[]
ENSPHENO:0001408	Rett syndrome	[DOID:1206,DOID:1206,MIM:312750,MIM:312750,SCTID_68618008]	[Rett syndrome,Rett syndrome,RETT SYNDROME,RETT SYNDROME,Rett's disorder]
ENSPHENO:0001409	Rheumatoid Arthritis cyclic citrullinated peptide (CCP) positive	[]	[]
ENSPHENO:0001410	Rheumatoid arthritis	[DOID:7148,DOID:7148,HP:0001370,HP:0001370,MP:0003561,MP:0003561,MIM:180300,MIM:180300,SCTID_69896004,SCTID_69896004]	[rheumatoid arthritis,rheumatoid arthritis,Rheumatoid arthritis,Rheumatoid arthritis,rheumatoid arthritis,rheumatoid arthritis,RHEUMATOID ARTHRITIS,RHEUMATOID ARTHRITIS,Rheumatoid arthritis,Rheumatoid arthritis]
ENSPHENO:0001411	Rickets vitamin D-dependent type 1A	[]	[]
ENSPHENO:0001412	Rippling muscle disease	[MIM:606072,MIM:606072]	[RIPPLING MUSCLE DISEASE,RIPPLING MUSCLE DISEASE]
ENSPHENO:0001413	SAETHRE-CHOTZEN SYNDROME	[DOID:14768,DOID:14768,MIM:101400,MIM:101400,SCTID_83015004,SCTID_83015004]	[Saethre-Chotzen syndrome,Saethre-Chotzen syndrome,SAETHRE-CHOTZEN SYNDROME,SAETHRE-CHOTZEN SYNDROME,Saethre-Chotzen syndrome,Saethre-Chotzen syndrome]
ENSPHENO:0001414	SANFILIPPO SYNDROME A	[DOID:12801,DOID:12801,MIM:605270.0001,MIM:605270.0001]	[mucopolysaccharidosis III,mucopolysaccharidosis III,SGSH.0001,SGSH.0001]
ENSPHENO:0001415	SARCOIDOSIS EARLY-ONSET	[MIM:609464,MIM:609464]	[SARCOIDOSIS, EARLY-ONSET,SARCOIDOSIS, EARLY-ONSET]
ENSPHENO:0001416	SC PHOCOMELIA SYNDROME	[DOID:0050536,DOID:0050536,MIM:269000,MIM:269000]	[SC phocomelia syndrome,SC phocomelia syndrome,SC PHOCOMELIA SYNDROME,SC PHOCOMELIA SYNDROME]
ENSPHENO:0001417	SCAD DEFICIENCY	[MIM:606885.0001,MIM:606885.0001]	[ACADS.0001,ACADS.0001]
ENSPHENO:0001418	SCHIZOPHRENIA 7	[MIM:603176,MIM:603176]	[SCHIZOPHRENIA 7,SCHIZOPHRENIA 7]
ENSPHENO:0001419	SCHIZOPHRENIA SUSCEPTIBILITY TO	[MIM:126451.0001,MIM:126451.0001,MIM:182135.0001,MIM:182135.0001,MIM:605210.0001,MIM:605210.0001,MIM:605566.0001,MIM:605566.0001]	[DRD3.0001,DRD3.0001,HTR2A.0001,HTR2A.0001,DISC1.0001,DISC1.0001,RTN4R.0001,RTN4R.0001]
ENSPHENO:0001420	SCIANNA BLOOD GROUP SYSTEM SC:-12	[MIM:609017.0001,MIM:609017.0001]	[ERMAP.0001,ERMAP.0001]
ENSPHENO:0001421	SCIANNA BLOOD GROUP SYSTEM STAR ANTIGEN	[]	[]
ENSPHENO:0001422	SCOLIOSIS IDIOPATHIC SUSCEPTIBILITY TO 3	[MIM:608765,MIM:608765]	[SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3,SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3]
ENSPHENO:0001423	SEIZURES BENIGN FAMILIAL NEONATAL 1	[MIM:121200,MIM:121200]	[SEIZURES, BENIGN FAMILIAL NEONATAL, 1,SEIZURES, BENIGN FAMILIAL NEONATAL, 1]
ENSPHENO:0001424	SEIZURES BENIGN FAMILIAL NEONATAL 1 AND/OR MYOKYMIA	[]	[]
ENSPHENO:0001425	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION	[]	[]
ENSPHENO:0001426	SEVERE COMBINED IMMUNODEFICIENCY AUTOSOMAL RECESSIVE T CELL-NEGATIVE B CELL-POSITIVE NK CELL-POSITIVE	[]	[]
ENSPHENO:0001427	SEVERE COMBINED IMMUNODEFICIENCY B CELL-NEGATIVE	[MIM:179615.0001,MIM:179615.0001,MIM:179616.0001,MIM:179616.0001]	[RAG1.0001,RAG1.0001,RAG2.0001,RAG2.0001]
ENSPHENO:0001428	SEVERE COMBINED IMMUNODEFICIENCY X-LINKED	[DOID:0060013,MIM:300400,MIM:300400,SCTID_203592006]	[gamma chain deficiency,SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED,SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED,X-linked severe combined immunodeficiency]
ENSPHENO:0001429	SEX HORMONE-BINDING GLOBULIN	[MIM:182205,MIM:182205]	[SEX HORMONE-BINDING GLOBULIN,SEX HORMONE-BINDING GLOBULIN]
ENSPHENO:0001430	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS	[]	[]
ENSPHENO:0001431	SHORT STATURE IDIOPATHIC AUTOSOMAL	[MIM:604271,MIM:604271]	[SHORT STATURE, IDIOPATHIC, AUTOSOMAL,SHORT STATURE, IDIOPATHIC, AUTOSOMAL]
ENSPHENO:0001432	SIALIDOSIS TYPE I	[MIM:608272.0001,MIM:608272.0001]	[NEU1.0001,NEU1.0001]
ENSPHENO:0001433	SIALIDOSIS TYPE II	[]	[]
ENSPHENO:0001434	SICKLE CELL ANEMIA	[DOID:10923,DOID:10923,MIM:603903,MIM:603903]	[sickle cell anemia,sickle cell anemia,SICKLE CELL ANEMIA,SICKLE CELL ANEMIA]
ENSPHENO:0001435	SKIN/HAIR/EYE PIGMENTATION 2 BLOND HAIR/FAIR SKIN	[]	[]
ENSPHENO:0001436	SKIN/HAIR/EYE PIGMENTATION 2 RED HAIR/FAIR SKIN	[MIM:155555.0001,MIM:155555.0001]	[MC1R.0001,MC1R.0001]
ENSPHENO:0001437	SKIN/HAIR/EYE PIGMENTATION 3 LIGHT/DARK SKIN	[]	[]
ENSPHENO:0001438	SKIN/HAIR/EYE PIGMENTATION VARIATION IN 3	[MIM:601800,MIM:601800]	[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3,SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3]
ENSPHENO:0001439	SKIN/HAIR/EYE PIGMENTATION VARIATION IN 5	[MIM:227240,MIM:227240]	[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5,SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5]
ENSPHENO:0001440	SLE	[]	[]
ENSPHENO:0001441	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE) MEMBER 2	[MIM:193001,MIM:193001]	[SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2,SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2]
ENSPHENO:0001442	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER ARALAR) MEMBER 12	[MIM:603667,MIM:603667]	[SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12,SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12]
ENSPHENO:0001443	SOLUTE CARRIER FAMILY 45 MEMBER 2	[MIM:606202,MIM:606202]	[SOLUTE CARRIER FAMILY 45, MEMBER 2,SOLUTE CARRIER FAMILY 45, MEMBER 2]
ENSPHENO:0001444	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER SEROTONIN) MEMBER 4	[]	[]
ENSPHENO:0001445	SORBIN AND SH3-DOMAINS CONTAINING 1	[MIM:605264,MIM:605264]	[SORBIN AND SH3-DOMAINS CONTAINING 1,SORBIN AND SH3-DOMAINS CONTAINING 1]
ENSPHENO:0001446	SPASTIC PARAPLEGIA 3 AUTOSOMAL DOMINANT	[MIM:182600,MIM:182600]	[SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT,SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT]
ENSPHENO:0001447	SPASTIC PARAPLEGIA 4	[MIM:604277.0001,MIM:604277.0001]	[SPG4.0001,SPG4.0001]
ENSPHENO:0001448	SPECIFIC LANGUAGE IMPAIRMENT 1	[MIM:606711,MIM:606711]	[SPECIFIC LANGUAGE IMPAIRMENT 1,SPECIFIC LANGUAGE IMPAIRMENT 1]
ENSPHENO:0001449	SPINAL MUSCULAR ATROPHY TYPE I	[MIM:253300,MIM:253300]	[SPINAL MUSCULAR ATROPHY, TYPE I,SPINAL MUSCULAR ATROPHY, TYPE I]
ENSPHENO:0001450	SPINAL MUSCULAR ATROPHY TYPE II	[MIM:253550,MIM:253550,SCTID_128212001,SCTID_128212001]	[SPINAL MUSCULAR ATROPHY, TYPE II,SPINAL MUSCULAR ATROPHY, TYPE II,Spinal muscular atrophy, type II,Spinal muscular atrophy, type II]
ENSPHENO:0001451	SPINOCEREBELLAR ATAXIA 1	[DOID:14784,DOID:14784,MIM:164400,MIM:164400]	[olivopontocerebellar atrophy,olivopontocerebellar atrophy,SPINOCEREBELLAR ATAXIA 1,SPINOCEREBELLAR ATAXIA 1]
ENSPHENO:0001452	SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 1	[MIM:606002,MIM:606002]	[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1,SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1]
ENSPHENO:0001453	SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 8	[MIM:610743,MIM:610743]	[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8,SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8]
ENSPHENO:0001454	SPONDYLOCOSTAL DYSOSTOSIS 1 AUTOSOMAL RECESSIVE	[MIM:277300,MIM:277300]	[SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE,SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE]
ENSPHENO:0001455	SPONDYLOEPIMETAPHYSEAL DYSPLASIA MATN3-RELATED	[]	[]
ENSPHENO:0001456	SPONDYLOMETAEPIPHYSEAL DYSPLASIA SHORT LIMB-HAND TYPE	[MIM:271665,MIM:271665]	[SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE,SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE]
ENSPHENO:0001457	SPONDYLOMETAPHYSEAL DYSPLASIA KOZLOWSKI TYPE	[MIM:184252,MIM:184252]	[SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE,SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE]
ENSPHENO:0001458	STARGARDT DISEASE 1	[MIM:248200,MIM:248200]	[STARGARDT DISEASE 1,STARGARDT DISEASE 1]
ENSPHENO:0001459	STATURE AS A QUANTITATIVE TRAIT	[MIM:606255,MIM:606255]	[STATURE AS A QUANTITATIVE TRAIT,STATURE AS A QUANTITATIVE TRAIT]
ENSPHENO:0001460	STATURE QUANTITATIVE TRAIT LOCUS 12	[MIM:612224,MIM:612224]	[STATURE QUANTITATIVE TRAIT LOCUS 12,STATURE QUANTITATIVE TRAIT LOCUS 12]
ENSPHENO:0001461	STATURE QUANTITATIVE TRAIT LOCUS 14	[MIM:612228,MIM:612228]	[STATURE QUANTITATIVE TRAIT LOCUS 14,STATURE QUANTITATIVE TRAIT LOCUS 14]
ENSPHENO:0001462	STATURE QUANTITATIVE TRAIT LOCUS 22	[MIM:613547,MIM:613547]	[STATURE QUANTITATIVE TRAIT LOCUS 22,STATURE QUANTITATIVE TRAIT LOCUS 22]
ENSPHENO:0001463	STATURE QUANTITATIVE TRAIT LOCUS 9	[MIM:611547,MIM:611547]	[STATURE QUANTITATIVE TRAIT LOCUS 9,STATURE QUANTITATIVE TRAIT LOCUS 9]
ENSPHENO:0001464	STEROID 5-ALPHA-REDUCTASE POLYMORPHISM	[]	[]
ENSPHENO:0001465	STROKE ISCHEMIC	[HP:0002140,MIM:601367,MIM:601367,SCTID_422504002]	[Ischemic stroke,STROKE, ISCHEMIC,STROKE, ISCHEMIC,Ischemic stroke]
ENSPHENO:0001466	SUBCORTICAL LAMINAR HETEROTOPIA	[]	[]
ENSPHENO:0001467	SUBCORTICAL LAMINAR HETEROTOPIA X-LINKED	[]	[]
ENSPHENO:0001468	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	[DOID:0060175,DOID:0060175,MIM:271980,MIM:271980]	[succinic semialdehyde dehydrogenase deficiency,succinic semialdehyde dehydrogenase deficiency,SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY,SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY]
ENSPHENO:0001469	SULFOTRANSFERASE FAMILY 1A PHENOL-PREFERRING MEMBER 1	[MIM:171150,MIM:171150]	[SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 1,SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 1]
ENSPHENO:0001470	SUPEROXIDE DISMUTASE 2 POLYMORPHISM	[MIM:147460.0001,MIM:147460.0001]	[SOD2.0001,SOD2.0001]
ENSPHENO:0001471	SYMPHALANGISM PROXIMAL	[HP:0100264,MIM:185800,MIM:185800]	[Proximal symphalangism,SYMPHALANGISM, PROXIMAL,SYMPHALANGISM, PROXIMAL]
ENSPHENO:0001472	SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATION WITH SUSCEPTIBILITY TO 10	[]	[]
ENSPHENO:0001473	SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 10	[MIM:612251,MIM:612251]	[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10,SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10]
ENSPHENO:0001474	SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 14	[MIM:613145,MIM:613145]	[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14,SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14]
ENSPHENO:0001475	SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 15	[MIM:300809,MIM:300809]	[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15,SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15]
ENSPHENO:0001476	SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 9	[MIM:610927,MIM:610927]	[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9,SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9]
ENSPHENO:0001477	Schizophrenia	[DOID:5419,DOID:5419,HP:0100753,HP:0100753,MIM:181500,MIM:181500,SCTID_58214004,SCTID_58214004]	[schizophrenia,schizophrenia,Schizophrenia,Schizophrenia,SCHIZOPHRENIA,SCHIZOPHRENIA,Schizophrenia,Schizophrenia]
ENSPHENO:0001478	Schizophrenia bipolar disorder and depression (combined)	[]	[]
ENSPHENO:0001479	Schizophrenia-Schizophrenia gender differentiated in females	[]	[]
ENSPHENO:0001480	Schizophrenia-Schizophrenia gender differentiated in males	[]	[]
ENSPHENO:0001481	Self-rated health	[]	[]
ENSPHENO:0001482	Serum LDL cholesterol levels	[]	[]
ENSPHENO:0001483	Serum calcium	[]	[]
ENSPHENO:0001484	Serum creatinine	[]	[]
ENSPHENO:0001485	Serum dehydroepiandrosterone sulphate levels	[]	[]
ENSPHENO:0001486	Serum hepcidin	[]	[]
ENSPHENO:0001487	Serum iron levels	[]	[]
ENSPHENO:0001488	Serum magnesium levels	[]	[]
ENSPHENO:0001489	Serum markers of iron status	[]	[]
ENSPHENO:0001490	Serum metabolites	[]	[]
ENSPHENO:0001491	Serum phosphorus levels	[]	[]
ENSPHENO:0001492	Serum urate	[]	[]
ENSPHENO:0001493	Serum uric acid	[]	[]
ENSPHENO:0001494	Serum uric acid levels	[]	[]
ENSPHENO:0001495	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative	[]	[]
ENSPHENO:0001496	Shwachman-Diamond syndrome	[MIM:260400,MIM:260400]	[SHWACHMAN-DIAMOND SYNDROME,SHWACHMAN-DIAMOND SYNDROME]
ENSPHENO:0001497	Sialidosis	[SCTID_38795005,SCTID_38795005]	[Sialidosis,Sialidosis]
ENSPHENO:0001498	Skin pigmentation	[]	[]
ENSPHENO:0001499	Skin sensitivity to sun	[]	[]
ENSPHENO:0001500	Sleep and circadian phenotypes-Epworth Sleepiness Scale score	[]	[]
ENSPHENO:0001501	Sleep and circadian phenotypes-Usual Bedtime (questionnaire)	[]	[]
ENSPHENO:0001502	Sleep and circadian phenotypes-Usual Sleep Duration (questionnaire)	[]	[]
ENSPHENO:0001503	Smith-Lemli-Opitz syndrome	[DOID:14692,DOID:14692,MIM:270400,MIM:270400,SCTID_43929004,SCTID_43929004]	[Smith-Lemli-Opitz syndrome,Smith-Lemli-Opitz syndrome,SMITH-LEMLI-OPITZ SYNDROME,SMITH-LEMLI-OPITZ SYNDROME,Smith-Lemli-Opitz syndrome,Smith-Lemli-Opitz syndrome]
ENSPHENO:0001504	Smoking behavior	[]	[]
ENSPHENO:0001505	Sphingolipid levels	[]	[]
ENSPHENO:0001506	Spinocerebellar ataxia autosomal recessive type 1	[]	[]
ENSPHENO:0001507	Sporadic Amyotrophic Lateral Sclerosis (ALS)	[]	[]
ENSPHENO:0001508	Sporadic Amyotrophic Lateral Sclerosis (ALS)-Amyotrophic Lateral Sclerosis (ALS) gender differentiated	[]	[]
ENSPHENO:0001509	Sporadic Amyotrophic Lateral Sclerosis (ALS)-Bulbar Onset Amyotrophic Lateral Sclerosis (ALS)	[]	[]
ENSPHENO:0001510	Sporadic Amyotrophic Lateral Sclerosis (ALS)-Early Onset Amyotrophic Lateral Sclerosis (ALS)	[]	[]
ENSPHENO:0001511	Sporadic post-menopausal breast cancer	[]	[]
ENSPHENO:0001512	Squamous cell carcinoma	[DOID:1749,DOID:1749,HP:0002860,HP:0002860,MP:0004207,MP:0004207,SCTID_402815007,SCTID_402815007]	[squamous cell carcinoma,squamous cell carcinoma,Squamous cell carcinoma,Squamous cell carcinoma,squamous cell carcinoma,squamous cell carcinoma,Squamous cell carcinoma,Squamous cell carcinoma]
ENSPHENO:0001513	Stargardt disease type 1	[]	[]
ENSPHENO:0001514	Stroke	[DOID:3455,DOID:3455,HP:0001297,HP:0001297]	[cerebrovascular accident,cerebrovascular accident,Stroke,Stroke]
ENSPHENO:0001515	Stroke-Lacunar Stroke	[]	[]
ENSPHENO:0001516	Subclinical atherosclerosis traits (other)	[]	[]
ENSPHENO:0001517	Subclinical atherosclerosis-Ankle brachial index	[]	[]
ENSPHENO:0001518	Subclinical atherosclerosis-Common carotid artery IMT (intimal medial thickness)	[]	[]
ENSPHENO:0001519	Subclinical atherosclerosis-Coronary artery calcification	[]	[]
ENSPHENO:0001520	Subclinical atherosclerosis-Internal carotid artery IMT (intimal medial thickness)	[]	[]
ENSPHENO:0001521	Sudden cardiac arrest	[]	[]
ENSPHENO:0001522	Suicide attempts in bipolar disorder	[]	[]
ENSPHENO:0001523	Systemic Lupus Erythematosus (SLE) gender differentiated in women	[]	[]
ENSPHENO:0001524	Systemic lupus erythematosus	[DOID:9074,DOID:9074,HP:0002725,HP:0002725,MIM:152700,MIM:152700,SCTID_55464009,SCTID_55464009]	[systemic lupus erythematosus,systemic lupus erythematosus,Systemic lupus erythematosus,Systemic lupus erythematosus,SYSTEMIC LUPUS ERYTHEMATOSUS,SYSTEMIC LUPUS ERYTHEMATOSUS,Systemic lupus erythematosus,Systemic lupus erythematosus]
ENSPHENO:0001525	Systemic sclerosis	[DOID:418,DOID:418,SCTID_89155008,SCTID_89155008]	[systemic scleroderma,systemic scleroderma,Systemic sclerosis,Systemic sclerosis]
ENSPHENO:0001526	Systolic blood pressure	[]	[]
ENSPHENO:0001527	TAY-SACHS DISEASE	[DOID:3320,DOID:3320,MIM:272800,MIM:272800,SCTID_111385000,SCTID_111385000]	[Tay-Sachs disease,Tay-Sachs disease,TAY-SACHS DISEASE,TAY-SACHS DISEASE,Tay-Sachs disease,Tay-Sachs disease]
ENSPHENO:0001528	TCN2 POLYMORPHISM	[]	[]
ENSPHENO:0001529	TELANGIECTASIA HEREDITARY HEMORRHAGIC TYPE 2	[MIM:600376,MIM:600376]	[TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2,TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2]
ENSPHENO:0001530	TELOMERE LENGTH MEAN LEUKOCYTE	[MIM:609113,MIM:609113]	[TELOMERE LENGTH, MEAN LEUKOCYTE,TELOMERE LENGTH, MEAN LEUKOCYTE]
ENSPHENO:0001531	TESTICULAR TUMORS	[MIM:273300,MIM:273300]	[TESTICULAR TUMORS,TESTICULAR TUMORS]
ENSPHENO:0001532	THROMBASTHENIA OF GLANZMANN AND NAEGELI	[MIM:273800,MIM:273800]	[THROMBASTHENIA OF GLANZMANN AND NAEGELI,THROMBASTHENIA OF GLANZMANN AND NAEGELI]
ENSPHENO:0001533	THROMBOCYTOPENIA 2	[MIM:188000,MIM:188000]	[THROMBOCYTOPENIA 2,THROMBOCYTOPENIA 2]
ENSPHENO:0001534	THROMBOCYTOPENIA AUTOSOMAL DOMINANT 2	[MIM:608221.0001,MIM:608221.0001]	[MASTL.0001,MASTL.0001]
ENSPHENO:0001535	THROMBOPHILIA DUE TO FACTOR V LEIDEN	[MIM:612309.0001,MIM:612309.0001]	[F5.0001,F5.0001]
ENSPHENO:0001536	THROMBOSIS SUSCEPTIBILITY TO	[MIM:188050,MIM:188050]	[THROMBOSIS, SUSCEPTIBILITY TO,THROMBOSIS, SUSCEPTIBILITY TO]
ENSPHENO:0001537	THYROID CARCINOMA FAMILIAL MEDULLARY	[DOID:0050547,DOID:0050547,MIM:155240,MIM:155240]	[familial medullary thyroid carcinoma,familial medullary thyroid carcinoma,THYROID CARCINOMA, FAMILIAL MEDULLARY,THYROID CARCINOMA, FAMILIAL MEDULLARY]
ENSPHENO:0001538	THYROID DYSHORMONOGENESIS 2A	[MIM:274500,MIM:274500]	[THYROID DYSHORMONOGENESIS 2A,THYROID DYSHORMONOGENESIS 2A]
ENSPHENO:0001539	THYROID DYSHORMONOGENESIS 6	[MIM:607200,MIM:607200]	[THYROID DYSHORMONOGENESIS 6,THYROID DYSHORMONOGENESIS 6]
ENSPHENO:0001540	THYROID HORMONE RESISTANCE GENERALIZED AUTOSOMAL DOMINANT	[MIM:188570,MIM:188570]	[THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT,THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT]
ENSPHENO:0001541	THYROXINE-BINDING GLOBULIN VARIANT P	[]	[]
ENSPHENO:0001542	TIETZ ALBINISM-DEAFNESS SYNDROME	[SCTID_403805009]	[Albinism-deafness syndrome of Tietz]
ENSPHENO:0001543	TOLL-LIKE RECEPTOR 3	[MIM:603029,MIM:603029]	[TOLL-LIKE RECEPTOR 3,TOLL-LIKE RECEPTOR 3]
ENSPHENO:0001544	TOOTH AGENESIS SELECTIVE 3	[MIM:604625,MIM:604625]	[TOOTH AGENESIS, SELECTIVE, 3,TOOTH AGENESIS, SELECTIVE, 3]
ENSPHENO:0001545	TORSIN 1A	[MIM:605204,MIM:605204]	[TORSIN 1A,TORSIN 1A]
ENSPHENO:0001546	TOWNES-BROCKS SYNDROME	[MIM:107480,MIM:107480]	[TOWNES-BROCKS SYNDROME,TOWNES-BROCKS SYNDROME]
ENSPHENO:0001547	TRANSCRIPTION FACTOR 7-LIKE 2	[MIM:602228,MIM:602228]	[TRANSCRIPTION FACTOR 7-LIKE 2,TRANSCRIPTION FACTOR 7-LIKE 2]
ENSPHENO:0001548	TRANSFERRIN	[MIM:190000,MIM:190000]	[TRANSFERRIN,TRANSFERRIN]
ENSPHENO:0001549	TREACHER COLLINS SYNDROME	[DOID:2908,DOID:2908,MIM:606847.0001,MIM:606847.0001,SCTID_82203000,SCTID_82203000]	[Treacher Collins syndrome,Treacher Collins syndrome,TCOF1.0001,TCOF1.0001,Treacher Collins syndrome,Treacher Collins syndrome]
ENSPHENO:0001550	TRICHORHINOPHALANGEAL SYNDROME TYPE I	[DOID:14743,DOID:14743,MIM:190350,MIM:190350]	[trichorhinophalangeal syndrome type I,trichorhinophalangeal syndrome type I,TRICHORHINOPHALANGEAL SYNDROME, TYPE I,TRICHORHINOPHALANGEAL SYNDROME, TYPE I]
ENSPHENO:0001551	TRIMETHYLAMINURIA	[HP:0003614,HP:0003614,MIM:602079,MIM:602079,SCTID_237959005,SCTID_237959005]	[Trimethylaminuria,Trimethylaminuria,TRIMETHYLAMINURIA,TRIMETHYLAMINURIA,Trimethylaminuria,Trimethylaminuria]
ENSPHENO:0001552	TRITANOPIA	[DOID:11661,DOID:11661,MIM:190900,MIM:190900,SCTID_85049009,SCTID_85049009]	[blue color blindness,blue color blindness,TRITANOPIA,TRITANOPIA,Tritanopia,Tritanopia]
ENSPHENO:0001553	TUBERCULOSIS SUSCEPTIBILITY TO	[MIM:602441.0001,MIM:602441.0001]	[CISH.0001,CISH.0001]
ENSPHENO:0001554	TUBEROUS SCLEROSIS 1	[MIM:191100,MIM:191100]	[TUBEROUS SCLEROSIS 1,TUBEROUS SCLEROSIS 1]
ENSPHENO:0001555	TUBEROUS SCLEROSIS 2	[MIM:613254,MIM:613254]	[TUBEROUS SCLEROSIS 2,TUBEROUS SCLEROSIS 2]
ENSPHENO:0001556	TUMORAL CALCINOSIS FAMILIAL HYPERPHOSPHATEMIC	[MIM:211900]	[TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL]
ENSPHENO:0001557	TYROSINASE	[MIM:606933,MIM:606933]	[TYROSINASE,TYROSINASE]
ENSPHENO:0001558	TYROSINEMIA TYPE I	[MIM:276700,MIM:276700,SCTID_410056006,SCTID_410056006]	[TYROSINEMIA, TYPE I,TYROSINEMIA, TYPE I,Tyrosinemia type I,Tyrosinemia type I]
ENSPHENO:0001559	TYROSINEMIA TYPE II	[MIM:276600,MIM:276600]	[TYROSINEMIA, TYPE II,TYROSINEMIA, TYPE II]
ENSPHENO:0001560	Tanning	[]	[]
ENSPHENO:0001561	Telomere length	[]	[]
ENSPHENO:0001562	Testicular germ cell cancer	[DOID:5557,DOID:5557]	[testicular germ cell cancer,testicular germ cell cancer]
ENSPHENO:0001563	Testicular germ cell tumor	[]	[]
ENSPHENO:0001564	Tetralogy of Fallot	[DOID:6419,DOID:6419,HP:0001636,HP:0001636,MIM:187500,MIM:187500,SCTID_86299006,SCTID_86299006]	[tetralogy of Fallot,tetralogy of Fallot,Tetralogy of Fallot,Tetralogy of Fallot,TETRALOGY OF FALLOT,TETRALOGY OF FALLOT,Tetralogy of Fallot,Tetralogy of Fallot]
ENSPHENO:0001565	Thiamine-responsive megaloblastic anemia syndrome	[MIM:249270,MIM:249270]	[THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME,THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME]
ENSPHENO:0001566	Thiopurine S-methyltransferase deficiency	[MIM:610460,MIM:610460,SCTID_238012003,SCTID_238012003]	[THIOPURINE S-METHYLTRANSFERASE DEFICIENCY,THIOPURINE S-METHYLTRANSFERASE DEFICIENCY,Thiopurine methyltransferase deficiency,Thiopurine methyltransferase deficiency]
ENSPHENO:0001567	Thrombocytopenia type 2	[]	[]
ENSPHENO:0001568	Thyroid volume	[]	[]
ENSPHENO:0001569	Tonometry	[]	[]
ENSPHENO:0001570	Total ventricular volume	[]	[]
ENSPHENO:0001571	Transient familial neonatal hyperbilirubinemia	[MIM:237900]	[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL]
ENSPHENO:0001572	Triglycerides	[]	[]
ENSPHENO:0001573	Tuberculosis	[DOID:399,DOID:399,SCTID_56717001,SCTID_56717001]	[tuberculosis,tuberculosis,Tuberculosis,Tuberculosis]
ENSPHENO:0001574	Two-hour glucose challenge	[]	[]
ENSPHENO:0001575	Type 1 diabetes	[]	[]
ENSPHENO:0001576	Type 1 diabetes autoantibodies	[]	[]
ENSPHENO:0001577	Type 2 diabetes	[]	[]
ENSPHENO:0001578	Type I Diabetes	[]	[]
ENSPHENO:0001579	Type II Diabetes Mellitus	[HP:0005978,HP:0005978,MIM:138033.0001,MIM:138430.0001,MIM:164731.0001,MIM:601724.0001]	[Type II diabetes mellitus,Type II diabetes mellitus,GCGR.0001,GPD2.0001,AKT2.0001,NEUROD1.0001]
ENSPHENO:0001580	Type II Diabetes Mellitus-Early onset Type II Diabetes Mellitus	[]	[]
ENSPHENO:0001581	Type II Diabetes Mellitus-End stage renal disease	[]	[]
ENSPHENO:0001582	Type II Diabetes Mellitus-FPG	[]	[]
ENSPHENO:0001583	Type II Diabetes Mellitus-Fasting glucose	[]	[]
ENSPHENO:0001584	Type II Diabetes Mellitus-Fasting insulin	[]	[]
ENSPHENO:0001585	Type II Diabetes Mellitus-Glucose - glucose tolerance test	[]	[]
ENSPHENO:0001586	Type II Diabetes Mellitus-HOMA-IR	[]	[]
ENSPHENO:0001587	Type II Diabetes Mellitus-HbA1c	[]	[]
ENSPHENO:0001588	Type II Diabetes Mellitus-ISI_0-120	[]	[]
ENSPHENO:0001589	Type II Diabetes Mellitus-Insulinogenic Index	[]	[]
ENSPHENO:0001590	Type II Diabetes Mellitus-Type II Diabetes Mellitus in NonObese Subjects	[]	[]
ENSPHENO:0001591	Type II Diabetes Mellitus-Type II Diabetes Mellitus in Obese Subjects	[]	[]
ENSPHENO:0001592	Type II Diabetes Mellitus-mFPG	[]	[]
ENSPHENO:0001593	Type II Diabetes Mellitus-tFPG	[]	[]
ENSPHENO:0001594	UCP3 POLYMORPHISM G/A	[MIM:602044.0001,MIM:602044.0001]	[UCP3.0001,UCP3.0001]
ENSPHENO:0001595	URIC ACID CONCENTRATION SERUM QUANTITATIVE TRAIT LOCUS 2	[MIM:606142.0001,MIM:606142.0001]	[SLC2A9.0001,SLC2A9.0001]
ENSPHENO:0001596	URIC ACID NEPHROLITHIASIS SUSCEPTIBILITY TO	[MIM:605990,MIM:607818.0001]	[NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO,ZNF365.0001]
ENSPHENO:0001597	USHER SYNDROME TYPE IB	[MIM:276903.0001,MIM:276903.0001]	[MYO7A.0001,MYO7A.0001]
ENSPHENO:0001598	USHER SYNDROME TYPE IC	[MIM:276904,MIM:276904]	[USHER SYNDROME, TYPE IC,USHER SYNDROME, TYPE IC]
ENSPHENO:0001599	USHER SYNDROME TYPE ID	[MIM:601067,MIM:601067]	[USHER SYNDROME, TYPE ID,USHER SYNDROME, TYPE ID]
ENSPHENO:0001600	USHER SYNDROME TYPE IG	[MIM:606943,MIM:606943]	[USHER SYNDROME, TYPE IG,USHER SYNDROME, TYPE IG]
ENSPHENO:0001601	USHER SYNDROME TYPE III	[MIM:276902,MIM:276902]	[USHER SYNDROME, TYPE III,USHER SYNDROME, TYPE III]
ENSPHENO:0001602	Ulcerative colitis	[DOID:8577,DOID:8577,HP:0100279,HP:0100279,SCTID_64766004,SCTID_64766004]	[ulcerative colitis,ulcerative colitis,Ulcerative colitis,Ulcerative colitis,Ulcerative colitis,Ulcerative colitis]
ENSPHENO:0001603	Upper aerodigestive tract cancers	[]	[]
ENSPHENO:0001604	Urinary albumin excretion	[]	[]
ENSPHENO:0001605	Urinary bladder cancer	[DOID:11054,DOID:11054]	[urinary bladder cancer,urinary bladder cancer]
ENSPHENO:0001606	Urinary metabolites	[]	[]
ENSPHENO:0001607	Usher syndrome type 2A	[]	[]
ENSPHENO:0001608	Uterine fibroids	[DOID:13223,HP:0000131]	[uterine fibroid,Uterine leiomyoma]
ENSPHENO:0001609	VENOUS MALFORMATIONS MULTIPLE CUTANEOUS AND MUCOSAL	[MIM:600195,MIM:600195]	[VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL,VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL]
ENSPHENO:0001610	VENTRICULAR FIBRILLATION PAROXYSMAL FAMILIAL 2	[MIM:612956,MIM:612956]	[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2,VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2]
ENSPHENO:0001611	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1	[MIM:612542,MIM:612542]	[VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1]
ENSPHENO:0001612	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1	[MIM:612957,MIM:612957]	[VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1,VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1]
ENSPHENO:0001613	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS TYPE 1A	[MIM:264700,MIM:264700]	[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A,VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A]
ENSPHENO:0001614	VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1	[MIM:608547,MIM:608547]	[VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1,VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1]
ENSPHENO:0001615	VLCAD DEFICIENCY	[MIM:609575.0001,MIM:609575.0001]	[ACADVL.0001,ACADVL.0001]
ENSPHENO:0001616	VOHWINKEL SYNDROME	[]	[]
ENSPHENO:0001617	VON HIPPEL-LINDAU SYNDROME	[DOID:14175,DOID:14175,MIM:193300,MIM:193300,SCTID_46659004,SCTID_46659004]	[von Hippel-Lindau disease,von Hippel-Lindau disease,VON HIPPEL-LINDAU SYNDROME,VON HIPPEL-LINDAU SYNDROME,Von Hippel-Lindau syndrome,Von Hippel-Lindau syndrome]
ENSPHENO:0001618	Vascular endothelial growth factor levels	[]	[]
ENSPHENO:0001619	Ventricular conduction	[]	[]
ENSPHENO:0001620	Vertical cup-disc ratio	[]	[]
ENSPHENO:0001621	Vitamin D levels	[]	[]
ENSPHENO:0001622	Vitelliform macular dystrophy type 2	[]	[]
ENSPHENO:0001623	Vitiligo	[DOID:12306,DOID:12306,HP:0001045,HP:0001045,MP:0010016,MP:0010016,MIM:193200,MIM:193200,SCTID_56727007,SCTID_56727007]	[vitiligo,vitiligo,Vitiligo,Vitiligo,variable depigmentation,variable depigmentation,VITILIGO,VITILIGO,Vitiligo,Vitiligo]
ENSPHENO:0001624	Volumetric brain MRI	[]	[]
ENSPHENO:0001625	Von Hippel-Lindau disease	[DOID:14175,DOID:14175,MIM:193300,MIM:193300,SCTID_46659004]	[von Hippel-Lindau disease,von Hippel-Lindau disease,VON HIPPEL-LINDAU SYNDROME,VON HIPPEL-LINDAU SYNDROME,Von Hippel-Lindau syndrome]
ENSPHENO:0001626	WAARDENBURG SYNDROME TYPE 1	[MIM:193500,MIM:193500]	[WAARDENBURG SYNDROME, TYPE 1,WAARDENBURG SYNDROME, TYPE 1]
ENSPHENO:0001627	WAARDENBURG SYNDROME TYPE 2E WITHOUT NEUROLOGIC INVOLVEMENT	[]	[]
ENSPHENO:0001628	WARFARIN RESISTANCE	[]	[]
ENSPHENO:0001629	WHITE SPONGE NEVUS	[DOID:0050448,DOID:0050448,MIM:193900,MIM:193900]	[hereditary mucosal leukokeratosis,hereditary mucosal leukokeratosis,WHITE SPONGE NEVUS,WHITE SPONGE NEVUS]
ENSPHENO:0001630	WOLFRAM SYNDROME 1	[MIM:222300,MIM:222300]	[WOLFRAM SYNDROME 1,WOLFRAM SYNDROME 1]
ENSPHENO:0001631	Waist circumference	[]	[]
ENSPHENO:0001632	Waist circumference and related phenotypes	[]	[]
ENSPHENO:0001633	Waist-hip ratio	[]	[]
ENSPHENO:0001634	Warfarin maintenance dose	[]	[]
ENSPHENO:0001635	Weight	[]	[]
ENSPHENO:0001636	Wet neovascular age-related macular degeneration (AMD)	[]	[]
ENSPHENO:0001637	White blood cell types	[]	[]
ENSPHENO:0001638	Wilson disease	[DOID:893,DOID:893,MIM:277900,MIM:277900,SCTID_88518009,SCTID_88518009]	[Wilson disease,Wilson disease,WILSON DISEASE,WILSON DISEASE,Wilson's disease,Wilson's disease]
ENSPHENO:0001639	Wolfram syndrome	[DOID:10632,DOID:10632,MIM:606201.0001,MIM:606201.0001]	[Wolfram syndrome,Wolfram syndrome,WFS1.0001,WFS1.0001]
ENSPHENO:0001640	Wrist bone mass	[]	[]
ENSPHENO:0001641	X-linked adrenal hypoplasia congenital	[SCTID_237764004,SCTID_237764004]	[Congenital adrenal hypoplasia, X-linked,Congenital adrenal hypoplasia, X-linked]
ENSPHENO:0001642	XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP A	[MIM:278700,MIM:278700]	[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A,XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A]
ENSPHENO:0001643	XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP C	[MIM:278720,MIM:278720]	[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C,XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C]
ENSPHENO:0001644	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	[]	[]
ENSPHENO:0001645	XERODERMA PIGMENTOSUM VARIANT TYPE	[MIM:278750,MIM:278750]	[XERODERMA PIGMENTOSUM, VARIANT TYPE,XERODERMA PIGMENTOSUM, VARIANT TYPE]
ENSPHENO:0001646	ZELLWEGER SYNDROME	[DOID:905,DOID:905,MIM:214100,MIM:214100,SCTID_88469006,SCTID_88469006]	[Zellweger syndrome,Zellweger syndrome,ZELLWEGER SYNDROME,ZELLWEGER SYNDROME,Zellweger syndrome,Zellweger syndrome]
ENSPHENO:0001647	phenotype_description	[]	[]
